C [ECS]

THE ENDOCANNABINOID SYSTEM 2010-2017

*Previous Articles/Studies 2000-2009

CBR ALLOSTERIC ACTIVATION (Compounds Work Through a “Back Door” Mechanism, Not The Usual Binding Site, Which Can Modify Their Effects)
CBR-CB1 CANNABINOID RECEPTOR* (Activated by THC, Anandamide, Synthetics, Activating CB1 Receptors in the Brain Causes the ‘High’)
CBR-CB1b CANNABINOID RECEPTOR (Slightly Different Isoform of a CB1 Receptor)
CBR-CB2 CANNABINOID RECEPTOR* (No ‘High’, Activated by THC, Anandamide, 2-AG, THC)
CB2A (Slightly Different Type of CB2 Receptor Found in Testes and Reward Center of Brain)
CBR-CBe* (Endothelial Cannabinoid Receptor)
CBR-GPR18 / CANNABINOID RECEPTOR* (Activated by Abnormal CBD, NAGly, O-1602, THC, Anandamide)
CBR-GPR35 / CXCR8
CBR-GPR40 / CANNABINOID RECEPTOR / FFAR1* (Activated by GW1100, TAK-875)
CBR-GPR55 / CB3 CANNABINOID RECEPTOR* (Activated by l-α-lysophosphatidylinositol [LPI] and to a lesser extent possibly by THC, CBD,O-1602, PEA, 2-AG, Anandamide, Virodhamine)
CBR-GPR109 / CANNABINOID RECEPTOR
CBR-GPR119 / CANNABINOID RECEPTOR* (Activated by PEA, OEA)
CBR-GPR135 CANNABINOID RECEPTOR
CBR-GPR137 CANNABINOID RECEPTOR
CBR-GPR158 / CANNABINOID RECEPTOR*
CBR – 5-HT1A (Activated by Cannabidiol)
CBR-NPR19 (G coupled receptor activated by Anandamide)
CBR-NPR32 (G coupled receptor activated by Anandamide)
CBR–PPARs (Mediate Some Effects of Cannabinoids, Works with CB1, CB2 and TRPV1 Receptors)
CBR-TRPV1 / TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 CHANNEL
CBR–TRPV2 / TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 2 CHANNEL
CRIP1a / CANNABINOID RECEPTOR INTERACTING PROTEIN 1a (Alters CB1R Interactions with their G-Proteins)


CBR ALLOSTERIC ACTIVATION
Parameterization of Org27569: An allosteric modulator of the cannabinoid CB(1) G protein-coupled receptor (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145811/
Allosteric modulator ORG27569 induces CB1 cannabinoid receptor high affinity agonist binding state, receptor internalization, and Gi protein-independent ERK1/2 kinase activation (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22343625
Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529012/
Lipoxin A4 is an allosteric endocannabinoid that strengthens anandamide-induced CB1 receptor activation (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529042/
A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460482/
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481297/
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794927/
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
Real-time characterisation of Cannabinoid Receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799602/
In-vivo pharmacological evaluation of the CB1-receptor allosteric modulator Org-27569 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4042670/
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING (full–2014) http://www.jbc.org/content/289/9/5828.full.pdf+html
Optimization of Chemical Functionalities of Indole-2-Carboxamides to Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203403/
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161648/
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186448/
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING (full–2014) http://www.jbc.org/content/289/9/5828.full.pdf+html
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 (abst–2014) http://www.nature.com/nature/journal/v513/n7516/full/nature13494.html
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015) http://www.nature.com/articles/srep15453 Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor (full–2015) http://molpharm.aspetjournals.org/content/early/2015/06/04/mol.115.099192.long
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864630/
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26218440
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621983/
Allosteric Modulators: A Side Door (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26645411 Allosteric Modulation of CB1 by Pregnenolone (abst–2015) http://www.fasebj.org/content/29/1_Supplement/LB60.abstract?sid=edf921ac-0690-4aa6-ac81-0546314dd384
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release (full-2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30509-8
Allosteric Modulation: An Alternate Approach Targeting the Cannabinoid CB1 Receptor (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27879006 Enantio-specific Allosteric Modulation of Cannabinoid 1 Receptor (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103441
top


CBR-CB1 CANNABINOID RECEPTOR
Endocannabinoid Overload (full–2010) http://molpharm.aspetjournals.org/content/78/6/993.full
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
Understanding Functional Residues of the Cannabinoid CB1 for Drug Discovery (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2980537/?tool=pubmed
Central and peripheral consequences of the chronic blockade of CB1 cannabinoid receptor with rimonabant or taranabant (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2009.06549.x/full
Anandamide suppresses pain initiation through a peripheral endocannabinoid mechanism (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3260554/?tool=pubmed
Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926165/
The Cannabinoid 1 Receptor (CNR1) 1359 G/A Polymorphism Modulates Susceptibility to Ulcerative Colitis and the Phenotype in Crohn’s Disease (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829088/?tool=pmcentrez
A common CNR1 (cannabinoid receptor 1) haplotype attenuates the decrease in HDL cholesterol that typically accompanies weight gain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3013130/?tool=pubmed
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice (full–2010) http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00132/full
Expression of cannabinoid CB1 receptors by vagal afferent neurons: kinetics and role in influencing neurochemical phenotype (full–2010) http://ajpgi.physiology.org/content/299/1/G63.full?sid=fc6948f0-78cf-405c-981b-afaa05ee417c
Potential role of the cannabinoid receptor CB in the pathogenesis of erosive and nonerosive gastro-oesophageal reflux disease (full-2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2010.04377.x/full
Cannabinoid–Dopamine Interaction in the Pathophysiology and Treatment of CNS Disorders (full–2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1755-5949.2010.00144.x/full
Voluntary Exercise and Sucrose Consumption Enhance Cannabinoid CB1 Receptor Sensitivity in the Striatum (full–2010) http://www.nature.com/npp/journal/v35/n2/full/npp2009141a.html
Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2878847/
Cannabinoid receptor CB1 mediates baseline and activity-induced survival of new neurons in adult hippocampal neurogenesis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2898685/?tool=pubmed
Enhanced endocannabinoid signaling elevates neuronal excitability in fragile X syndrome (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2906112/
Preservation of Striatal Cannabinoid CB1 Receptor Function Correlates with the Antianxiety Effects of Fatty Acid Amide Hydrolase Inhibition (full–2010) http://molpharm.aspetjournals.org/content/78/2/260.long
AAV vector-mediated overexpression of CB1 cannabinoid receptor in pyramidal neurons of the hippocampus protects against seizure-induced excitoxicity (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3006205/?tool=pubmed
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full–2010) http://www.karger.com/Article/Pdf/320527
Human sperm anatomy: ultrastructural localization of the cannabinoid1 receptor and a potential role of anandamide in sperm survival and acrosome reaction (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/ar.21042/full
Widespread Decrease of Type 1 Cannabinoid Receptor Availability in Huntington Disease In Vivo (full–2010) http://jnm.snmjournals.org/cgi/content/full/51/9/1413
JWH018, a common constituent of ‘Spice’ herbal blends, is a potent and efficacious cannabinoid CB(1) receptor agonist (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931559/?tool=pubmed
top
Attenuation of morphine antinociceptive tolerance by a CB(1) receptor agonist and an NMDA receptor antagonist: Interactive effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2813317/?tool=pubmed
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?tool=pubmed
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/?tool=pubmed
Endocannabinoid involvement in endometriosis. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2972363/
Regulatory Role of Cannabinoid Receptor 1 in Stress-Induced Excitotoxicity and Neuroinflammation (full–2010) http://www.nature.com/npp/journal/vaop/ncurrent/full/npp2010214a.html
Loss of cannabinoid CB1 receptor expression in the 6-hydroxydopamine-induced nigrostriatal terminal lesion model of Parkinson’s disease in the rat (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659808/
Dynamic changes of CB1-receptor expression in hippocampi of epileptic mice and humans (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2909018/
Inhibitor of fatty acid amide hydrolase normalizes cardiovascular function in hypertension without adverse metabolic effects (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3003779/
The Neuroprotective Effect of Cannabinoid Receptor Agonist (WIN55,212-2) in Paraoxon Induced Neurotoxicity in PC12 Cells and N-methyl-D-aspartate Receptor Interaction (full–2010) http://celljournal.org/library/upload/article/af_4334422Hashemi.pdf
Architecture of cannabinoid signaling in mouse retina. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982216/
Energetic Metabolism and Human Sperm Motility: Impact of CB1 Receptor Activation (full–2010) http://endo.endojournals.org/content/151/12/5882.full
Perspectives of CB1 Antagonist in Treatment of Obesity: Experience of RIO-Asia (full–2010) http://www.hindawi.com/journals/jobes/2011/957268/
The Peptide Hemopressin Acts through CB1 Cannabinoid Receptors to Reduce Food Intake in Rats and Mice (full–2010) http://www.jneurosci.org/content/30/21/7369.full
Characterization of the Endocannabinoid System in Human Spermatozoa and Involvement of Transient Receptor Potential Vanilloid 1 Receptor in Their Fertilizing Ability (full–2010) http://endo.endojournals.org/content/150/10/4692.full?sid=f5b14012-9fbe-4f10-890c-386313060cf8
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full–2010) http://jpet.aspetjournals.org/content/334/3/973.long
Endocannabinoid control of gastric sensorimotor function in man. (full – 2010) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2010.04259.x/full
Inhibition of 3-hydroxy-3-methylglutaryl-coenzyme A reductase activity and of Ras farnesylation mediate antitumor effects of anandamide in human breast cancer cells. (full – 2010) http://erc.endocrinology-journals.org/content/17/2/495.long
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806825/?tool=pubmed
Delta9-tetrahydrocannabinol is a full agonist at CB1 receptors on GABA neuron axon terminals in the hippocampus (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2882293/pdf/nihms200194.pdf
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors. (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/
Polymorphisms in the endocannabinoid receptor 1 in relation to fat mass distribution (full–2010) http://www.eje-online.org/content/163/3/407.full
Pharmacological exploitation of the endocannabinoid system: new perspectives for the treatment of depression and anxiety disorders? (full–2010) http://www.scielo.br/pdf/rbp/v32s1/en_a04v32s1.pdf
Oleamide administered into the nucleus accumbens shell regulates feeding behaviour via CB1 and 5-HT2C receptors (full–2010) http://ijnp.oxfordjournals.org/content/13/9/1247.long
A clinical trial assessing the safety and efficacy of the CB1R inverse agonist taranabant in obese and overweight patients: low-dose study (full–2010) http://www.nature.com/ijo/journal/v34/n5/full/ijo201021a.html
Inactivation of the cannabinoid receptor CB1 prevents leukocyte infiltration and experimental fibrosis (full–2010) http://onlinelibrary.wiley.com/doi/10.1002/art.27642/full
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/
Novel 1′,1′-Chain Substituted Hexahydrocannabinols: 9β-Hydroxy-3-(1-hexyl-cyclobut- 1-yl)-hexahydrocannabinol (AM2389) a Highly Potent Cannabinoid Receptor 1 (CB1) Agonist (full – 2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650853/ Endocannabinoids selectively enhance sweet taste (full–2010) http://www.pnas.org/content/107/2/935.long
NSAIDs, Opioids, Cannabinoids and the Control of Pain by the Central Nervous System. (full – 2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4033984/
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/
Mechanisms of Broad-Spectrum Antiemetic Efficacy of Cannabinoids against Chemotherapy-Induced Acute and Delayed Vomiting (link to PDF–2010) http://www.mdpi.com/1424-8247/3/9/2930
G1359A polymorphism of the cannabinoid receptor gene (CNR1) and clinical results of biliopancreatic diversion (link to PDF–2010) http://www.europeanreview.org/article/724
Endocannabinoids and Human Sperm Cells (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3200
Endocannabinoids and Schizophrenia (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3101
Tocolytic Effect of Δ9-Tetrahydrocannabinol in Mice Model of Lipopolysaccharide— Induced Preterm Delivery: Role of Nitric Oxide (link to download-2010) http://journals.sagepub.com/doi/abs/10.1177/1933719109358456
A model of endocannabinoid 2-AG-mediated depolarization-induced suppression of inhibition (article–2010) http://www.biomedcentral.com/1471-2202/11/S1/P189
Genes differentially expressed in CB1 knockout mice: involvement in the depressive-like phenotype (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20692131
Altered expression of cannabinoid receptors 1 and 2 and activated endocannabinoid system in patients with severe chronic heart failure (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1246924
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities (abst–2010) http://www.sciencedirect.com/science/article/pii/S0006295210001553
In vivo type 1 cannabinoid receptor mapping in the 6-hydroxydopamine lesion rat model of Parkinson’s disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20026090
Involvement of ERK 1/2 activation in electroacupuncture pretreatment via cannabinoid CB1 receptor in rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20654595
Effects of caffeine on striatal neurotransmission: focus on cannabinoid CB1 receptors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20087854
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
Expression of cannabinoid receptors in human kidney (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20607655
Abnormal sensitivity of cannabinoid CB1 receptors in the striatum of mice with experimental amyotrophic lateral sclerosis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19452308
A common variation in the cannabinoid 1 receptor (CNR1) gene is associated with preeclampsia in the Central European population (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21129839
Binding of the hemopressin peptide to the cannabinoid CB1 receptor: structural insights (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21062041
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with metabolic syndrome in the Chinese Han population (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20851297
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931541
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19147270
Expression of cannabinoid receptor I during mice skin incised wound healing course (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20967946
CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20621164
CB1 receptor deficiency decreases wheel-running activity: consequences on emotional behaviours and hippocampal neurogenesis (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20138171
Bimodal control of stimulated food intake by the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20139974
AM 251 differentially effects food-maintained responding depending on food palatability (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20331999
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19733001
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20369362
Endocannabinoid (EC) Receptor, CB1, and EC Enzymes’ Expression in Primary Adipocyte Cultures of Lean and Obese Pre-pubertal Children in Relation to Adiponectin and Insulin (abst–2010) http://www.degruyter.com/abstract/j/jpem.2010.23.issue-10/jpem.2010.162/jpem.2010.162.xml?rskey=38kdx0&result=22&q=cannabinoid
Endocannabinoids and voluntary activity in mice: runner’s high and long-term consequences in emotional behaviors (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20353785
Cannabinoid receptor CB1-immunoreactive nerve fibres in painful and non-painful human tooth pulp (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20705472 Cannabinoid receptor type 1 expression modulates alcohol-induced liver fibrosis: Role of Acetaldehyde (abst – 2010) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0029-1246364
An endocannabinoid system is localized to the hypophysial pars tuberalis of Syrian hamsters and responds to photoperiodic changes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20165884
Novel natural and synthetic ligands of the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20166928
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/?tool=pubmed
Endocannabinoids and traumatic brain injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165950/?tool=pubmed
Increased Expression of Cannabinoid CB(1) Receptors in Achilles Tendinosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3169627/?tool=pubmed
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711000128
Local activation of cannabinoid CB1 receptors in the urinary bladder reduces the inflammation-induced sensitization of bladder afferents (full–2011) http://www.molecularpain.com/content/pdf/1744-8069-7-31.pdf
Cannabinoid CB1 receptor antagonists modulate transport activity of multidrug resistance-associated proteins MRP1, MRP2, MRP3, and MRP4 (full–2011) http://dmd.aspetjournals.org/content/early/2011/04/21/dmd.110.037812.full.pdf+html?maxtoshow=&hits=80&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=80&sortspec=date&resourcetype=HWCIT
Cannabinoid receptor signalling in neurodegenerative diseases: a potential role for membrane fluidity disturbance (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165948/
CP47,497-C8 and JWH073, commonly found in ‘Spice’ herbal blends, are potent and efficacious CB(1) cannabinoid receptor agonists (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3094488/
Anandamide inhibits Theiler’s virus induced VCAM-1 in brain endothelial cells and reduces leukocyte transmigration in a model of blood brain barrier by activation of CB1 receptors (full–2011) http://www.jneuroinflammation.com/content/pdf/1742-2094-8-102.pdf
Parameterization of Org27569: An allosteric modulator of the cannabinoid CB(1) G protein-coupled receptor (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145811/
Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678284/
Regulation of hippocampal cannabinoid CB1 receptor actions by adenosine A1 receptors and chronic caffeine administration: implications for the effects of Δ9- tetrahydrocannabinol on spatial memory. (full – 2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055664/
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01444.x/full
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
Central mediation and differential blockade by cannabinergics of the discriminative stimulus effects of the cannabinoid CB1 receptor antagonist rimonabant in rats (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3727221/
Effect of rimonabant on oesophageal motor function in man (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2036.2011.04576.x/full
Endocannabinoid system in cardiovascular disorders – new pharmacotherapeutic opportunities (full–2011) http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha
Disruption of metabotropic glutamate receptor signalling is a major defect at cerebellar parallel fibre-Purkinje cell synapses in staggerer mutant mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3145934/
Variation in the human Cannabinoid Receptor (CNR1) gene modulates gaze duration for happy faces (full–2011) http://www.molecularautism.com/content/pdf/2040-2392-2-10.pdf
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Differential signaling in human cannabinoid CB(1) receptors and their splice variants in autaptic hippocampal neurons (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01744.x/pdf
A Pilot Study into the Effects of the CB1 Cannabinoid Receptor Agonist WIN55,212-2 or the Antagonist/Inverse Agonist AM251 on Sleep in Rats (full–2011) http://www.hindawi.com/journals/sd/2011/178469/
Hyperactivation of anandamide synthesis and regulation of cell-cycle progression via cannabinoid type 1 (CB1) receptors in the regenerating liver (full–2011) http://www.pnas.org/content/108/15/6323.full
Cannabinoid and GABA modulation of sympathetic nerve activity and blood pressure in the dorsal periaqueductal gray of the rat (full–2011) http://ajpregu.physiology.org/content/301/6/R1765.full
Molecular reorganization of endocannabinoid signalling in Alzheimer’s disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069704/pdf/awr046.pdf
Intracellular Cannabinoid Type 1 (CB1) Receptors Are Activated by Anandamide (full–2011) http://www.jbc.org/content/286/33/29166.full
Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington’s disease (full–2011) http://brain.oxfordjournals.org/content/134/1/119.long
Redistribution of CB1 Cannabinoid Receptors in the Acute and Chronic Phases of Pilocarpine-Induced Epilepsy (full–2011) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0027196
Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2010.07041.x/full
Cannabinoid exposure during zebra finch sensorimotor vocal learning persistently alters expression of endocannabinoid signaling elements and acute agonist responsiveness (full–2011) http://www.biomedcentral.com/1471-2202/12/3
Genetic deletion of monoacylglycerol lipase alters endocannabinoid-mediated retrograde synaptic depression in the cerebellum (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3224879/
Adipose tissue endocannabinoid system gene expression: depot differences and effects of diet and exercise (full–2011) http://www.lipidworld.com/content/10/1/194
Endocannabinoid tone versus constitutive activity of cannabinoid receptors (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01364.x/full
Comparison of Cannabinoid CB1 Receptor Binding in Adolescent and Adult Rats: A Positron Emission Tomography Study Using [18F]MK-9470 (full–2011) http://www.hindawi.com/journals/ijmi/2011/548123/
Cannabinoid Receptor Type 1 Protects Nigrostriatal Dopaminergic Neurons against MPTP Neurotoxicity by Inhibiting Microglial Activation (full–2011) http://www.jimmunol.org/content/187/12/6508.full?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01519.x/full
Genetic and pharmacological inactivation of cannabinoid CB1 receptor inhibits angiogenesis (full–2011) http://bloodjournal.hematologylibrary.org/content/117/20/5541.long
The central cannabinoid CB1 receptor is required for diet-induced obesity and rimonabant’s antiobesity effects in mice (full–2011) http://onlinelibrary.wiley.com/doi/10.1038/oby.2011.250/full
Chronic Δ⁹-tetrahydrocannabinol treatment in rhesus monkeys: differential tolerance and cross-tolerance among cannabinoids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051379/pdf/bph0162-1060.pdf
ENDOGENOUS CANNABINOID SYSTEM REGULATES INTESTINAL BARRIER FUNCTION IN VIVO THROUGH CANNABINOID TYPE 1 RECEPTOR ACTIVATION (full–2011) http://ajpgi.physiology.org/content/early/2011/11/28/ajpgi.00158.2011.full-text.pdf+html
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
Cannabinoid receptor-mediated regulation of neuronal activity in the main olfactory bulb (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397690/
Cannabinomimetic lipid from a marine cyanobacterium (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325759/
Sexually dimorphic effects of cannabinoid compounds on emotion and cognition (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181427/pdf/fnbeh-05-00064.pdf
Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ9-Tetrahydrocannabinol and CP55,940 in the Rat (full–2011) http://jpet.aspetjournals.org/content/340/3/787.full
Effects of Chronic Oral Rimonabant Administration on Energy Budgets of Diet-Induced Obese C57BL/6 Mice (full–2011) http://www.ncbi.nlm.nih.gov/pubmed/22173576
Altered endocannabinoid signalling after a high-fat diet in Apoe(-/-) mice: relevance to adipose tissue inflammation, hepatic steatosis and insulin resistance. (full – 2011) http://link.springer.com/article/10.1007/s00125-011-2274-6/fulltext.html
Activation of spinal and supraspinal cannabinoid-1 receptors leads to antinociception in a rat model of neuropathic spinal cord injury pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3159760/
Cannabinoid type 1 receptor mediates depot-specific effects on differentiation, inflammation and oxidative metabolism in inguinal and epididymal white adipocytes (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3303536/
The cannabinoid type-1 receptor carboxyl-terminus, more than just a tail (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3055937/pdf/nihms267227.pdf
Cannabinoid receptor 1 gene polymorphisms and marijuana misuse interactions on white matter and cognitive deficits in schizophrenia (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3085576/
CB1 receptors mediate rimonabant-induced pruritic responses in mice: investigation of locus of action (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3606913/
In vivo activation of endocannabinoid system in temporal lobe epilepsy with hippocampal sclerosis (full–2011) http://brain.oxfordjournals.org/content/134/4/1033.long
The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3156975/
Indirect Sympatholytic Actions at β-Adrenoceptors Account for the Ocular Hypotensive Actions of Cannabinoid Receptor Agonists (full–2011) http://jpet.aspetjournals.org/content/339/3/757.full.pdf+html
Bioactivation Pathways of the Cannabinoid Receptor 1 Antagonist Rimonabant (full–2011) http://dmd.aspetjournals.org/content/39/10/1823.long
PAX3-FOXO1 induces cannabinoid receptor 1 to enhance cell invasion and metastasis (full–2011) http://cancerres.aacrjournals.org/content/71/24/7471.long
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
Type I cannabinoid receptor trafficking: all roads lead to lysosome (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1600-0854.2010.01130.x/full
The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141881/
Expression of the cannabinoid system in muscle: effects of a high fat diet and CB1 receptor blockade (full–2011) http://www.biochemj.org/content/433/1/175
Regulation of nausea and vomiting by cannabinoids (full-2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165951/
Anxiolytic-like effect induced by the cannabinoid CB1 receptor agonist, arachydonilcyclopropylamide (ACPA), in the rat amygdala is mediated through the D1 and D2 dopaminergic systems (full–2011) http://journals.sagepub.com/doi/full/10.1177/0269881110376688
Investigations of the human endocannabinoid system in two subcutaneous adipose tissue depots in lean subjects and in obese subjects before and after weight loss (full–2011) http://www.nature.com/ijo/journal/v35/n11/full/ijo20118a.html
Alterations in Corticolimbic Dendritic Morphology and Emotional Behavior in Cannabinoid CB1 Receptor–Deficient Mice Parallel the Effects of Chronic Stress (full-2011) http://cercor.oxfordjournals.org/content/21/9/2056.full
The Endocannabinoid System as Pharmacological Target Derived from Its CNS Role in Energy Homeostasis and Reward. Applications in Eating Disorders and Addiction (link to PDF-2011) http://www.mdpi.com/1424-8247/4/8/1101
Association between lipid accumulation and the cannabinoid system in Huh7 cells expressing HCV genes (link to PDF–2011) http://www.spandidos-publications.com/ijmm/27/5/619
The role of the cannabinoid system in the pathogenesis and treatment of alcohol dependence (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21934185
Biosynthesis and degradation of the endocannabinoid 2-arachidonoylglycerol (abst–2011) http://onlinelibrary.wiley.com/doi/10.1002/biof.131/abstract
Possible involvement of the endocannabinoid system in memory modulation effect of general anesthetics (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21555187/abstract/Possible_involvement_of_the_endocannabinoid_system_in_memory_modulation_effect_of_general_anesthetics_
Role of endocannabinoid and glutamatergic systems in DOI-induced head-twitch response in mice (abst–2011) http://www.sciencedirect.com/science/article/pii/S0091305711001067
Cannabidiol as an anti-arrhythmic, the role of the CB1 receptors (abst–2011) http://heart.bmj.com/content/97/24/e8.9.abstract
The role of cannabinoid receptors and the endocannabinoid system in mantle cell lymphoma and other non-Hodgkin lymphomas (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22024769
Regional changes in type 1 cannabinoid receptor availability in Parkinson’s disease in vivo (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21459482/abstract/Regional_changes_in_type_1_cannabinoid_receptor_availability_in_Parkinson%27s_disease_in_vivo_
Effects of cannabinoid CB(1) receptor agonism and antagonism on SKF81297-induced dyskinesia and haloperidol-induced dystonia in Cebus apella monkeys (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21029743
Neuropathology of sporadic Parkinson disease before the appearance of parkinsonism: preclinical Parkinson disease. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/20862500
Early onset of aging-like changes is restricted to cognitive abilities and skin structure in Cnr1(-/-) mice (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20724033
Effects of repeated electroacupuncture on gene expression of cannabinoid receptor-1 and dopamine 1 receptor in nucleus accumbens-caudate nucleus region in inflammatory-pain rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21585053
The G protein-coupled cannabinoid-1 (CB(1)) receptor of mammalian brain: Inhibition by phthalate esters in vitro (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21763743
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
The antinociceptive potency of N-arachidonoyl-dopamine (NADA) and its interaction with endomorphin-1 at the spinal level (abst–2011) http://www.sciencedirect.com/science/article/pii/S0091305711001626
Residual effects of focal brain ischaemia upon cannabinoid CB(1) receptor density and functionality in female rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21145311
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
Alkamides and a neolignan from Echinacea purpurea roots and the interaction of alkamides with G-protein-coupled cannabinoid receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21764086
Brain Type 1 Cannabinoid Receptor Availability in Patients with Anorexia and Bulimia Nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21718968
Personalized medicine can pave the way for the safe use of CB₁ receptor antagonists (abst–2011) http://www.cell.com/trends/pharmacological-sciences/abstract/S0165-6147(11)00035-6 Plasticity in vagal afferent neurones during feeding and fasting: mechanisms and significance (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21062423
Increment of hypothalamic 2-arachidonoylglycerol induces the preference for a high-fat diet via activation of cannabinoid 1 receptors (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/20817042/abstract/Increment_of_hypothalamic_2_arachidonoylglycerol_induces_the_preference_for_a_high_fat_diet_via_activation_of_cannabinoid_1_receptors_
2-Arachidonoylglycerol (2-AG) Induces Corneal Epithelial Cell Migration via Cannabinoid CB1 Receptors (abst–2011) http://iovs.arvojournals.org/article.aspx?articleid=2352973&resultClick=1
Targetting CB1 Cannabinoid Receptor for Neuroprotetion in Spinal Cord Injury (abst–2011) http://www.fasebj.org/content/25/1_Supplement/lb422.abstract?sid=ebd6611b-9cd5-451c-8d4ca78d4d17cca1
Intact cannabinoid CB1 receptors in the Alzheimer’s disease cortex (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21034788
Endocannabinoid CB1 receptors modulate visual output from the thalamus (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21773721
Cannabinoids and emotionality: a neuroanatomical perspective (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21827834
Loss of striatal cannabinoid CB1 receptor function in attention-deficit / hyperactivity disorder mice with point-mutation of the dopamine transporter (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22034972
α-Tocopherol and α-tocopheryl phosphate interact with the cannabinoid system in the rodent hippocampus (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21843633
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells (abst–2011) http://eprints.hud.ac.uk/16197/
Fatty acid amide hydrolase expression during retinal postnatal development in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21867744
Interictal Type 1 Cannabinoid Receptor Binding is Increased in Female Migraine Patients (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22077199
The endocannabinoid system in the cancer therapy: an overview (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21428888
Inhibition of basal and ultraviolet B-induced melanogenesis by cannabinoid CB(1) receptors: a keratinocyte-dependent effect (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21298280
Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts (abst–2011)http://www.ncbi.nlm.nih.gov/pubmed/21575494
Impaired hippocampal glucoregulation in the cannabinoid CB(1) receptor knockout mice as revealed by an optimized in vitro experimental approach (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22155442
The Effect of Hypoxia on G Protein Coupled (CB1) Receptor Gene Expression in Cortical B50 Neurons in Culture (abst–2011) http://www.maxwellsci.com/jp/abstract.php?jid=BJPT&no=92&abs=05
CB1 cannabinoid receptor mediates glucocorticoid effects on hormone secretion induced by volume and osmotic changes (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22211674
Endogenously generated 2-arachidonoylglycerol plays an inhibitory role in bombesin induced activation of central adrenomedullary outflow in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21371452
Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21513772/abstract/Association_between_a_cannabinoid_receptor_gene__CNR1__polymorphism_and_cannabinoid_induced_alterations_of_the_auditory_event_related_P300_potential_
Unbalance of CB1 receptors expressed in GABAergic and glutamatergic neurons in a transgenic mouse model of Huntington’s disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22207189
Resorcinol-sn-Glycerol Derivatives: Novel 2-Arachidonoylglycerol Mimetics Endowed with High Affinity and Selectivity for Cannabinoid Type 1 Receptor (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22044209
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with coronary artery disease in the Chinese Han population (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22029183
Nonopioid placebo analgesia is mediated by CB1 cannabinoid receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21963514
A role for the ventral hippocampal endocannabinoid system in fear-conditioned analgesia and fear responding in the presence of nociceptive tone in rats (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21864979
Comparison Of Rat And Human Eyes For The Presence And Distribution Of Cb1 And Cb2 Receptors (abst – 2011) http://iovs.arvojournals.org/article.aspx?articleid=2357116&resultClick=1
Localization of Cannabinoid-Related Proteins in the Murine Anterior Eye (abst–2011) http://iovs.arvojournals.org/article.aspx?articleid=2356236&resultClick=1
2-Arachidonoylglycerol (2-AG) Induces Corneal Epithelial Cell Migration via Cannabinoid CB1 Receptors (abst–2011) http://iovs.arvojournals.org/article.aspx? articleid=2352973&resultClick=1 Tak1
Interactions With TRPV1 and CB1 Control IL-6 and IL-8 Release in Human Corneal Epithelial Cells (abst–2011) http://iovs.arvojournals.org/article.aspx? articleid=2349956&resultClick=1
CB1 Activation Reduces TRPV1-induced Responses in Human Corneal Epithelial Cells (abst–2011) http://iovs.arvojournals.org/article.aspx?articleid=2353114&resultClick=1
Increased vulnerability to 6-hydroxydopamine lesion and reduced development of dyskinesias in mice lacking CB1 cannabinoid receptors (abst–2011) http://europepmc.org/abstract/med/19419794
Expression of cannabinoid receptors by human articular chondrocytes (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900386-3/abstract
Intermittent ethanol consumption depresses endocannabinoid-signaling in the dorsolateral striatum of rat (abst–2011) http://www.sciencedirect.com/science/article/pii/S0028390811000177
Screening of selected Asian spices for anti obesity-related bioactivities (abst–2011) http://www.sciencedirect.com/science/article/pii/S0308814610016870
Cannabinoid receptors: nomenclature and pharmacological principles (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378782/
The dynamic nature of type 1 cannabinoid receptor (CB1) gene transcription (full-2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02175.x/full
Pathological plasticity in fragile X syndrome (full–2012) http://www.hindawi.com/journals/np/2012/275630/
Synaptic Targets of Δ9-Tetrahydrocannabinol in the Central Nervous System (full–2012) http://perspectivesinmedicine.cshlp.org/content/early/2012/12/03/cshperspect.a012237.long
Epileptiform activity in the CA1 region of the hippocampus becomes refractory to attenuation by cannabinoids in part because of endogenous γ-aminobutyric acid type B receptor activity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3350599/
Cannabinoid modulation of noradrenergic circuits: Implications for psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3351574/
Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2- arachidonoyl glycerol attenuates nausea in rats. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423233/
Upregulation of cannabinoid type 1 receptors in dopamine D2 receptor knockout mice is reversed by chronic forced ethanol consumption (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004984/?tool=pubmed
Mechanistic and Pharmacological Characterization of PF-04457845: A Highly Potent and Selective Fatty Acid Amide Hydrolase Inhibitor That Reduces Inflammatory and Noninflammatory Pain (full–2012) http://jpet.aspetjournals.org/content/338/1/114.full
Cannabinoids and atherosclerotic coronary heart disease (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf
Cannabinoid Receptor Type 1 (CB1) Activation Inhibits Small GTPase RhoA Activity and Regulates Motility of Prostate Carcinoma Cells (full–2012) http://endo.endojournals.org/content/153/1/29.full
Excess of the endocannabinoid anandamide during lactation induces overweight, fat accumulation and insulin resistance in adult mice (full–2012) http://www.dmsjournal.com/content/4/1/35
Angiotensin II induces vascular endocannabinoid release, which attenuates its vasoconstrictor effect via CB1 cannabinoid receptors (full–2012) http://www.jbc.org/content/early/2012/07/11/jbc.M112.346296.full.pdf+html
Allosteric modulator ORG27569 induces a CB1 Cannabinoid receptor high affinity agonist binding state, receptor internalization and Gi-independent ERK1/2 activation. (full – 2012) http://www.jbc.org/content/early/2012/02/16/jbc.M111.316463.long
Acetaminophen differentially enhances social behavior and cortical cannabinoid levels in inbred mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3389197/
Reduced alcohol intake and reward associated with impaired endocannabinoid signaling in mice with a deletion of the glutamate transporter GLAST (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372600/
Resistance to diet-induced adiposity in cannabinoid receptor-1 deficient mice is not due to impaired adipocyte function (full–2012) http://www.nutritionandmetabolism.com/content/pdf/1743-7075-8-93.pdf
Cannabinoids Facilitate the Swallowing Reflex Elicited by the Superior Laryngeal Nerve Stimulation in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507745/
Anti-inflammatory lipoxin A4 is an endogenous allosteric enhancer of CB1 cannabinoid receptor (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529012/
Homology modelling of CB1 receptor and selection of potential inhibitor against Obesity (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22829723?dopt=Abstract
Cannabinoid Receptor 1 (CNR1) 4895 C/T Genetic Polymorphism was Associated with Obesity in Japanese Men (full–2012) https://www.jstage.jst.go.jp/article/jat/19/8/19_12732/_pdf
A polymorphism in the gene of the endocannabinoid-degrading enzyme FAAH (FAAH C385A) is associated with emotional–motivational reactivity (full–2012) http://link.springer.com/article/10.1007/s00213-012-2785-y/fulltext.html
Differences in the endocannabinoid system of sperm from fertile and infertile men (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047704
Deficiency of type 1 cannabinoid receptors worsens acute heart failure induced by pressure overload in mice (full–2012) http://eurheartj.oxfordjournals.org/content/33/24/3124.full
Cannabinoids prevent the development of behavioral and endocrine alterations in a rat model of intense stress (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242307/
Δ9-Tetrahydrocannabinol attenuates MDMA-induced hyperthermia in rhesus monkeys (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3258357/
Autocrine Endocannabinoid Signaling Through CB1 Receptors Potentiates OX1 Orexin Receptor Signaling (full–2012) http://molpharm.aspetjournals.org/content/early/2012/12/11/mol.112.080523.long
To Be or Not To Be—Obese (full–2012) http://endo.endojournals.org/content/152/10/3592.long
Relationships between glucose, energy intake and dietary composition in obese adults with type 2 diabetes receiving the cannabinoid 1 (CB1) receptor antagonist, rimonabant (full–2012) http://www.nutritionj.com/content/11/1/50
Role of CB1 cannabinoid receptors on GABAergic neurons in brain aging (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3131310/?tool=pubmed
An amyloid β42-dependent deficit in anandamide mobilization is associated with cognitive dysfunction in Alzheimer’s disease. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154439/
Loss of CB1 receptors leads to differential age-related changes in reward-driven learning and memory (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3514639/
A Role for the Cannabinoid 1 Receptor in Neuronal Differentiation of Adult Spinal Cord Progenitors in vitro is Revealed through Pharmacological Inhibition and Genetic Deletion (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3265030/?tool=pubmed
Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor (full–2012) http://www.jbc.org/content/early/2012/03/19/jbc.M111.314880.full.pdf+html
Contribution of Hypothermia and CB(1) Receptor Activation to Protective Effects of TAK-937, a Cannabinoid Receptor Agonist, in Rat Transient MCAO Model (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3397930/?tool=pubmed
Cannabinoid type-1 receptor reduces pain and neurotoxicity produced by chemotherapy (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3366638/
Dimerization with Cannabinoid Receptors Allosterically Modulates Delta Opioid Receptor Activity during Neuropathic Pain (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0049789
Type-1 Cannabinoid Receptor Signaling in Neuronal Development (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000339075&typ=pdf
Endocannabinoids via CB₁ receptors act as neurogenic niche cues during cortical development (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3229.long
Differences in Spontaneously Avoiding or Approaching Mice Reflect Differences in CB1-Mediated Signaling of Dorsal Striatal Transmission (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033260
Neonatal DSP-4 Treatment Modifies Antinociceptive Effects of the CB(1) Receptor Agonist Methanandamide in Adult Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526738/
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
Role of cannabinoids in the regulation of bone remodeling (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55 (full–2012) http://www.jbc.org/content/early/2012/11/16/jbc.M112.364109.long
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions (full–2012) http://maxwellsci.com/print/bjpt/v3-76-88.pdf
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full – 2012) http://www.jneuroinflammation.com/content/9/1/79
Cannabinoid receptor-mediated regulation of neuronal activity and signaling in glomeruli of the main olfactory bulb (full–2012) http://www.jneurosci.org/content/32/25/8475.long
Spinal administration of the monoacylglycerol lipase inhibitor JZL184 produces robust inhibitory effects on nociceptive processing and the development of central sensitization in the rat (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02179.x/full
Probing the Interaction of SR141716A with the CB1 Receptor (full–2012) http://www.jbc.org/content/287/46/38741.full.pdf+html
Neuron to Astrocyte Communication via Cannabinoid Receptors Is Necessary for Sustained Epileptiform Activity in Rat Hippocampus (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0037320
The effects of peptide and lipid endocannabinoids on arthritic pain at the spinal level (full–2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/The_Effects_of_Peptide_and_Lipid_Endocannabinoids.30.aspx
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Interleukin-1β causes anxiety by interacting with the endocannabinoid system (full–2012) http://www.jneurosci.org/content/32/40/13896.long
2-Arachidonoylglycerol Signaling in Forebrain Regulates Systemic Energy Metabolism (full–2012) http://ac.els-cdn.com/S1550413112000526/1-s2.0-S1550413112000526-main.pdf?_tid=186a88ec-7369-11e3-8095-00000aab0f02&acdnat=1388638277_735058a6f79f41a9199132aed604fdab
CNR1 genotype influences HDL-cholesterol response to change in dietary fat intake (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342253/
The CB(2)-preferring agonist JWH015 also potently and efficaciously activates CB(1) in autaptic hippocampal neurons (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601544/
Lipoxin A4 is an allosteric endocannabinoid that strengthens anandamide-induced CB1 receptor activation (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3529042/
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22553354
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3254.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Cellular and intracellular mechanisms involved in the cognitive impairment of cannabinoids (full-2012) http://rstb.royalsocietypublishing.org/content/367/1607/3254.full? sid=1569c370-cd5c-4358-89ff-857201f5e069
Review article: Why do cannabinoid receptors have more than one endogenous ligand? (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3216.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Identification and quantification of a new family of peptide endocannabinoids (Pepcans) showing negative allosteric modulation at CB1 receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481297/
Cannabinoid Receptor Antagonist-Induced Striated Muscle Toxicity and Ethylmalonic-Adipic Aciduria in Beagle Dogs (full–2012) http://toxsci.oxfordjournals.org/content/129/2/268.full
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372737/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Cannabinoid receptor expression at the MNTB-LSO synapse in developing rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3406926/
JWH-018 and JWH-073: {Delta}9-Tetrahydrocannabinol-Like Discriminative Stimulus Effects in Monkeys (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251026/pdf/zpt37.pdf
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936256/
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Neural Circuit in the Dorsal Raphe Nucleus Responsible for Cannabinoid-Mediated Increases in 5-HT Efflux in the Nucleus Accumbens of the Rat Brain (full–2012) http://www.hindawi.com/isrn/pharmacology/2012/276902/
The effects of fasting duration on gastric emptying in man, an exploration of the role of the endocannabinoid system and inter-individual responsiveness (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2012.01954.x/full
Localization of mGluR5, GABA(B) , GABA(A) , and cannabinoid receptors on the vagovagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01868.x/full
Irritable Bowel Syndrome: Methods, Mechanisms, and Pathophysiology. Genetic epidemiology and pharmacogenetics in irritable bowel syndrome (full–2012) http://ajpgi.physiology.org/content/302/10/G1075
Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes (full–2012) http://press.endocrine.org/doi/full/10.1210/jc.2012-1780
Brain regional differences in CB1 receptor adaptation and regulation of transcription (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3772765/
Downregulation of cannabinoid receptor 1 from neuropeptide Y interneurons in the basal ganglia of patients with Huntington’s disease and mouse models (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699342/
The CB1 Cannabinoid Receptor Drives Corticospinal Motor Neuron Differentiation through the Ctip2/Satb2 Transcriptional Regulation Axis (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545190/
Hypothalamic CB1 Cannabinoid Receptors Regulate Energy Balance in Mice (full–2012) http://press.endocrine.org/doi/full/10.1210/en.2012-1405
Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607947/
Bimodal Control of Fear-Coping Strategies by CB1 Cannabinoid Receptors (full–2012) http://www.jneurosci.org/content/32/21/7109.long
Cannabinoid Type 1 Receptor Gene Polymorphism and Macronutrient Intake (full–2012) http://www.karger.com/Article/FullText/343563
Marine Cyanobacterial Fatty Acid Amides Acting on Cannabinoid Receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3748600/
top
Failure to extinguish fear and genetic variability in the human cannabinoid receptor 1 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3565211/
Endocannabinoid signaling in female reproduction (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382454/
On Disruption of Fear Memory by Reconsolidation Blockade: Evidence from Cannabidiol Treatment (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3398715/
Medial prefrontal cortex endocannabinoid system modulates baroreflex activity through CB1 receptors (full–2012) http://ajpregu.physiology.org/content/302/7/R876
The Volitional Nature of Nicotine Exposure Alters Anandamide and Oleoylethanolamide Levels in the Ventral Tegmental Area (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3572454/
Cannabinoid receptors in submandibular acinar cells: Functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling (full–2012) http://jcs.biologists.org/content/125/8/1884.full
Tumor necrosis factor activation of vagal afferent terminal calcium is blocked by cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342927/
Statistical parametric mapping reveals regional alterations in cannabinoid CB1 receptor distribution and G-protein activation in the 3D reconstructed epileptic rat brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799958/
Alteration of endocannabinoid system in human gliomas (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2011.07625.x/full
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Cannabinoid receptor 1 inhibition causes seizures during anesthesia induction in experimental sepsis (full–2012) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2012/06000/Cannabinoid_Receptor_1_Inhibition_Causes_Seizures.12.aspx
The cannabinoid CB1 receptor antagonists rimonabant (SR141716) and AM251 directly potentiate GABAA receptors (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01405.x/full
Δ9-Tetrahydrocannabinol acts as a partial agonist/antagonist in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697741/
Cannabinoid Receptor Genotype Moderation of the Effects of Childhood Physical Abuse on Anhedonia and Depression (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706194/
Cannabinoid receptor 1 in the vagus nerve is dispensable for body weight homeostasis but required for normal gastrointestinal motility (full–2012) http://www.jneurosci.org/content/32/30/10331.long
Effects of gonadal hormones on the peripheral cannabinoid receptor 1 (CB1R) system under a myositis condition in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3578305/
Functional diversity on synaptic plasticity mediated by endocannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481528/
Anandamide regulates the expression of GnRH1, GnRH2, and GnRH-Rs in frog testis (full–2012) http://ajpendo.physiology.org/content/303/4/E475.long
Cannabinoid Receptor Antagonist-Induced Striated Muscle Toxicity and EthylmalonicAdipic Aciduria in Beagle Dogs (full–2012) http://toxsci.oxfordjournals.org/content/129/2/268.long
Cortical basket cell dysfunction in schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3381305/
The cannabinoid agonist WIN55212-2 decreases l-DOPA-induced PKA activation and dyskinetic behavior in 6-OHDA-treated rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3273613/
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375509/
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Uncovering a role for endocannabinoid signaling in autophagy in preimplantation mouse embryos (full–2012) http://molehr.oxfordjournals.org/content/19/2/93.full
Modulation of neuropathic-pain-related behaviour by the spinal endocannabinoid/endovanilloid system (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481534/
Acute cannabinoids impair working memory through astroglial CB1 receptor modulation of hippocampal LTD (full–2012) http://www.sciencedirect.com/science/article/pii/S0092867412001420
The Contractile Effect of Anandamide in the Guinea-Pig Small Intestine is Mediated by Prostanoids but not TRPV1 Receptors or Capsaicin-Sensitive Nerves (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12041/full
A key agonist-induced conformational change in the cannabinoid receptor CB1 is blocked by the allosteric ligand Org 27569 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3460482/
Dietary conditions and highly palatable food access alter rat cannabinoid receptor expression and binding density (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3621143/
Autocrine Endocannabinoid Signaling through CB1 Receptors Potentiates OX1 Orexin Receptor Signaling (full–2012) http://molpharm.aspetjournals.org/content/83/3/621.full.pdf+html
Progesterone-dependent regulation of endometrial cannabinoid receptor type 1 (CB1-R) expression is disrupted in women with endometriosis and in isolated stromal cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3462249/
Binding of a tritiated inverse agonist to cannabinoid CB1 receptors is increased in patients with schizophrenia (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3463751/
Extinction learning of rewards in the rat: is there a role for CB1 receptors? (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161161/
Positron Emission Tomography Shows Elevated Cannabinoid CB 1 Receptor Binding in Men with Alcohol Dependence (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418442/
Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3288656/
Cannabinoids inhibit peptidoglycan-induced phosphorylation of NF-κB and cell growth in U87MG human malignant glioma cells (full–2012) http://www.spandidospublications.com/or/28/4/1176;jsessionid=52ED17697BFDC92E6F5F848306023474?text=fulltext
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242309/
Sensation-seeking genes and physical activity in youth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3581711/
A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3921679/
Tolerance to cannabinoid-induced behaviors in mice treated chronically with ethanol (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249519/
Biphasic Effects of Cannabinoids in Anxiety Responses: CB1 and GABA(B) Receptors in the Balance of GABAergic and Glutamatergic Neurotransmission (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3473327/
Endocannabinoids limit excessive mast cell maturation and activation in human skin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22226549
[(125)I]SD-7015 reveals fine modalities of CB(1) cannabinoid receptor density in the prefrontal cortex during progression of Alzheimer’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22222721
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
CB1 cannabinoid receptor activation rescues amyloid β-induced alterations in behaviour and intrinsic electrophysiological properties of rat hippocampal CA1 pyramidal neurones (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22508047
The cannabinoid CB1 receptor biphasically modulates motor activity and regulates dopamine and glutamate release region dependently (full–2012) http://ijnp.oxfordjournals.org/content/16/2/393.long
Receptor-dependent and Receptor-independent Endocannabinoid Signaling: A Therapeutic Target for Regulation of Cancer Growth (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226396/
WIN55,212-2 protects oligodendrocyte precursor cells in stroke penumbra following permanent focal cerebral ischemia in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
WIN55, 212-2 promotes differentiation of oligodendrocyte precursor cells and improve remyelination through regulation of the phosphorylation level of the ERK 1/2 via cannabinoid receptor 1 after stroke-induced demyelination (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086494/
The decrease of dopamine D(2)/D(3) receptor densities in the putamen and nucleus caudatus goes parallel with maintained levels of CB(1) cannabinoid receptors in Parkinson’s disease: A preliminary autoradiographic study with the selective dopamine D(2)/D(3) antagonist [(3)H]raclopride and the novel CB(1) inverse agonist [(125)I]SD7015 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180092/
Regulation of endocannabinoid release by G proteins: A paracrine mechanism of G protein-coupled receptor action. (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169275/ Psychopharmacology of the endocannabinoids: far beyond anandamide. (full – 2012) http://www.researchgate.net/publication/51201177_Psychopharmacology_of_the_endocannabinoids_far_be yond_anandamide Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff- 857201f5e069 CHRONIC, NONINVASIVE GLUCOCORTICOID ADMINISTRATION SUPPRESSES LIMBIC ENDOCANNABINOID SIGNALING IN MICE (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697830/ Endocannabinoid system: A newer molecular target for the treatment of alcohol-related behaviors (full – 2012) http://www.wjgnet.com/2220-3192/full/v1/i3/44.htm Photoperiodic Changes in Endocannabinoid Levels and Energetic Responses to Altered Signalling at CB1 Receptors in Siberian Hamsters (full – 2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4060156/ Determination of naphthalen-1-yl-(1-pentylindol-3-yl)methanone (JWH-018) in mouse blood and tissue after inhalation exposure to ‘buzz’ smoke by HPLC/MS/MS (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697740/
Adolescent Exposure of JWH-018 “Spice” Produces Subtle Effects on Learning and Memory Performance in Adulthood (full–2012) http://file.scirp.org/Html/2-3900080_19505.htm
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (full–2012) http://journals.sagepub.com/doi/full/10.1177/0269881112454229
Effects of CP 55,940–agonist of CB1 cannabinoid receptors on ghrelin and somatostatin producing cells in the rat pancreas (link to PDF–2012) https://journals.viamedica.pl/folia_histochemica_cytobiologica/article/view/18705
The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22540859
The genetic basis of the endocannabinoid system and drug addiction in humans (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21937688
Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22895861
Diet-dependent modulation of hippocampal expression of endocannabinoid signaling related proteins in cannabinoid antagonist-treated obese rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23033907
Protective effect of cannabinoid CB1 receptor activation against altered intrinsic repetitive firing properties induced by Aβ neurotoxicity (abst–2012) http://www.sciencedirect.com/science/article/pii/S0304394011015667
A cell population that strongly expresses the CB1 cannabinoid receptor in the ependyma of the rat spinal cord (abst–2012) http://www.biomedexperts.com/Abstract.bme/22791629/A_cell_population_that_strongly_expresses_the_CB1_cannabinoid_receptor_in_the_ependyma_of_the_rat_spinal_cord
The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: Evidence from postmortem human brain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22093909
Contrasting effects of different cannabinoid receptor ligands on mouse ingestive behavior (abst–2012) http://www.unboundmedicine.com/medline/ebm/record/22772336/abstract/Contrasting_effects_of_different_cannabinoid_receptor_ligands_on_mouse_ingestive_behaviour_
Metamizol, a non-opioid analgesic, acts via endocannabinoids in the PAG-RVM axis during inflammation in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337336 The cannabinoid receptor CB₁ inverse agonist AM251 potentiates the anxiogenic activity of urocortin I in the basolateral amygdala (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21736884
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22354705
Cannabinoids ameliorate disease progression in a model of multiple sclerosis in mice, acting preferentially through CB(1) receptor-mediated anti-inflammatory effects (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22342378
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001980
Cannabinoid 1 (CB1) receptor mediates WIN55, 212-2 induced hypothermia and improved survival in a rat post-cardiac arrest model (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22289684
Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22248639
Cannabinoid CB(1) receptor mediates glucocorticoid effects on hormone secretion induced by volume and osmotic changes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22211674
CB1 Agonist ACEA Protects Neurons and Reduces the Cognitive Impairment of AβPP/PS1 Mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22451318
Anandamide dysfunction in prodromal and established psychosis. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22716147
Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized controlled Trial Results (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22367503
Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22366523
Effect of delta-9-tetrahydrocannabinol on behavioral despair and on presynaptic and postsynaptic serotonergic transmission (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22386778
Cannabinoid type 1 receptors and transient receptor potential vanilloid type 1 channels in fear and anxiety-two sides of one coin? (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21906661
Expression and localization of the cannabinoid receptor type 1 and the enzyme fatty acid amide hydrolase in the retina of vervet monkeys (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22142900
Mitochondrial CB(1) receptors regulate neuronal energy metabolism (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22388959
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
Effects of cannabinoid receptor agonist WIN 55,212-2 on blood-brain barrier disruption in focal cerebral ischemia in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22678129 Sex differences in cannabinoid receptor-1 (CB1) pharmacology in mice selectively bred for high voluntary wheel-running behavior (abst–2012) http://www.sciencedirect.com/science/article/pii/S0091305712000597 ∆(9)-Tetrahydrocannabinol decreases NOP receptor density and mRNA levels in human SH-SY5Y cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21603976
Effects of amphetamine on dopamine release in the rat nucleus accumbens shell region depend on cannabinoid CB1 receptor activation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22426202
Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22625418
Revisiting CB1 Receptor as Drug Target in Human Melanoma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22447182
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22738050
Stimulation of acumbens shell cannabinoid CB(1) receptors by noladin ether, a putative endocannabinoid, modulates food intake and dietary selection in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22728691
Lower levels of cannabinoid 1 receptor mRNA in female eating disorder patients: Association with wrist cutting as impulsive self-injurious behavior (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22542985
Cannabinoid modulation of midbrain urocortin 1 neurones during acute and chronic stress (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22734681
Neuroprotective agents: cannabinoids. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Anandamide Induces Matrix Metalloproteinase-2 Production through Cannabinoid-1 Receptor and Transient Receptor Potential Vanilloid-1 in Human Dental Pulp Cells in Culture (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22595113
Cannabinoid CB1 receptor deficiency increases contextual fear memory under highly aversive conditions and long-term potentiation in vivo (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22579951
Expression pattern of the cannabinoid receptor genes in the frontal cortex of mood disorder patients and mice selectively bred for high and low fear (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22534181
G1359A polymorphism in the cannabinoid receptor-1 gene is associated with the presence of coronary artery disease in patients with type 2 diabetes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22138970
Associations of variants of CNR1 with obesity and obesity-related traits in Chinese women (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22244745
Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2′-deoxycytidine. (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22262103
Role of G1359A polymorphism of the cannabinoid receptor gene on weight loss and adipocytokines levels after two different hypocaloric diets (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21543209
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22763024
Age-related changes of anandamide metabolism in CB1 cannabinoid receptor knockout mice: correlation with behaviour (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/11982628
THE CO-EXPRESSION OF THE ENDOCANNABINOID SYSTEM AND THE RANK/RANKL SIGNALLING PATHWAY IN HUMAN BONE AND OSTEOCLAST CULTURE (abst–2012) http://www.bjjprocs.boneandjoint.org.uk/content/94-B/SUPP_XVIII/7.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Non-Δ⁹tetrahydrocannabinol phytocannabinoids stimulate feeding in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22157176
Modulation of sweet responses of taste receptor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22947916
The role of the endocannabinoid system in skeletal muscle and metabolic adaptations to exercise: potential implications for the treatment of obesity (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22943701
Expression and functions of μ-opioid receptors and cannabinoid receptors type 1 in T lymphocytes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22823387
Cannabinoid CB(1) receptor in the modulation of stress coping behaviour in mice: the role of serotonin and different forebrain neuronal subpopulations (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23000076
Opposing local effects of endocannabinoids on the activity of noradrenergic neurons and release of noradrenaline: relevance for their role in depression and in the actions of CB(1) receptor antagonists (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22990678
Childhood Obesity and the Role of Dopamine D2 Receptor and Cannabinoid Receptor-1 Gene Polymorphisms (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23057570
Distribution and function of the endocannabinoid system in the rat and human bladder (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23081739
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
Receptor-dependent and Receptor-independent Endocannainoid Signaling: A Therapeutic Target for Regulation of Cancer Growth (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23069587
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22613131
CB1 receptor activation in the nucleus accumbens core impairs contextual fear learning (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23018128
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23199705
Cannabinoid type 1 receptor ligands WIN 55,212-2 and AM 251 alter anxiety-like behaviors of marmoset monkeys in an open-field test (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23183218
Oleamide restores sleep in adult rats that were subjected to maternal separation (abst–2012) http://www.sciencedirect.com/science/article/pii/S0091305712002493
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23206503
TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22656960?dopt=Abstract
Tumour epithelial expression levels of endocannabinoid markers modulates the value of endoglin-positive vascular density as a prognostic marker in prostate cancer (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23262399
Age of Stress Exposure Modulates the Immediate and Sustained Effects of Repeated Stress on (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23200786
Ventral Tegmental Area Cannabinoid Type-1 Receptors Control Voluntary Exercise Performance (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23237313
Discovery of agonists of cannabinoid receptor 1 with restricted CNS penetration aimed for treatment of gastroesophageal reflux disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23227781
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253273
Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and Bladder Overactivity in Awake Rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23219540
Cannabidiol for the treatment of cannabis withdrawal syndrome: a case report (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/jcpt.12018/abstract
Inverse relationship of cannabimimetic (R+)WIN 55, 212 on behavior and seizure threshold during the juvenile period (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22019959
A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22561283
Combined deficiency of the CB1 and CB2 receptors enhances peak bone mass by inhibiting osteoclast differentiation but increases age-related bone loss by promoting adipocyte differentiation and reducing osteoblast differentiation (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900153-6/abstract
Evidence For Functional Role Of CB1 Cannabinoid Receptors In The Mammalian Cone Pathway (abst–2012) http://iovs.arvojournals.org/article.aspx? articleid=2356936&resultClick=1
Electroacupuncture inhibits CB1 upregulation induced by ethanol withdrawal in mice (abst–2012) http://www.sciencedirect.com/science/article/pii/S019701861200174X
Positron emission tomography offers new perspectives for evidence-based treatment development in PTSD (abst-forum repost–2012) http://forum.grasscity.com/medical-marijuana-usage-applications/1374895-ptsd-study.html
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
Temporal changes of CB1 cannabinoid receptor in the basal ganglia as a possible structure-specific plasticity process in 6-OHDA lesioned rats (full–2013) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0076874
Ghrelin-Induced Orexigenic Effect in Rats Depends on the Metabolic Status and Is Counteracted by Peripheral CB1 Receptor Antagonism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060918
Developmental and Visual Input-Dependent Regulation of the CB1 Cannabinoid Receptor in the Mouse Visual Cortex (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3540079/
Endocannabinoid system and mood disorders: Priming a target for new therapies (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584612002801
Bladder function in a cannabinoid receptor type 1 knock-out mouse (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bju.12350/full
Role of endocannabinoids and cannabinoid-1 receptors in cerebrocortical blood flow regulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537620/
Molecular basis for dramatic changes in cannabinoid CB1 G protein-coupled receptor activation upon single and double point mutations (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/pro.2192/full
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function (full–2013) http://www.clinsci.org/cs/124/0467/1240467.pdf
Novel Insights Into CB1 Cannabinoid Receptor Signaling: A Key Interaction Identified Between EC3-Loop and TMH2 (full–2013) http://jpet.aspetjournals.org/content/early/2013/02/21/jpet.112.201046.long
Type-1 (CB(1)) Cannabinoid Receptor Promotes Neuronal Differentiation and Maturation of Neural Stem Cells (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0054271
Of mice and (wo)men: factors influencing successful implantation including endocannabinoids (full–2013) http://humupd.oxfordjournals.org/content/20/3/415.long
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
Modulating the endocannabinoid system in human health and disease: successes and failures (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12260/pdf
DIFFERENTIAL DRUG-DRUG INTERACTIONS OF THE SYNTHETIC CANNABINOIDS JWH-018 AND JWH-073: IMPLICATIONS FOR DRUG ABUSE LIABILITY AND PAIN THERAPY (full–2013) http://jpet.aspetjournals.org/content/early/2013/06/25/jpet.113.206003.long
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells (full–2013) http://www.nature.com/cddis/journal/v4/n6/pdf/cddis2013151a.pdf
Acetaldehyde as a drug of abuse: insight into AM281 administration on operant-conflict paradigm in rats (full–2013) http://www.frontiersin.org/Behavioral_Neuroscience/10.3389/fnbeh.2013.00064/full
Chronic treatment with krill powder reduces plasma triglyceride and anandamide levels in mildly obese men (full–2013) http://www.lipidworld.com/content/12/1/78
The Dual Effect of Cannabinoid Receptor-1 Deficiency on the Murine Postoperative Ileus (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067427
Insulin induces long-term depression of VTA dopamine neurons via endocannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4072656/
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078
Alterations to Melanocortinergic, GABAergic and Cannabinoid Neurotransmission Associated with Olanzapine-Induced Weight Gain (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033548
Activation of Type 1 Cannabinoid Receptor (CB1R) Promotes Neurogenesis in Murine Subventricular Zone Cell Cultures (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063529
Electroacupuncture inhibition of hyperalgesia in rats with adjuvant arthritis: involvement of cannabinoid receptor 1 and dopamine receptor subtypes in striatum (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677619/
Using the endocannabinoid system as a neuroprotective strategy in perinatal hypoxicischemic brain injury. (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146074/
Reduced Food Intake is the Major Contributor to the Protective Effect of Rimonabant on Islet in Established Obesity-Associated Type 2 Diabetes (full–2013) http://www.eymj.org/DOIx.php?id=10.3349/ymj.2013.54.5.1127
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2013) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Obesity-driven synaptic remodeling affects endocannabinoid control of orexinergic neurons (full–2013) http://www.pnas.org/content/110/24/E2229.full
Role of endogenous cannabinoid system in the gut (full–2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
Activation of cannabinoid CB1 receptors modulates evoked action potentials in rat retinal ganglion cells (full–2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-01.pdf
A novel control of human keratin expression: cannabinoid receptor 1-mediated signaling down-regulates the expression of keratins K6 and K16 in human keratinocytes in vitro and in situ (full–2013) https://peerj.com/articles/40/
A common functional promoter variant links CNR1 gene expression to HDL cholesterol level (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3873874/
An investigation into “two hit” effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice (full–2013) http://www.frontiersin.org/Journal/10.3389/fnbeh.2013.00149/full
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813752/
Endocannabinoids as markers of sperm quality: hot spots (full–2013) http://www.frontiersin.org/Journal/10.3389/fendo.2013.00169/full
The Gastric CB1 Receptor Modulates Ghrelin Production through the mTOR Pathway to Regulate Food Intake (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080339
Further evidence for association of polymorphisms in the CNR1 gene with cocaine addiction: confirmation in an independent sample and meta-analysis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223560/
Estrogens and Spermiogenesis: New Insights from Type 1 Cannabinoid Receptor Knockout Mice (full–2013) http://www.hindawi.com/journals/ije/2013/501350/
On the g-protein-coupled receptor heteromers and their allosteric receptor-receptor interactions in the central nervous system: focus on their role in pain modulation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730365/
Expression and functional relevance of cannabinoid receptor 1 in hodgkin lymphoma (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081675
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Rod Photoreceptors Express GPR55 in the Adult Vervet Monkey Retina (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081080
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis. (full – 2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907
Hepatic Cannabinoid Receptor Type 1 Mediates Alcohol-Induced Regulation of Bile Acid Enzyme Genes Expression Via CREBH (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0068845
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Low 17beta-Estradiol Levels in Cnr1 Knock-Out Mice Affect Spermatid Chromatin Remodeling by Interfering with Chromatin Reorganization (full–2013) http://www.biolreprod.org/content/88/6/152.long
Association between Cannabinoid CB1 Receptor Expression and Akt Signalling in Prostate Cancer (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0065798
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060040
Rimonabant effects on anxiety induced by simulated public speaking in healthy humans: a preliminary report (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/hup.2374/full
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
Monounsaturated fatty acids generated via stearoyl CoA desaturase-1 are endogenous inhibitors of fatty acid amide hydrolase (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839776/
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/nau.22442/full
Molecular targets underlying SUMO-mediated neuroprotection in brain ischemia (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12347/full
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Association between a Genetic Variant of Type-1 Cannabinoid Receptor and Inflammatory Neurodegeneration in Multiple Sclerosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877004/
Cannabinoids, Neurogenesis and Antidepressant Drugs: Is there a Link? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3648779/
HINT1 protein cooperates with cannabinoid 1 receptor to negatively regulate glutamate NMDA receptor activity (full–2013) http://www.molecularbrain.com/content/6/1/42
Stimulatory and Inhibitory Roles of Brain 2-Arachidonoylglycerol in Bombesin-Induced Central Activation of Adrenomedullary Outflow in Rats (full–2013) https://www.jstage.jst.go.jp/article/jphs/121/2/121_12208FP/_pdf
Activation-dependent plasticity of polarized GPCR distribution on the neuronal surface (full–2013) http://jmcb.oxfordjournals.org/content/5/4/250.long
Neuregulin-1 Impairs the Long-term Depression of Hippocampal Inhibitory Synapses by Facilitating the Degradation of Endocannabinoid 2-AG (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776056/
Cannabinoids ameliorate impairments induced by chronic stress to synaptic plasticity and short-term memory (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3682147/
Diacylglycerol Lipaseα (DAGLα) and DAGLβ Cooperatively Regulate the Production of 2-Arachidonoyl Glycerol in Autaptic Hippocampal Neurons (full–2013) http://molpharm.aspetjournals.org/content/84/2/296.full.pdf+html
Cannabinoid (CB)1 receptors are critical for the innate immune response to TLR4 stimulation (full–2013) http://ajpregu.physiology.org/content/305/3/R224
Cannabinoid 1 Receptors in Keratinocytes Modulate Proinflammatory Chemokine Secretion and Attenuate Contact Allergic Inflammation (full–2013) http://www.jimmunol.org/content/190/10/4929.long
Fasting induces CART down-regulation in the zebrafish nervous system in a cannabinoid receptor 1-dependent manner (full–2013) http://press.endocrine.org/doi/full/10.1210/me.2011-1180
Rapid Glucocorticoid-Induced Activation of TRP and CB1 Receptors Causes Biphasic Modulation of Glutamate Release in Gastric-Related Hypothalamic Preautonomic Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3560102/
Effects of glucagon-like peptide-1 receptor stimulation and blockade on food consumption and body weight in rats treated with a cannabinoid CB1 receptor agonist WIN 55,212-2 (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3638658/
The pharmacologic and clinical effects of medical cannabis (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System (full–2013) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2013/02000/CB1_and_CB2_Cannabinoid_Receptor_Agonists_Induce.31.aspx
Developmental Role for Endocannabinoid Signaling in Regulating Glucose Metabolism and Growth (full–2013) http://diabetes.diabetesjournals.org/content/62/7/2359.full?sid=2f5bda2b-a9c7-432a-9588-80c99189164d
Activation of the sympathetic nervous system mediates hypophagic and anxiety-like effects of CB1 receptor blockade (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3607008/
The role of endocannabinoids system in fatty liver disease and therapeutic potentials (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745655/
A role for the endocannabinoid system in exercise-induced spatial memory enhancement in mice (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/24115292
Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis (full–2013) http://www.hh.um.es/pdf/Vol_29/29_4/Borsani-29-523-533-2014.pdf
Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice (full–2013) http://www.iovs.org/content/54/13/8079.long
Endocannabinoid signaling in the gut mediates preference for dietary unsaturated fats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3659363/
Inhibitory effects of endocannabinoid on the action potential of pacemaker cells in sinoatrial nodes of rabbits (full–2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-2-03.pdf
Chemical probes of endocannabinoid metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639726/
Behavioral effects of the novel potent cannabinoid CB1 agonist AM 4054 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015344/
Phencyclidine-induced social withdrawal results from deficient stimulation of cannabinoid CB1 receptors: implications for schizophrenia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3717536/
Antibodies to cannabinoid type 1 receptor co-react with stomatin-like protein 2 in mouse brain mitochondria (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3902808/
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
Expression of the cannabinoid type I receptor and prognosis following surgery in colorectal cancer (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3576207/
Long-term CB1 receptor blockade enhances vulnerability to anxiogenic-like effects of cannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3691020/
Recent Progress in Understanding the Pathophysiology of Post-Traumatic Stress Disorder : Implications for Targeted Pharmacological Treatment (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629370/
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Evaluation of the role of striatal cannabinoid CB1 receptors on movement activity of parkinsonian rats induced by reserpine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3730975/
Endocannabinoids in the Brainstem Modulate Dural Trigeminovascular Nociceptive Traffic via CB1 and “Triptan” Receptors: Implications in Migraine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3771033/
Cannabinoid CB1 Receptors Mediate the Gastroprotective Effect of Neurotensin (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586888/
Cannabinoid Receptor 1 Gene and Irritable Bowel Syndrome: Phenotype and Quantitative Traits (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3602676/
Surinabant, a selective CB(1) antagonist, inhibits THC-induced central nervous system and heart rate effects in humans (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703229/
Effect of Cannabinoid Receptor Activation on Spreading Depression (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3586901/
Cannabinoid receptors and pain (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/wmts.83/full
Astroglial CB1 cannabinoid receptors regulate leptin signaling in mouse brain astrocytes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3854987/
Neuron-type specific cannabinoid-mediated G protein signalling in mouse hippocampus (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12137/full
Cannabinoid modulation of chronic mild stress-induced selective enhancement of trace fear conditioning in adolescent rats (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883309/
Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: a positron emission tomography study (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752332/
Striatal Molecular Signature of Subchronic Subthalamic Nucleus High Frequency Stimulation in Parkinsonian Rat (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617149/
Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776019
Modulation of the cannabinoid receptors by hemopressin peptides (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594051/
Distinct roles of β-arrestin 1 and β-arrestin 2 in ORG27569-induced biased signaling and internalization of the cannabinoid receptor one (CB1) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3617280/
LiCABEDS II. Modeling of Ligand Selectivity for G-protein Coupled Cannabinoid Receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967758/
Endogenous Lipid Activated G Protein-Coupled Receptors: Emerging Structural Features From Crystallography and Molecular Dynamics Simulations (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034697/
Functional activity of the cannabinoid 1 receptor is not affected by opioid antagonists in the rat brain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3611077/
Striatal CB1 and D2 receptors regulate expression of each other, crip1a and delta opioid systems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697910/
Repeated Low Dose Administration of the Monoacylglycerol Lipase Inhibitor JZL184 Retains CB1 Receptor Mediated Antinociceptive and Gastroprotective Effects (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3657109/
CB1 receptor mediates the effects of glucocorticoids on AMPK activity in the hypothalamus. (full– 2013) http://joe.endocrinology-journals.org/content/219/1/79.long
Cannabinoid signaling and liver therapeutics (full–2013) http://www.journal-of-hepatology.eu/article/S0168-8278%2813%2900212-2/fulltext
Therapeutic Opportunities through the Modulation of Endocannabinoid Transport (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4255948/
The CB1 receptor mediates the peripheral effects of ghrelin on AMPK activity but not on growth hormone release (full–2013) http://www.fasebj.org/content/27/12/5112.long
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF–2013) http://www.mdpi.com/1422-0067/14/12/23341
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23453134
Cannabinoid receptor 1 controls human mucosal-type mast cell degranulation and maturation in situ (full–2013) http://www.jacionline.org/article/S0091-6749%2813%2900057-2/fulltext
Differential expression and functional role of cannabinoid genes in alcohol users (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24060590
Differential expression and functional role of cannabinoid genes in alcohol users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818789/
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24172113
Impulsivity, Variation in the Cannabinoid Receptor (CNR1) and Fatty Acid Amide Hydrolase (FAAH) Genes, and Marijuana-Related Problems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3817049/
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23298518
The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system (full–2013) http://ijnp.oxfordjournals.org/content/16/6/1407.long
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23521775
Involvement of prelimbic medial prefrontal cortex in panic-like elaborated defensive behaviour and innate fear-induced antinociception elicited by GABAA receptor blockade in the dorsomedial and ventromedial hypothalamic nuclei: role of the endocannabinoid CB1 receptor (full–2013) http://ijnp.oxfordjournals.org/content/16/8/1781.long
The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy (abst–2013) http://press.endocrine.org/doi/abs/10.1210/jc.2013-2922?url_ver=Z39.88-2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed&
The Effect of Mifepristone (RU486) on the Endocannabinoid System in Human Plasma and First Trimester Trophoblast of Women undergoing Termination of Pregnancy (full–2013) http://press.endocrine.org/doi/full/10.1210/jc.2013-2922
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24256257
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23673278
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753184/
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148245
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860589/
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression (abst–2013) mhttp://www.ncbi.nlm.nih.gov/pubmed/24141570
Cannabinoid Receptor Activation Prevents the Effects of Chronic Mild Stress on Emotional Learning and LTP in a Rat Model of Depression (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3924526/
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24180398
Endocannabinoid Signaling in the Etiology and Treatment of Major Depressive Illness (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4002665/
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24075694
Common polymorphism in the cannabinoid type 1 receptor gene (CNR1) is associated with microvascular complications in type 2 diabetes. (full – 2013) http://www.jdcjournal.com/article/S1056-8727%2813%2900199-2/fulltext
The Role of CB1-Receptors in the Proconvulsant Effect of Leptin on Penicillin-Induced Epileptiform Activity in Rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23521910
The Role of CB1-Receptors in the Proconvulsant Effect of Leptin on Penicillin-Induced Epileptiform Activity in Rats (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/cns.12075/full
The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23732642
The du2J mouse model of ataxia and absence epilepsy has deficient cannabinoid CB1 receptor-mediated signalling (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3764637/
The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24055403
The role of androgen receptor in transcriptional modulation of cannabinoid receptor type 1 gene in rat trigeminal ganglia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3870904/
Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24316201
Endocannabinoid Signaling in Hypothalamic-Pituitary-Adrenocortical Axis Recovery Following Stress: Effects of Indirect Agonists and Comparison of Male and Female Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3929302/
Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23122699
Differential expression of endocannabinoid system in normal and preeclamptic placentas: effects on nitric oxide synthesis (full-2013) http://www.placentajournal.org/article/S0143-4004%2812%2900393-1/fulltext
Depolarisation-induced suppression of a glycinergic synapse in the superior olivary complex by endocannabinoids (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23859596
Depolarisation-induced suppression of a glycinergic synapse in the superior olivary complex by endocannabinoids (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12369/full
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23850608
CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752375/
Effects of a novel CB1 agonist on visual attention in male rats: Role of strategy and expectancy in task accuracy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24099361
Effects of a novel CB1 agonist on visual attention in male rats: Role of strategy and expectancy in task accuracy (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4006576/
CB1 Receptor-Mediated Signaling Underlies the Hippocampal Synaptic, Learning and Memory Deficits Following Treatment with JWH-081, a New Component of Spice/K2 Preparations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24123667
CB1 Receptor-Mediated Signaling Underlies the Hippocampal Synaptic, Learning and Memory Deficits Following Treatment with JWH-081, a New Component of Spice/K2 Preparations (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3959795/
Differential effects of the cannabinoid agonist WIN55,212-2 on delay and trace eyeblink conditioning (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24128358
Differential effects of the cannabinoid agonist WIN55,212-2 on delay and trace eyeblink conditioning (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3963426/
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24121462
Control of spasticity in a multiple sclerosis model using central nervous system-excluded CB1 cannabinoid receptor agonists (full–2013) http://www.fasebj.org/content/28/1/117.long
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus) (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23991698
Anandamide transport inhibition by ARN272 attenuates nausea-induced behaviour in rats, and vomiting in shrews (Suncus murinus) (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949659/
CB1 Cannabinoid Receptors Promote Maximal FAK Catalytic Activity By Stimulating Cooperative Signaling Between Receptor Tyrosine Kinases and Integrins in Neuronal Cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23571270
CB1 Cannabinoid Receptors Promote Maximal FAK Catalytic Activity By Stimulating Cooperative Signaling Between Receptor Tyrosine Kinases and Integrins in Neuronal Cells (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4165595/
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24190932
Optogenetic identification of an intrinsic cholinergically driven inhibitory oscillator sensitive to cannabinoids and opioids in hippocampal CA1 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3903354/
Targeting the cannabinoid system for pain relief? (abst–2013) http://www.sciencedirect.com/science/article/pii/S1875459713001197
Targeting the cannabinoid system for pain relief? (full–2013) http://www.e-aat.com/article/S1875-4597%2813%2900119-7/fulltext
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5- HT1A receptors activation in mice (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
Amygdala FAAH and anandamide: mediating protection and recovery from stress (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24325918
Amygdala FAAH and anandamide: mediating protection and recovery from stress (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4169112/
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9- THC: Mechanism underlying greater toxicity? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945037/
The role of cannabinoid 1 receptor expressing interneurons in behavior (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/24239560
The role of cannabinoid 1 receptor expressing interneurons in behavior (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3946968/
Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944940/
CB1 receptor signaling regulates social anxiety and memory (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23647582
CB1 receptor signaling regulates social anxiety and memory (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12045/full
Real-time characterisation of Cannabinoid Receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23937487
Real-time characterisation of Cannabinoid Receptor 1 (CB1 ) allosteric modulators reveals novel mechanism of action (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799602/
High fat diet and body weight have different effects on cannabinoid CB1 receptor expression in rat nodose ganglia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24145047
High fat diet and body weight have different effects on cannabinoid CB1 receptor expression in rat nodose ganglia (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866822/
The cannabinoid receptor type 1 is essential for mesenchymal stem cell survival and differentiation: implications for bone health (full–2013) http://www.hindawi.com/journals/sci/2013/796715/
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm
Stirring the Pot With Estrogens (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697880/
Biphasic effects of Δ9-tetrahydrocannabinol on brain stimulation reward and motor activity (full–2013) http://ijnp.oxfordjournals.org/content/16/10/2273
Reduced Cannabinoid CB1 Receptor Binding in Alcohol Dependence Measured with Positron Emission Tomographys (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3594469/
Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23954857
Loss of CB1 receptors leads to decreased cathepsin D levels and accelerated lipofuscin accumulation in the hippocampus (full–2013) http://www.sciencedirect.com/science/article/pii/S0047637413000869
The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23587012
The inverse agonist of CB1 receptor SR141716 blocks compulsive eating of palatable food (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3720761/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Cannabinoid receptor modulation of the endothelial cell inflammatory response (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption (abst–2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21639/abstract
A spontaneous deletion of α-Synuclein is associated with an increase in CB1 mRNA transcript and receptor expression in the hippocampus and amygdala: Effects on alcohol consumption (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3931467/
Distribution and Possible Function of Cannabinoid Receptor Subtype 1 in the Human Prostate*—An Inhibitory Role for Growth in the Human Prostate Cancer (full–2013) http://file.scirp.org/Html/12-5000121_31406.htm
Diuretic effects of cannabinoid agonists in mice (abst–2013) http://www.sciencedirect.com/science/article/pii/S0014299913007176
Diuretic effects of cannabinoid agonists in mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3872476/
Pathophysiology of Human Visceral Obesity: An Update (full–2013) http://physrev.physiology.org/content/93/1/359.long
Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23408552
Computationally-predicted CB1 cannabinoid receptor mutants show distinct patterns of salt-bridges that correlate with their level of constitutive activity reflected in G protein coupling levels, thermal stability, and ligand binding (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4872635/
Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24152087
Performance in working memory and attentional control is associated with the rs2180619 SNP in the CNR1 gene (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/gbb.12097/full
β-Arrestins: Regulatory Role and Therapeutic Potential in Opioid and Cannabinoid Receptor-Mediated Analgesia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24292843
β-Arrestins: Regulatory Role and Therapeutic Potential in Opioid and Cannabinoid Receptor-Mediated Analgesia (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4804701/
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (link to PDF–2013) http://content.iospress.com/articles/journal-of-alzheimers-disease/jad130050
GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors (link to PDF-2013) http://www.eurekaselect.com/105678/article
Endocannabinoid signaling in cancer: a rather complex puzzle (letter-2013) http://www.cell.com/trends/pharmacologicalsciences//retrieve/pii/S016561471300117X?_returnURL=http://linkinghub.elsevier.com/retrieve/pii/S016561471300117X?showall=true
The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD (1st page–2013) http://onlinelibrary.wiley.com/doi/10.1002/da.22031/abstract
Predator threat stress promotes long lasting anxiety-lik behaviors and modulates synaptophysin and CB1 receptors expression in brain areas associated with PTSD symptoms (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23178193
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Activation of STAT3 is involved in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptors in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23880371
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296044
Endocannabinoid/GABA interactions in the entopeduncular nucleus modulates alcohol intake in rats (abst– 2013) http://www.ncbi.nlm.nih.gov/pubmed/23291357
Evidence for the involvement of cannabinoid receptors’ polymorphisms in the pathophysiology of human diseases (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23293857
Behavioral Responses to Acute and Sub-chronic Administration of the Synthetic Cannabinoid JWH-018 in Adult Mice Prenatally Exposed to Corticosterone (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296549
Cannabinoid CB(1) receptor is expressed in chromophobe renal cell carcinoma and renal oncocytoma (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23318578
Functional Residues Essential for the Activation of the CB1 Cannabinoid Receptor (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23332708
Curcumin modulates cannabinoid receptors in liver fibrosis in vivo and inhibits extracellular matrix expression in hepatic stellate cells by suppressing cannabinoid receptor type-1 in vitro (abst–2013) http://www.sciencedirect.com/science/article/pii/S0014299913006961
DHA prevents altered 5-HT1(A), 5-HT2(A), CB1 and GABA(A) receptor binding densities in the brain of male rats fed a high-saturated-fat diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23337348
Genetic variation in the cannabinoid receptor gene (CNR1) (G1359A polymorphism) and their influence on anthropometric parameters and metabolic parameters under a high monounsaturated vs. high polyunsaturated fat hypocaloric diets (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23337343
Developmentally-induced hypothyroidism alters the expression of Egr-1 and Arc genes and the sensitivity to cannabinoid agonists in the hippocampus. Possible implications for memory and learning (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23079472
The CB1 cannabinoid receptor mediates glucocorticoid-induced effects on behavioural and neuronal responses during lactation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23417606
Endocannabinoids and obesity (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23374723
Nicotine-Induced Neuroprotection Against Ischemic Injury Involves Activation of Endocannabinoid System in Rats (abst–2013) http://link.springer.com/article/10.1007/s11064-012-0927-6
Involvement of cannabinoid CB1 receptors in the antinociceptive effect of dipyrone (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23784345
Neonatal lipopolysaccharide treatment has long term effects on monoaminergic and cannabinoid receptors in the rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23389966
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23396229
Role of cannabinoid and vanilloid receptors in invasion of human breast carcinoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23394450
Screening genetic variability at the CNR1 gene in both major depression etiology and clinical response to citalopram treatment (abst–2013) http://link.springer.com/article/10.1007%2Fs00213-013-2995-y
CNR1 Gene and Risk of the Metabolic Syndrome in Patients With Schizophrenia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23422373
Cannabinoids and traumatic stress modulation of contextual fear extinction and GR expression in the amygdala-hippocampal-prefrontal circuit (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23433741
Characterisation of cannabinoid-induced relief of neuropathic pain in a rat model of cisplatin-induced neuropathy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454533
Changes in cannabinoid CB1 receptor functionality in the female rat prefrontal cortex following a high fat diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454443
Preventive and therapeutic oral administration of the pentacyclic triterpene α,β-amyrin ameliorates dextran sulfate sodium-induced colitis in mice: The relevance of cannabinoid system. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23454360
Neuroprotective effects of topical CB1 agonist WIN 55212-2 on Retinal ganglion cells after acute rise in intraocular pressure induced ischemia in rat (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23454099
L-DOPA-treatment in primates disrupts the expression of A(2A) adenosine-CB(1) cannabinoid-D(2) dopamine receptor heteromers in the caudate nucleus (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813005121
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23463621
Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23474373
Toxicological profiles of selected synthetic cannabinoids showing high binding affinities to the cannabinoid receptor subtype CB1 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23494106
Endocannabinoid system and drug addiction: new insights from mutant mice approaches (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23490550
Role of intra-accumbal cannabinoid CB1 receptors in the potentiation, acquisition and expression of morphine-induced conditioned place preference (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23523958
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23499687
An ultra-low dose of tetrahydrocannabinol provides cardioprotection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23537701
Targeting the endocannabinoid system in the treatment of fragile X syndrome (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23542787
Central functional response to the novel peptide cannabinoid, hemopressin (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23542442
Entopeduncular nucleus endocannabinoid system modulates sleep-waking cycle and mood in rats. (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23584096
2-AG into the lateral hypothalamus increases REM sleep and cFos expression in melanin concentrating hormone neurons in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23603032
Cannabinoids increase type 1 cannabinoid receptor expression in a cell culture model of striatal neurons: implications for Huntington’s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23602984
Cannabinoid receptors and cholecystokinin in feeding inhibition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23601425
Cytotoxic effect of Efavirenz is selective against cancer cells and associated with the cannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23612009
Effects of CB1 receptor blockade on monosodium glutamate induced hypometabolic and hypothalamic obesity in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23620336
Infusion of cannabidiol into infralimbic cortex facilitates fear extinction via CB1 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23643693
Neonatal lipopolysaccharide treatment has long-term effects on monoaminergic and cannabinoid receptors in the rat (abst – 2013) http://onlinelibrary.wiley.com/doi/10.1002/syn.21640/abstract
Adolescent peer-rejection persistently alters pain perception and CB1 receptor expression in female rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23669059
Impact of omega-6 polyunsaturated fatty acid supplementation and γ-aminobutyric acid on astrogliogenesis through the endocannabinoid system (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23633391
Cardiorespiratory control as a function of wake-sleep behavior and diet in mice lacking CB1 cannabinoid receptors (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/926.1?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Effects of anandamide and other CB1 ligands on cognitive function (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.10?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
The 2-arachidonoylglycerol effect on myosin light chain phosphorylation in human platelets (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23702422
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23714073
Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23722450
Dysregulation of Cannabinoid CB1 Receptor and Associated Signaling Networks in Brains of Cocaine Addicts and Cocaine-Treated Rodents (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23727505
Transient changes in the endocannabinoid system after acute and chronic ethanol exposure and abstinence in the rat: a combined PET and microdialysis study (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23740372
CNR1 variation is associated with the age at onset in Huntington disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747361
The role of α2-adrenoceptors in the anti-convulsant effects of cannabinoids on pentylenetetrazole-induced seizure threshold in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23756131
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24142157
Male and Female Rats Differ in Brain Cannabinoid CB1 Receptor Density and Function and in Behavioural Traits Predisposing To Drug Addiction: Effect of Ovarian Hormones (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829370
Cannabinoid receptor 1 deficiency in a mouse model of Alzheimer’s disease leads to enhanced cognitive impairment despite of a reduction in amyloid deposition (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23838176
Analysis of the “endocannabinoidome” in peripheral tissues of obese Zucker rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23830028
The Role of the Endocannabinoid System in Eating Disorders: Neurochemical and Behavioural Preclinical Evidence (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23829365
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
CB1 agonists, locally applied to the cortico-thalamic circuit of rats with genetic absence epilepsy, reduce epileptic manifestations (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23860329
Endocannabinoid receptor (CB1R) deficiency affects maternal care and alters the dam’s hippocampal oxytocin receptor and BDNF expression (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23895426
Complex interaction between anandamide and the nitrergic system in the dorsolateral periaqueductal gray to modulate anxiety-like behavior in rats (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003250
CB1 cannabinoid receptor-mediated aggressive behavior (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003304
Cannabinoids and glucocorticoids modulate emotional memory after stress (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23954749
Effects of endocannabinoid and endovanilloid systems on aversive memory extinction (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23948212
Targeted Metabolomic Approach for Assessing Human Synthetic Cannabinoid Exposure and Pharmacology (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23987522
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006151
The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24048885
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24084605
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9-THC: Mechanism underlying greater toxicity? (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24084047
Expression of the cannabinoid receptor type 1 in the pituitary of rabbits and its role in the control of LH secretion (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24099736
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24126189
Small animal PET imaging of the type 1 cannabinoid receptor in a rodent model for anorexia nervosa (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24006151
The endocannabinoid anandamide induces apoptosis of rat decidual cells through a mechanism involving ceramide synthesis and p38 MAPK activation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24048885
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
Calcium regulation by temperature-sensitive transient receptor potential channels in human uveal melanoma cells (abst–2013) http://www.sciencedirect.com/science/article/pii/S0898656813002982
Peripherally restricted CB1 receptor blockers (abst–2013) http://www.sciencedirect.com/science/article/pii/S0960894X13007993
Expression of the cannabinoid receptor type 1 in the pituitary of rabbits and its role in the control of LH secretion (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24099736
No association of endocannabinoid genes with bipolar disorder or lithium response in a Sardinian sample (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24126189
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148808
Angiotensin II-induced activation of central AT1 receptors exerts endocannabinoid mediated gastroprotective effect in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24145131
Nephrogenic adenoma of the urinary tract: clinical, histological, and immunohistochemical characteristics (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24142157
Synthetic cannabinoid quinones: Preparation, in vitro antiproliferative effects and in vivo prostate antitumor activity (abst–2013) http://www.sciencedirect.com/science/article/pii/S0223523413006247
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24164198
Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24175626
In vivo type 1 cannabinoid receptor availability in Alzheimer’s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24189376
The combination of oral L-DOPA/rimonabant for effective dyskinesia treatment and cytological preservation in a rat model of Parkinson’s disease and L-DOPA-induced dyskinesia (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24196024
Cytotoxicity of synthetic cannabinoids on primary neuronal cells of the forebrain: the involvement of cannabinoid CB1 receptors and apoptotic cell death (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24211273
Dominant negative DISC1 mutant mice display specific social behaviour deficits and aberration in BDNF and cannabinoid receptor expression (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24219803
Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24247477
Erratum to: Endocannabinoids underlie reconsolidation of hedonic memories in Wistar rats (correction to chart–2013) http://link.springer.com/article/10.1007%2Fs00213-013-3380-6
Delineation of Domains Within the Cannabinoid CB1 and Dopamine D2 Receptors That Mediate the Formation of the Heterodimer Complex (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24264530
Secondary Metabolites from Eupenicillium parvum and Their in Vitro Binding Affinity for Human Opioid and Cannabinoid Receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288291
Role of Genetic Variation in the Cannabinoid Receptor Gene (CNR1) (G1359A Polymorphism) on Weight Loss and Cardiovascular Risk Factors After Liraglutide Treatment in Obese Patients With Diabetes Mellitus Type 2 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24322329
Glutamate spillover drives endocannabinoid production and inhibits GABAergic transmission in the Substantia Nigra pars compacta (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24334069
Decreased Enteric Fatty Acid Amide Hydrolase Activity is Associated with Colonic Inertia in Slow Transit Constipation (abst–2013) http://onlinelibrary.wiley.com/doi/10.1111/jgh.12346/abstract
The cytokine and endocannabinoid systems are co-regulated by NF-κB p65/RelA in cell culture and transgenic mouse models of Huntington’s disease and in striatal tissue from Huntington’s disease patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24360910
Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24378736
Concurrent pharmacological modification of cannabinoid-1 and glucagon-like peptide-1 receptor activity affects feeding behavior and body weight in rats fed a free-choice, highcarbohydrate diet (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24370558
The role of Cannabinoid receptors on light-induced photoreceptor degeneration (abst–2013) http://iovs.arvojournals.org/article.aspx?articleid=2149928&resultClick=1
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003419
Getting high on the endocannabinoid system (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3997295/
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
Genetic Variations in the Human Cannabinoid Receptor Gene Are Associated with Happiness (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093771
A Systems Pharmacology Perspective on the Clinical Development of Fatty Acid Amide Hydrolase Inhibitors for Pain (full–2014) http://www.nature.com/psp/journal/v3/n1/full/psp201372a.html
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
Endocannabinoid Modulation of Cortical Up-States and NREM Sleep (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3919802/
Multiple sleep alterations in mice lacking cannabinoid type 1 receptors (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0089432
The vital role of constitutive GPCR activity in the mesolimbic dopamine system (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/24518399
Cannabinoid neuromodulation in the adult early visual cortex (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0087362
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Identification of odorant-receptor interactions by global mapping of the human odorome (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0093037
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full–2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
Involvement of the Cannabinoid CB1 Receptor in Modulation of Dopamine Output in the Prefrontal Cortex Associated with Food Restriction in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954872/
Reduced expression of brain cannabinoid receptor 1 (Cnr1) is coupled with an increased complementary micro-RNA (miR-26b) in a mouse model of fetal alcohol spectrum disorders (full–2014) http://www.clinicalepigeneticsjournal.com/content/5/1/14
Long-term changes in the ghrelin-CB1R axis associated with the maintenance of lower body weight after sleeve gastrectomy (full–2014) http://www.nature.com/nutd/journal/v4/n7/full/nutd201424a.html
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
Involvement of cannabinoid receptors in peripheral and spinal morphine analgesia (full–2014) http://www.sciencedirect.com/science/article/pii/S0306452213010531
The influence of monoacylglycerol lipase inhibition upon the expression of epidermal growth factor receptor in human PC-3 prostate cancer cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4109781/
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Modulation of pilocarpine-induced seizures by cannabinoid receptor 1 (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0095922
The Endocannabinoid System – Back to the Scene of Cardiometabolic Risk Factors Control? (full–2014) https://www.thieme-connect.com/products/ejournals/html/10.1055/s-0034-1375653
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Cardiorespiratory Anomalies in Mice Lacking CB1 Cannabinoid Receptors (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100536
Prolonged monoacylglycerol lipase blockade causes equivalent CB1-receptor mediated adaptations in FAAH wild type and knockout mice (full–2014) http://jpet.aspetjournals.org/content/early/2014/05/21/jpet.114.212753.long
CB1 cannabinoid receptors are involved in neuroleptic-induced enhancement of brain neurotensin. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4016688/
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full–2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representation=PDF
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
Potential upstream regulators of cannabinoid receptor 1 signaling in prostate cancer: a Bayesian network analysis of data from a tissue microarray. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4145668/
Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3972466/
The expression of cannabinoid receptor 1 is significantly increased in atopic patients (full–2014) http://www.jacionline.org/article/S0091-6749%2813%2902936-9/fulltext
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full–2014) http://www.hindawi.com/journals/bmri/2014/502542/
Anandamide Protects HT22 Cells Exposed to Hydrogen Peroxide by Inhibiting CB1 Receptor-Mediated Type 2 NADPH Oxidase. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127243/
Cannabinoid receptor 1 gene polymorphisms and nonalcoholic Fatty liver disease in women with polycystic ovary syndrome and in healthy controls (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4127238/
Dependence Potential of the Synthetic Cannabinoids JWH-073, JWH-081, and JWH-210: In Vivo and In Vitro Approaches (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4131522/
Chronic ethanol alters network activity and endocannabinoid signaling in the prefrontal cortex (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnint.2014.00058/full
Astrocytic expression of cannabinoid type 1 receptor in rat and human sclerotic hippocampi (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4097232/
Pregnenolone can protect the brain from cannabis intoxication (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057431/
Hepatic cannabinoid-1 receptors mediate diet-induced insulin resistance by increasing de novo synthesis of long-chain ceramides (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3839256/
A restricted population of CB1 cannabinoid receptors with neuroprotective activity (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4050577/
Localization of the cannabinoid CB1 receptor and the 2-AG synthesizing (DAGLα) and degrading (MAGL, FAAH) enzymes in cells expressing the Ca(2+)-binding proteins calbindin, calretinin, and parvalbumin in the adult rat hippocampus (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnana.2014.00056/full
Regulatory effects of anandamide on intracellular Ca(2+) concentration increase in trigeminal ganglion neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146256/
The CB1 cannabinoid receptor agonist reduces L-DOPA-induced motor fluctuation and ERK1/2 phosphorylation in 6-OHDA-lesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4226453/
Cannabinoid receptors contribute to astroglial Ca2+-signalling and control of synaptic plasticity in the neocortex (full–2014) http://rstb.royalsocietypublishing.org/content/369/1654/20140077.long
Association of polymorphisms in the endocannabinoid system genes with myocardial infarction and plasma cholesterol levels. (full – 2014) http://biomed.papers.upol.cz/getrevsrc.php?identification=public&mag=bio&raid=825&type=fin&ver=3
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of SerotoninInduced Reflex Apneas by Dronabinol in Sprague-Dawley Rats (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0111412
Increased placental expression of cannabinoid receptor 1 in preeclampsia: an observational study (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/25444073 Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253664/
CB1 receptor affects cortical plasticity and response to physiotherapy in multiple sclerosis (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268035/
Behavioral effects of the cannabinoid CB1 receptor allosteric modulator ORG27569 in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4186448/
Input- and Cell-Type-Specific Endocannabinoid-Dependent LTD in the Striatum (full–2014) http://www.cell.com/cell-reports/fulltext/S2211-1247%2814%2901016-X
Localization of diacylglycerol lipase alpha and monoacylglycerol lipase during postnatal development of the rat retina (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnana.2014.00150/full
Involvement of the cannabinoid CB1 receptor in modulation of dopamine output in the prefrontal cortex associated with food restriction in rats (full–2014) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0092224
Individual differences in response to positive and negative stimuli: endocannabinoidbased insight on approach and avoidance behaviors (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnsys.2014.00238/full
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322151/
Characterization of endocannabinoid-mediated induction of myeloid-derived suppressor cells involving mast cells and MCP-1 (full–2014) http://www.jleukbio.org/content/95/4/609.long
Evaluation of WIN 55,212-2 self-administration in rats as a potential cannabinoid abuse liability model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3930061/
Cannabinoid modulation of predator fear: involvement of the dorsolateral periaqueductal gray (full–2014) http://ijnp.oxfordjournals.org/content/17/8/1193.long
Mutation of Putative GRK Phosphorylation Sites in the Cannabinoid Receptor 1 (CB1R) Confers Resistance to Cannabinoid Tolerance and Hypersensitivity to Cannabinoids in Mice (full–2014) http://www.jneurosci.org/content/34/15/5152.long
Enhanced Endocannabinoid-Mediated Modulation of Rostromedial Tegmental Nucleus Drive onto Dopamine Neurons in Sardinian Alcohol-Preferring Rats (full–2014) http://www.jneurosci.org/content/34/38/12716.long
Modulation of Fear Memory by Dietary Polyunsaturated Fatty Acids via Cannabinoid Receptors (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4059893/
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014) http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
Interaction between Antagonist of Cannabinoid Receptor and Antagonist of Adrenergic Receptor on Anxiety in Male Rat (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4202541/
Translational evidence for a role of endocannabinoids in the etiology and treatment of posttraumatic stress disorder (full–2014) http://www.psyneuen-journal.com/article/S0306-4530%2814%2900396-5/fulltext
CB1 cannabinoid receptor in SF1-expressing neurons of the ventromedial hypothalamus determines metabolic responses to diet and leptin (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4209357/
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats (full–2014) http://www.nutritionjrnl.com/article/S0899-9007%2814%2900297-4/fulltext
Neural Effects of Cannabinoid CB1 Neutral Antagonist Tetrahydrocannabivarin (THCv) on Food Reward and Aversion in Healthy Volunteers (full–2014) http://ijnp.oxfordjournals.org/content/18/6/pyu094.long
Tapping into the endocannabinoid system to ameliorate acute inflammatory flares and associated pain in mouse knee joints (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4201700/
CB1 augments mGluR5 function in medial prefrontal cortical neurons to inhibit amygdala hyperactivity in an arthritis pain model (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4288820/
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
Cocaine-Induced Behavioral Sensitization Is Associated With Changes in the Expression of Endocannabinoid and Glutamatergic Signaling Systems in the Mouse Prefrontal Cortex (full–2014) http://ijnp.oxfordjournals.org/content/18/1/pyu024.long
Cannabinoid Transmission in the Prefrontal Cortex Bi-Phasically Controls Emotional Memory Formation via Functional Interactions with the Ventral Tegmental Area (full–2014) http://www.jneurosci.org/content/34/39/13096.long
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (full–2014) http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
β-Amyloid Inhibits E-S Potentiation through Suppression of Cannabinoid Receptor 1- Dependent Synaptic Disinhibition (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4114400/
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ (PPARβ/δ) in the Brain (full–2014) http://www.jbc.org/content/289/18/12748.full.pdf+html
Multiple Mechanistically Distinct Modes of Endocannabinoid Mobilization at Central Amygdala Glutamatergic Synapses (full–2014) http://www.sciencedirect.com/science/article/pii/S0896627314000178
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
Advances in the management of multiple sclerosis spasticity: multiple sclerosis spasticity nervous pathways (full–2014) http://www.karger.com/Article/Pdf/367615
The endocannabinoid 2-AG controls skeletal muscle cell differentiation via CB1 receptor-dependent inhibition of Kv7 channels (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4066524/
Aberrant Location of Inhibitory Synaptic Marker Proteins in the Hippocampus of Dystrophin-Deficient Mice: Implications for Cognitive Impairment in Duchenne Muscular Dystrophy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178163/
Control of synaptic function by endocannabinoid-mediated retrograde signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237895/
Hemopressin, an inverse agonist of cannabinoid receptors, inhibits neuropathic pain in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4112957/
Effects of repeated dosing with mechanistically distinct antinociceptive ligands in a rat model of neuropathic spinal cord injury pain (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4184706/
Changes in Cerebral CB1 Receptor Availability after Acute and Chronic Alcohol Abuse and Monitored Abstinence (full–2014) http://www.jneurosci.org/content/34/8/2822.long Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954486/
The cannabinoid acids, analogs and endogenous counterparts (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4351512/
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING (abst–2014) http://www.jbc.org/content/289/9/5828.abstract?sid=9a3f2c47-b737-4ecc-b47c-2f6edbe16774
Allosteric Modulation of a Cannabinoid G Protein-coupled Receptor BINDING SITE ELUCIDATION AND RELATIONSHIP TO G PROTEIN SIGNALING (full–2014) http://www.jbc.org/content/289/9/5828.full.pdf+html
Optimization of Chemical Functionalities of Indole-2-Carboxamides to Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1) (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24635495
Optimization of Chemical Functionalities of Indole-2-Carboxamides to Improve Allosteric Parameters for the Cannabinoid Receptor 1 (CB1). (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4203403/
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24692267
Involvement of cannabinoid receptor-1 activation in mitochondrial depolarizing effect of lipopolysaccharide in human spermatozoa. (full – 2014) http://onlinelibrary.wiley.com/doi/10.1111/j.2047-2927.2014.00210.x/full
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24648181
Elevation of Endogenous Anandamide Impairs LTP, Learning and Memory through CB1 Receptor Signaling in Mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4077345/
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12716/abstract
Relationships between serotonergic and cannabinoid system in depressive-like behavior: a PET study with [11C]-DASB (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/jnc.12716/full
The antitumor action of cannabinoids on glioma tumorigenesis (full–2014) http://www.hh.um.es/pdf/Vol_30/30_6/Zogopoulos-30-629-645-2015.pdf
Endocannabinoid signalling and the deteriorating brain. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471876/
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Overactive cannabinoid 1 receptor in podocytes drives type 2 diabetic nephropathy (full–2014) http://www.pnas.org/content/111/50/E5420.full?sid=66cd362f-ac53-47ba-920e-b7dae50940a2
Baseline Anandamide Levels and Body Weight Impact the Weight Loss Effect of CB1 Receptor Antagonism in Male Rats (full – 2014) http://press.endocrine.org/doi/10.1210/en.2014-1730#sthash.Fbslw7v2.dpuf
Astrocytes in endocannabinoid signalling (full–2014) http://rstb.royalsocietypublishing.org/content/369/1654/20130599
Acute Resistance Exercise Induces Antinociception by Activation of the Endocannabinoid System in Rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24977916
Acute Resistance Exercise Induces Antinociception by Activation of the Endocannabinoid System in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4139418/
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24718372
The CB1 Receptor as an Important Mediator of Hedonic Reward Processing (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4138748/
Stress regulates endocannabinoid-CB1 receptor signaling (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247817/
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias (full–2014) http://www.karger.com/Article/FullText/358127
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24818658
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243976/
Epigenetic Regulation of Genes that Modulate Chronic Stress-induced Visceral Pain in the Peripheral Nervous System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4274248/
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice (full–2014) http://diabetes.diabetesjournals.org/content/64/3/808.long
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615720/
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268146/
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24820537
Cannabinoid Type 1 Receptor Availability in the Amygdala Mediates Threat Processing in Trauma Survivors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4207337/
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual FAAH Enzyme and TRPV1 Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24674273
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual FAAH Enzyme and TRPV1 Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12232/full
Molecular Basis for the Improvement in Muscle Metaboreflex and Mechanoreflex Control in Exercise-Trained Humans with Chronic Heart Failure (full–2014) http://ajpheart.physiology.org/content/307/11/H1655
Role of corticosterone in the murine enteric nervous system during fasting (full–2014) http://ajpgi.physiology.org/content/307/9/G905
Genetic rescue of CB1 receptors on medium spiny neurons prevents loss of excitatory striatal synapses but not motor impairment in HD mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4180675/
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24911431
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261058/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25058512
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Functional Genetic Variation of the Cannabinoid Receptor 1 and Cannabis use Interact on Prefrontal Connectivity and Related Working Memory Behavior (full–2014) http://www.nature.com/npp/journal/v40/n3/full/npp2014213a.html
Increased angiotensin II contraction of the uterine artery at early gestation in a transgenic model of hypertensive pregnancy is reduced by inhibition of endocannabinoid hydrolysis (full–2014) http://hyper.ahajournals.org/content/64/3/619.long
Morphological and Behavioural Evidence for Impaired Prefrontal Cortical Function in Female CB1 Receptor Deficient Mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4128323/
Endocannabinoid modulation by FAAH and MAGL within the analgesic circuitry of the periaqueductal grey (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294036/ Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626020/
Type 1 Cannabinoid Receptor Ligands Display Functional Selectivity in a Cell Culture Model of Striatal Medium Spiny Projection Neurons (full–2014) http://www.jbc.org/content/289/36/24845.long
The analgesic effect of dipyrone in peripheral tissue involves two different mechanisms: Neuronal KATP channel opening and CB1 receptor activation (full–2014) http://www.sciencedirect.com/science/article/pii/S0014299914005561
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDAlesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323744/
Interaction between the Cholecystokinin and Endogenous Cannabinoid Systems in Cued Fear Expression and Extinction Retention (full–2014) http://www.nature.com/npp/journal/v40/n3/full/npp2014225a.html
Effects of the cannabinoid CB1 receptor allosteric modulator ORG 27569 on reinstatement of cocaine- and methamphetamine-seeking behavior in rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161648/
Sterol Carrier Protein-2: Binding Protein for Endocannabinoids (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450258/
Strain differences in the expression of endocannabinoid genes and in cannabinoid receptor binding in the brain of Lewis and Fischer 344 rats (full–2014) http://www.sciencedirect.com/science/article/pii/S0278584614000426
Endocannabinoid signaling and food addiction (full–2014) http://www.sciencedirect.com/science/article/pii/S0149763414002061
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging (full–2014) http://www.sciencedirect.com/science/article/pii/S0531556514001296
Haloperidol and rimonabant increase delay discounting in rats fed high-fat and standardchow diets (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4772744/ Cannabinoid Type 1 (CB1) Receptors on Sim1-Expressing Neurons Regulate Energy Expenditure in Male Mice (full–2014) http://press.endocrine.org/doi/10.1210/en.2014-1437
Inhibition of anandamide hydrolysis attenuates nociceptor sensitization in a murine model of chemotherapy-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4346731/
Dual inhibition of monoacylglycerol lipase and cyclooxygenases synergistically reduces neuropathic pain in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4376450/
The dual FAAH/MAGL inhibitor JZL195 has enhanced effects on endocannabinoid transmission and motor behavior in rats as compared to those of the MAGL inhibitor JZL184 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4150743/
In vivo effects of synthetic cannabinoids JWH-018 and JWH-073 and phytocannabinoid Δ9-THC in mice: inhalation versus intraperitoneal injection (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4340656/
Endocannabinoid contribution to Δ9-tetrahydrocannabinol discrimination in rodents (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110679/
In Vitro Anticancer Activity of Plant-Derived Cannabidiol on Prostate Cancer Cell Lines (full–2014) http://file.scirp.org/Html/5-2500510_47691.htm
The peripheral cannabinoid receptor 1 antagonist VD60 efficiently inhibits carbon tetrachloride-intoxicated hepatic fibrosis progression (full–2014) http://journals.sagepub.com/doi/full/10.1177/1535370213514922
The initiation of synaptic 2-AG mobilization requires both an increased supply of diacylglycerol precursor and increased postsynaptic calcium (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312705/
N-Acylethanolamines: lipid metabolites with functions in plant growth and development (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/tpj.12427/full
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Nutritional omega-3 modulates neuronal morphology in the prefrontal cortex along with depression-related behaviour through corticosterone secretion (full–2014) http://www.nature.com/tp/journal/v4/n9/full/tp201477a.html
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=2233
Expression and localization of cannabinoid receptor 1 in rats’ brain treated with acute and repeated morphine (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/25231848
Cannabinoid Receptor Type 1 Antagonist, AM251, Attenuates Mechanical Allodynia and Thermal Hyperalgesia after Burn Injury (link to PDF–2014) http://anesthesiology.pubs.asahq.org/article.aspx?articleid=1936541&resultClick=3
Cannabinoid receptor activation inhibits cell cycle progression by modulating 14-3-3β (link to PDF–2014) http://www.degruyter.com/view/j/cmble.2014.19.issue-3/s11658-014-0200-x/s11658-014-0200-x.xml
Cannabinoids Prevent the Effects of a Footshock Followed by Situational Reminders on Emotional Processing (link to PDF–2014) http://www.nature.com/npp/journal/v39/n12/full/npp2014132a.html
Brain regional cannabinoid CB1 receptor signalling and alternative enzymatic pathways for 2-arachidonoylglycerol generation in brain sections of diacylglycerol lipase deficient mice (abst–2014) http://www.sciencedirect.com/science/article/pii/S0928098713003497
Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24399199
L-DOPA disrupts adenosine A2A-cannabinoid CB1-dopamine D2 receptor heteromer cross-talk in the striatum of hemiparkinsonian rats: Biochemical and behavioral studies (abst–2014) http://www.sciencedirect.com/science/article/pii/S0014488614000028 Cannabinoid type-1 Receptors in The Paraventricular Nucleus of The Hypothalamus Inhibit Stimulated Food Intake (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24434770
CB1 blockade-induced weight loss over 48 weeks decreases liver fat in proportion to weight loss in humans (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/22828945
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis (abst–2014) http://www.sciencedirect.com/science/article/pii/S0028390814000148
The effect of propofol on intrathecal morphine-induced pruritus and its mechanism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24445631
Association of cannabinoid type 1 receptor and fatty acid amide hydrolase genetic polymorphisms in Chinese patients with irritable bowel syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24444427
Anti-depressive mechanism of repetitive transcranial magnetic stimulation in rat: The role of the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24479995
Microinjection of 2-arachidonoyl glycerol into the rat ventral hippocampus differentially modulates contextually induced fear, depending on a persistent pain state (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494683
Anandamide in primary sensory neurons: too much of a good thing? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24494681
The endocannabinoid system controls food intake via olfactory processes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24509429
Altered Expression of the CB1 Cannabinoid Receptor in the Triple Transgenic Mouse Model of Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24496074
Anandamide activation of CB1 receptors increases spontaneous bursting and oscillatory activity in the thalamus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508153
Dexamethasone alleviates motion sickness in rats in part by enhancing the endocannabinoid system (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24508383
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against LPS-Induced Impairments in Rat Caudate Nucleus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24510751
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24561047
Cannabinoid receptor type 1 activation by arachidonylcyclopropylamide in rat aortic rings causes vasorelaxation involving calcium-activated potassium channel subunit alpha-1 and calcium channel, voltage-dependent, L type, alpha 1C subunit (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24561046
Upregulation of Cannabinoid Receptor-1 and Fibrotic Activation of Mouse Hepatic Stellate Cells during Schistosoma J. Infection: Role of NADPH Oxidase (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24657416
Low anandamide doses facilitate male rat sexual behaviour through the activation of CB1 receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24671517
Cannabinoid receptor type 1 receptors on GABAergic vs. glutamatergic neurons differentially gate sex-dependent social interest in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24698342
Cannabinoid receptor type 1 immunoreactivity and disease severity in human epithelial ovarian tumors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24721263
Modulation of the extinction of fear learning (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24742526
Anandamide attenuates haloperidol-induced vacuous chewing movements in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747871
Endocannabinoid-mediated retrograde modulation of synaptic transmission (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24747340
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Cannabinoid 1 receptors in keratinocytes attenuate FITC-induced mouse atopic-like dermatitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24750433
Effect of N-Arachidonoyl Dopamine on Activity of Neuronal Network in Primary Hippocampus Culture upon Hypoxia Modelling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24771427
Vagal anandamide signaling via cannabinoid receptor 1 contributes to luminal 5-HT modulation of visceral nociception in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24813296
Harnessing neuroendocrine controls of keratin expression: A new therapeutic strategy for skin diseases? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24823963
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24373545
O-2050 facilitates noradrenaline release and increases the CB1 receptor inverse agonistic effect of rimonabant in the guinea pig hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24853577
Cannabinoids negatively modulate striatal glutamate and dopamine release and behavioural output of acute d-amphetamine (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24867330
WIN55212-2 impairs non-associative, recognition and spatial memory in rats via CB1 receptor stimulation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24867078
Augmented tonic pain-related behavior in knockout mice lacking monoacylglycerol lipase, a major degrading enzyme for the endocannabinoid 2-arachidonoylglycerol (abst–2014) http://www.sciencedirect.com/science/article/pii/S0166432814003660
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood Brain Barrier (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
The endocannabinoid system and appetite: relevance for food reward (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24933167
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24951841
Type-1 Cannabinoid Receptor Activity During Alzheimer’s Disease Progression (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24946872
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24967683
Role of CNR1 polymorphisms in moderating the effects of psychosocial adversity on impulsivity in adolescents (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24980155
Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24979612
Inhibition of diacylglycerol lipase (DAGL) in the lateral hypothalamus of rats prevents the increase in REMS and food ingestion induced by PAR1 stimulation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24996194
Endocannabinoid signaling modulates neurons of the pedunculopontine nucleus (PPN) via astrocytes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25009314
Endocannabinoid 2-Arachidonylglycerol Protects Primary Cultured Neurons Against Homocysteine-Induced Impairments in Rat Caudate Nucleus Through CB1 Receptor (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25007951
CB1 receptor antagonism in the granular insular cortex or somatosensory area facilitates consolidation of object recognition memory (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25004406
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24844690
The Potential Therapeutic Effects of THC on Alzheimer’s Disease (abst–2014) http://iospress.metapress.com/content/8421pvx80144t354/?p=ff122a13e6cf4bf78324e26d253bd883&pi=8
The endocannabinoid system is altered in the post-mortem prefrontal cortex of alcoholic subjects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1111/adb.12160/abstract
Cannabinoid receptor intracellular signalling: The long journey from binding sites to biological effects (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/9781118451281.ch2/summary
Ultralow doses of cannabinoid drugs protect the mouse brain from inflammation-induced cognitive damage (abst–2014) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23452/abstract
The therapeutic efficacy of cannabinoid receptor type 1 ligands in Huntington’s disease may depend on their functional selectivity (abst–2014) http://www.fasebj.org/content/28/1_Supplement/846.6.abstract?sid=467bb529-0ecc-4ddc-af27-3f56f520a102
Dual agonism of peripheral cannabinoid CB1/CB2 receptors suppresses cardiac myocyte hypertrophy (abst–2014) http://www.fasebj.org/content/28/1_Supplement/652.9.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
top
The interaction between serotonergic and cannabinoidergic modulations involved in the fear extinction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25069241
Effects of cannabinoids on tension induced by acetylcholine and choline in slow skeletal muscle fibers of the frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24218022
Presence and Colocalization of Type-1 Cannabinoid Receptors with Acetylcholine Receptors in the Motor End-Plate of Twitch Skeletal Muscle Fibers in the Frog (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25161032
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25147120
Mechanism of endocannabinoids system in glucose metabolism of rats with chronic intermittent hypoxia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25146750
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25136745
Analysis in conditional cannabinoid 1 receptor-knockout mice reveals neuronal subpopulation-specific effects on epileptogenesis in the kindling paradigm (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25123336
Genetic variability in the human cannabinoid receptor 1 is associated with resting state EEG theta power in humans (abst–2014) http://www.sciencedirect.com/science/article/pii/S0166432814005154
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0006291X14014144
Differential regulation of NMDAR and NMDAR-mediated metaplasticity by anandamide and 2-AG in the hippocampus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25087967
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573 Mooreamide A: A Cannabinomimetic Lipid from the Marine Cyanobacterium Moorea bouillonii. (abst – 2014) http://link.springer.com/article/10.1007%2Fs11745-014-3949-9 Cannabinoid-induced changes in respiration of brain mitochondria. (abst – 2014) http://www.sciencedirect.com/science/article/pii/S0378427414013228
Harmful effects of law-evading herbs as a new trend in Japan: behavioral and cytotoxicological properties of synthetic cannabinoids (abst–2014) http://www.researchgate.net/publication/265649661_P-47harmful_effects_of_lawevading_herbs_as_a_new_trend_in_Japan_behavioral_and_cytotoxicological_properties_of_synthetic_cannabinoids
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Gene-Specific Disruption of Endocannabinoid Receptor 1 (cnr1a) by Ethanol Probably Leads to the Development of Fetal Alcohol Spectrum Disorder (FASD) Phenotypes in Japanese Rice Fish (Oryzias latipes) Embryogenesis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25251458
Effects of Δ9-tetrahydrocannabinol in individuals with a familial vulnerability to alcoholism (abst–2014) http://link.springer.com/article/10.1007%2Fs00213-013-3402-4
Cannabinoid CB1 receptor signaling dichotomously modulates inhibitory and excitatory synaptic transmission in rat inner retina (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25273281
Cannabis, cannabidiol and epilepsy – From receptors to clinical response (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25282526
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Haloperidol, a Novel Treatment for Cannabinoid Hyperemesis Syndrome (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25393073
Anti-aversive role of the endocannabinoid system in the periaqueductal gray stimulation model of panic attacks in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25388290 Mn-SOD
Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25432886
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Anxiogenic-like effects induced by hemopressin in rats (abst–2014) http://www.sciencedirect.com/science/article/pii/S009130571400313X
AM404 inhibits NFAT and NF-κB signaling pathways and impairs migration and invasiveness of neuroblastoma cells (abst–2014) http://www.sciencedirect.com/science/article/pii/S0014299914008048 Rising stars: Modulation of brain functions by astroglial type-1 cannabinoid receptors (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25452006
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447228
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
Changes and overlapping distribution in the expression of CB1/OX1-GPCRs in rat hippocampus by kainic acid-induced status epilepticus (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446454
Systemic or intra-amygdala infusion of an endocannabinoid CB1 receptor antagonist AM251 blocked propofol-induced anterograde amnesia (abst–2014) http://www.sciencedirect.com/science/article/pii/S0304394014008684
The learning of fear extinction (abst–2014) http://www.sciencedirect.com/science/article/pii/S0149763414002681
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst–2014) http://www.eurekaselect.com/126560/article
Cerebellar Endocannabinoids: Retrograde Signaling from Purkinje Cells (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/25520276
Activation of cannabinoid system in anterior cingulate cortex and orbitofrontal cortex modulates cost-benefit decision making (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25529106
Differential effects and potential adverse outcomes of ionic silver and silver nanoparticles in vivo and in vitro (abst–2014) http://pubs.acs.org/doi/abs/10.1021/es4042258
Extravirgin olive oil up-regulates CB1 tumor suppressor gene in human colon cancer cells and in rat colon via epigenetic mechanisms (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25533906
Elevated CB1 and GPR55 receptor expression in proximal tubule cells and whole kidney exposed to diabetic conditions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25545857
Glycogen synthase kinase-3β is involved in electroacupuncture pretreatment via the cannabinoid CB1 receptor in ischemic stroke (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/23943518
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst–2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
Cannabinoid Type 1 Receptor Antagonist, AM251, Prevents Attenuation Of Serotonininduced Apneas By Dronabinol In Sprague-Dawley Rats (abst–2014) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2014.189.1_MeetingAbstracts.A3901
NONRETROGRADE ENDOCANNABINOID SIGNALING MODULATES RETINAL GANGLION CELL CALCIUM HOMEOSTASIS THROUGH THE TRPV1 CATION CHANNEL (abst-2014) http://iovs.arvojournals.org/article.aspx? articleid=2268407&resultClick=1
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24285567
Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats (full–2015) http://www.rbej.com/content/13/1/5
Muscarinic M1 receptor and cannabinoid CB1 receptor do not modulate paraoxon induced seizures (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/prp2.100/full
Understanding Cannabinoid Psychoactivity with Mouse Genetic Models (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.0050280
Cannabinoid receptor 1 signaling in cardiovascular regulating nuclei in the brainstem: A review. (full – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25685481
The Combined Inhibitory Effect of the Adenosine A1 and Cannabinoid CB1 Receptors on cAMP Accumulation in the Hippocampus Is Additive and Independent of A1 Receptor Desensitization. (full – 2015) http://www.hindawi.com/journals/bmri/2015/872684/
Cocaine-induced endocannabinoid release modulates behavioral and neurochemical sensitization in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/adb.12080/full
Lack of hypophagia in CB1 null mice is associated to decreased hypothalamic POMC and CART expression (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/03/09/ijnp.pyv011.long
Negative Regulation of Leptin-induced ROS Formation by CB1 Receptor Activation in Hypothalamic Neurons (full–2015) http://www.jbc.org/content/early/2015/04/13/jbc.M115.646885.full.pdf+html
Role for Endogenous BDNF in Endocannabinoid-Mediated Long-Term Depression at Neocortical Inhibitory Synapses (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4415885/
Sex-dependent vulnerability to Cannabis abuse in adolescence (full–2015) http://journal.frontiersin.org/article/10.3389/fpsyt.2015.00056/full
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015) http://www.hindawi.com/journals/mi/2015/349176/
top
Full Fatty Acid Amide Hydrolase Inhibition Combined with Partial Monoacylglycerol Lipase Inhibition: Augmented and Sustained Antinociceptive Effects with Reduced Cannabimimetic Side Effects in Mice (full–2015) http://jpet.aspetjournals.org/content/354/2/111.full
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients’ cells (full–2015) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=3895&path%5B%5D=8966
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Biased Agonism and Biased Allosteric Modulation at the CB1 Cannabinoid Receptor (full–2015) http://molpharm.aspetjournals.org/content/early/2015/06/04/mol.115.099192.long
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full–2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Involvement of GluR2 up-regulation in neuroprotection by electroacupuncture pretreatment via cannabinoid CB1 receptor in mice (full–2015) http://www.nature.com/srep/2015/150330/srep09490/full/srep09490.html
Intrathecal cannabinoid-1 receptor agonist prevents referred hyperalgesia in acute acrolein-induced cystitis in rats (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4446380/
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459020/
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Increased Cerebral Cannabinoid-1 Receptor Availability Is a Stable Feature of Functional Dyspepsia: A [F]MK-9470 PET Study (full–2015) http://www.karger.com/Article/FullText/375454
Cannabis in cancer care (full–2015) http://escholarship.org/uc/item/6367m6vj#page-1
Role of the endocannabinoid system in obesity induced by neuropeptide Y over-expression in noradrenergic neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4423197/
Rapid Non-Genomic Glucocorticoid Actions in Male Mouse Hypothalamic Neuroendocrine Cells Are Dependent on the Nuclear Glucocorticoid Receptor (full–2015) http://press.endocrine.org/doi/pdf/10.1210/en.2015-1273
The CB1 cannabinoid receptor signals striatal neuroprotection via a PI3K / Akt / mTORC1 / BDNF pathway (full–2015) http://www.nature.com/cdd/journal/vaop/ncurrent/full/cdd201511a.html
Gastric mucosal protection: from the periphery to the central nervous system (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Bi-directional CB1 receptor-mediated cardiovascular effects of cannabinoids in anaesthetized rats: role of the paraventricular nucleus (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/343_06_15_article.pdf
Tonic endocannabinoid-mediated modulation of GABA release is independent of the CB1 content of axon terminals (full–2015) http://www.nature.com/ncomms/2015/150420/ncomms7557/full/ncomms7557.html
Coadministration of indomethacin and minocycline attenuates established paclitaxelinduced neuropathic thermal hyperalgesia: Involvement of cannabinoid CB1 receptors (full–2015) http://www.nature.com/srep/2015/150618/srep10541/pdf/srep10541.pdf
A cannabinoid receptor agonist N-arachidonoyl dopamine inhibits adipocyte differentiation in human mesenchymal stem cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428713/
A Basal Tone of 2-Arachidonoylglycerol Contributes to Early Oligodendrocyte Progenitor Proliferation by Activating Phosphatidylinositol 3-Kinase (PI3K)/AKT and the Mammalian Target of Rapamycin (MTOR) Pathways (full–2015) http://link.springer.com/article/10.1007/s11481-015-9609-x/fulltext.html
Role of the endogenous cannabinoid system in nicotine addiction: novel insights (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4373509/
Diacylglycerol lipase α knockout mice demonstrate metabolic and behavioral phenotypes similar to those of cannabinoid receptor 1 knockout mice (full–2015) http://journal.frontiersin.org/article/10.3389/fendo.2015.00086/full
The endocannabinoid anandamide during lactation increases body fat content and CB1 receptor levels in mice adipose tissue (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4491858/
Hypothalamic POMC neurons promote cannabinoid-induced feeding (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4496586/
Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation (full–2015) http://cardiovascres.oxfordjournals.org/content/early/2015/06/30/cvr.cvv179.long
Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002194
Interaction between Cannabinoid Compounds and Capsazepine in Protection against Acute Pentylenetetrazole-induced Seizure in Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4499434/
Hormonal status and age differentially affect tolerance to the disruptive effects of delta-9-tetrahydrocannabinol (Δ(9)-THC) on learning in female rats (full–2015) http://journal.frontiersin.org/article/10.3389/fphar.2015.00133/full
Cannabinoid-induced autophagy regulates suppressor of cytokine signaling-3 in intestinal epithelium (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101681/
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Metabolic Interplay between Astrocytes and Neurons Regulates Endocannabinoid Action (full–2015) http://www.cell.com/cell-reports/fulltext/S2211-1247%2815%2900725-1
Impaired 2-AG signaling in hippocampal glutamatergic neurons: aggravation of anxietylike behavior and unaltered seizure susceptibility (full–2015) http://ijnp.oxfordjournals.org/content/ijnp/early/2015/07/29/ijnp.pyv091.full.pdf
Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492759/
Current Status and Future of Cannabis Research (full–2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release (full–2015) http://www.jneurosci.org/content/35/27/10039.full?sid=7e769d1b-9b77-42fe-92d0-8b337b34b9b6
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://www.arthritis-research.com/content/17/1/226
N-Oleoyl glycine, a lipoamino acid, stimulates adipogenesis associated with activation of CB1 receptor and Akt signaling pathway in 3T3-L1 adipocyte (full–2015) http://www.sciencedirect.com/science/article/pii/S0006291X15305635
Enhancing Brain Pregnenolone May Protect Cannabis Intoxication but Should Not Be Considered as an Anti-addiction Therapeutic: Hypothesizing Dopaminergic Blockade and Promoting Anti-Reward (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545660/
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136546
The skeletal endocannabinoid system: clinical and experimental insights (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0073/jbcpp-2015-0073.xml
Endogenous vs Exogenous Allosteric Modulators in GPCRs: A dispute for shuttling CB1 among different membrane microenvironments (full–2015) http://www.nature.com/articles/srep15453
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
The Cannabinoid Receptor CB1 Interacts with the WAVE1 Complex and Plays a Role in Actin Dynamics and Structural Plasticity in Neurons (full–2015) http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.1002286
Increased Cortical Inhibition in Autism-Linked Neuroligin-3R451C Mice Is Due in Part to Loss of Endocannabinoid Signaling (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140638
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619873/
Emerging drugs of abuse: current perspectives on synthetic cannabinoids (full–2015) https://www.dovepress.com/emerging-drugs-of-abuse-current-perspectives-on-synthetic-cannabinoids-peerreviewed-fulltext-article-SAR
Fine-tuning of synaptic upscaling at excitatory synapses by endocannabinoid signaling is mediated via the CB1 receptor (full–2015) http://www.nature.com/articles/srep16257
Fetal Alcohol Spectrum Disorder: Potential Role of Endocannabinoids Signaling (full–2015) http://www.mdpi.com/2076-3425/5/4/456/htm
Endocannabinoid signaling mediates oxytocin-driven social reward (full–2015) http://www.pnas.org/content/112/45/14084.full
Loss of Either Rac1 or Rac3 GTPase Differentially Affects the Behavior of Mutant Mice and the Development of Functional GABAergic Networks (full–2015) http://cercor.oxfordjournals.org/content/early/2015/11/17/cercor.bhv274.long
Perinatal asphyxia results in altered expression of the hippocampal acylethanolamide / endocannabinoid signaling system associated to memory impairments in postweaned rats (full–2015) http://journal.frontiersin.org/article/10.3389/fnana.2015.00141/full
The effect of BLA GABA(A) receptors in anxiolytic-like effect and aversive memory deficit induced by ACPA (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669909/
Endocannabinoids Mediate Muscarinic Acetylcholine Receptor-Dependent Long-Term Depression in the Adult Medial Prefrontal Cortex (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00457/full
Cardioprotective effects of fatty acid amide hydrolase inhibitor URB694, in a rodent model of trait anxiety (full–2015) http://www.nature.com/articles/srep18218
Pharmacological Blockade of Cannabinoid CB1 Receptors in Diet-Induced Obesity Regulates Mitochondrial Dihydrolipoamide Dehydrogenase in Muscle (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0145244
Biased Type 1 Cannabinoid Receptor Signalling Influences Neuronal Viability in a Cell Culture Model of Huntington Disease (full–2015) http://molpharm.aspetjournals.org/content/early/2015/12/23/mol.115.101980.long
Preferential epithelial expression of type-1 cannabinoid receptor (CB1R) in the developing canine embryo (full–2015) http://www.springerplus.com/content/4/1/804
Cannabinoid-Induced Chemotaxis in Bovine Corneal Epithelial Cells (full–2015) http://iovs.arvojournals.org/article.aspx?articleid=2297919&resultClick=1 Impact of CB1 Receptor Deletion on Visual Responses and Organization of Primary Visual Cortex in Adult Mice (full–2015) http://iovs.arvojournals.org/article.aspx?articleid=2474494&resultClick=1
Monoglyceride lipase deficiency causes desensitization of intestinal cannabinoid receptor type 1 and increased colonic μ-opioid receptor sensitivity (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4556478/
cnrip1 is a regulator of eye and neural development in Xenopus laevis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12225/full
TRPV1 Channel: A Potential Drug Target for Treating Epilepsy (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598436/
A synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487012/
To Act or Not to Act: Endocannabinoid/Dopamine Interactions in Decision-Making (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681836/
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner (full–2015) http://www.arthritis-research.com/content/17/1/321
Tetrahydrocannabivarin (THCv) reduces Default Mode Network and increases Executive Control Network Resting State Functional Connectivity in Healthy Volunteers (full–2015) http://ijnp.oxfordjournals.org/content/early/2015/09/10/ijnp.pyv092.long
Fatty acid binding protein deletion suppresses inflammatory pain through endocannabinoid/N-acylethanolamine-dependent mechanisms (full–2015) http://molecularpain.biomedcentral.com/articles/10.1186/s12990-015-0056-8
Brain transcriptome profiles in mouse model simulating features of post-traumatic stress disorder (full–2015) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-015-0104-3
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://link.springer.com/article/10.1186/s13075-015-0743-x Proapoptotic effect of endocannabinoids in prostate cancer cells (full–2015) http://www.spandidos-publications.com/or/33/4/1599
The role of the Cannabinoid Receptor 1 in adolescents’ processing of facial expressions (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/ejn.13118/full
Interactions between ethanol and the endocannabinoid system at GABAergic synapses on basolateral amygdala principal neurons (full–2015) http://www.alcoholjournal.org/article/S0741-8329%2815%2930019-7/fulltext
Corticotropin-Releasing Hormone Drives Anandamide Hydrolysis in the Amygdala to Promote Anxiety (full-2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4348185/
Cannabinoid type-1 receptor signaling in central serotonergic neurons regulates anxiety like behavior and sociability (full–2015) http://journal.frontiersin.org/article/10.3389/fnbeh.2015.00235/full
Dietary DHA reduced downstream endocannabinoid and inflammatory gene expression, epididymal fat mass, and improved aspects of glucose use in muscle in C57BL/6J mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4722239/
Cannabinoid CB1 receptors and mTORC1 signalling pathway interact to modulate glucose homeostasis (full–2015) http://dmm.biologists.org/content/9/1/51.long
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26215450
Mitochondrial CB1 receptor is involved in ACEA-induced protective effects on neurons and mitochondrial functions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4516969/
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25740514
Cannabinoid CB1 Receptor Calibrates Excitatory Synaptic Balance in the Mouse Hippocampus (full–2015) http://www.jneurosci.org/content/35/9/3842.long
Role of the Endocannabinoid System in Diabetes and Diabetic Complications (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
The basolateral amygdala γ-aminobutyric acidergic system in health and disease (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/jnr.23690/full
Enhanced Functional Activity of the Cannabinoid Type-1 Receptor Mediates Adolescent Behavior (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604232/
Protective effect of Xingnaojia formulation on rats with brain and liver damage caused by chronic alcoholism (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4665616/
A runner’s high depends on cannabinoid receptors in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620874/
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (full–2015) http://jpet.aspetjournals.org/content/353/1/169.long
Orphan nuclear receptor oestrogen-related receptor γ (ERRγ) plays a key role in hepatic cannabinoid receptor type 1-mediated induction of CYP7A1 gene expression (full–2015) http://ajpendo.physiology.org/content/308/7/E583.long
Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25575795
Activation of cannabinoid receptor 1 inhibits increased bladder activity induced by nerve growth factor (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4339033/
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25572435
AM841, a covalent cannabinoid ligand, powerfully slows gastrointestinal motility in normal and stressed mice in a peripherally-restricted manner (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403103/
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684407
Inhibiting endocannabinoid biosynthesis: a novel approach to the treatment of constipation (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459026/
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25933444
Enhancement of endocannabinoid signalling protects against cocaine-induced neurotoxicity (full–2015) http://www.sciencedirect.com/science/article/pii/S0041008X15001556
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470774/
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25975960
Endocannabinoid and ceramide levels are altered in patients with colorectal cancer (full–2015) https://www.spandidos-publications.com/or/34/1/447
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904556
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (full–2015) http://molpharm.aspetjournals.org/content/88/1/64.long
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Selective Monoacylglycerol Lipase Inhibitors: Antinociceptive versus Cannabimimetic Effects in Mice (full–2015) http://jpet.aspetjournals.org/content/353/2/424.full.pdf+html
Chronic administration with AM251 improves albuminuria and renal tubular structure in obese rats (full–2015) http://joe.endocrinology-journals.org/content/225/2/113.long
Sequelae of Cannabis as Medicine (full–2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
A highly selective, reversible inhibitor identified by comparative chemoproteomics modulates diacylglycerol lipase activity in neurons (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773911/
The Cannabinoid Receptor-1 is an imaging biomarker of Brown Adipose Tissue (full–2015) http://jnm.snmjournals.org/content/56/12/1937.full.pdf+html
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25754762
Effects of Fatty Acid Amide Hydrolase (FAAH) Inhibitors in Non-Human Primate Models of Nicotine Reward and Relapse (full–2015) http://www.nature.com/npp/journal/v40/n9/full/npp201562a.html
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1) receptors located on glutamatergic neurons and on astrocytes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25626460
Opposite control of frontocortical 2-arachidonoylglycerol turnover rate by cannabinoid type-1 (CB1 ) receptors located on glutamatergic neurons and on astrocytes (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13044/full
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate (abst–2015) http://www.fasebj.org/content/29/4/1446
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate (full – 2015) http://www.fasebj.org/content/29/4/1446.full.pdf+html
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (full–2015) http://molpharm.aspetjournals.org/content/87/4/747.long
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25657338
HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt™ Column Extraction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25737338
HPLC-MS-MS Determination of ZCZ-011, A Novel Pharmacological Tool for Investigation of the Cannabinoid Receptor in Mouse Brain Using Clean Screen FASt™ Column Extraction (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542657/
Anandamide Depresses Glycinergic and GABAergic Inhibitory Transmissions in Adult Rat Substantia Gelatinosa Neurons (full–2015) http://file.scirp.org/Html/1-2500613_54452.htm Intake of farmed Atlantic salmon fed soybean oil increases hepatic levels of arachidonic acid-derived oxylipins and ceramides in mice (full–2015) http://www.jnutbio.com/article/S0955-2863(15)00021-2/fulltext
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332989/
The Endocannabinoid System and its Modulation by Phytocannabinoids (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604172/
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881114565142 Altered CB1 receptor coupling to G-proteins in the post-mortem caudate nucleus and cerebellum of alcoholic subjects (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115599388
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601395
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881114566259
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like Behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25944409
Epigenetic and Proteomic Expression Changes Promoted by Eating Addictive-like Behavior (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864655/
Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26053311
Endocannabinoid and nitric oxide interaction mediates food intake in neonatal chicken (full–2015) http://www.tandfonline.com/doi/full/10.1080/00071668.2015.1059407
A pivotal role for enhanced brainstem orexin receptor 1 signaling in the central cannabinoid receptor 1-mediated pressor response in conscious rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562882/
Fasting stimulates 2-AG biosynthesis in the small intestine: role of cholinergic pathways (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666947/
In vitro and non-invasive in vivo effects of the cannabinoid-1 receptor agonist AM841 on gastrointestinal motor function in the rat (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4918633/
Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935491
Endocannabinoid system activation may be associated with insulin resistance in women with polycystic ovary syndrome (full–2015) http://www.fertstert.org/article/S0015-0282(15)00232-0/fulltext
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26144572
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (full–2015) http://www.fertstert.org/article/S0015-0282(15)00440-9/fulltext
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor (full–2015) http://www.reproduction-online.org/content/150/6/463.long
Type 1 cannabinoid receptor modulates water deprivation-induced homeostatic responses (full–2015) http://ajpregu.physiology.org/content/309/11/R1358.long
Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25833345
Imaging the cannabinoid CB1 receptor in humans with [11C]OMAR: assessment of kinetic analysis methods, test-retest reproducibility, and gender differences (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528005/
Safety of oral dronabinol during opioid withdrawal in humans (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663169/
Progesterone and anandamide in pregnancy loss (full–2015) http://www.placentajournal.org/article/S0143-4004%2815%2900515-9/fulltext
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26034207
Δ9-Tetrahydrocannabinol attenuates allogeneic host-versus-graft response and delays skin graft rejection through activation of cannabinoid receptor 1 and induction of myeloid-derived suppressor cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4541500/
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26209559
Endogenous 2-Arachidonoylglycerol Alleviates Cyclooxygenases-2 Elevation-Mediated Neuronal Injury from SO2 Inhalation via PPARγ Pathway (full–2015) http://toxsci.oxfordjournals.org/content/147/2/535.long
The cannabinoid system in the retrosplenial cortex modulates fear memory consolidation, reconsolidation, and extinction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4749733/
The endocannabinoid system in renal cells: Regulation of Na+ transport by CB1 receptors through distinct cell signaling pathways (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537261
The role of cannabinoids in adult neurogenesis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25951750
The role of cannabinoids in adult neurogenesis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
Differential Pharmacological Regulation of Sensorimotor-Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895455
Differential Pharmacological Regulation of Sensorimotor-Gating Deficit in CB1 Knockout Mice and Associated Neurochemical and Histological Alterations (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4569956/
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26037800
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents
and endocannabinoid-synthesizing post-synaptic neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26162236
Ultrastructural evidence for synaptic contacts between cortical noradrenergic afferents and endocannabinoid-synthesizing post-synaptic neurons (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4542008/
Cannabinoid receptor type 1 agonist ACEA improves motor recovery and protects neurons in ischemic stroke in mice (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/jnc.13288/full
Habenular CB1 Receptors Control the Expression of Aversive Memories (full – 2015) http://www.cell.com/neuron/fulltext/S0896-6273(15)00729-1
β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling (full–2015) http://www.cell.com/cell/fulltext/S0092-8674(15)00826-0
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26052038
A Cannabinoid CB1 Receptor Positive Allosteric Modulator Reduces Neuropathic Pain in the Mouse with no Psychoactive Effects (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4864630/
Spinal RGS4 inhibition effectively attenuates neuropathic hyperalgesia and restores cannabinoid receptor type 1 signaling (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13324/full
Protection from Radiation-Induced Pulmonary Fibrosis by Peripheral Targeting of Cannabinoid Receptor-1 (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4599364/
Neurobiological Interactions Between Stress and the Endocannabinoid System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26068727
Neurobiological Interactions Between Stress and the Endocannabinoid System (full–2015) http://www.nature.com/npp/journal/v41/n1/full/npp2015166a.html
Cannabinoid withdrawal in mice: inverse agonist vs neutral antagonist (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504748/
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26218440
Cannabidiol is a negative allosteric modulator of the type 1 cannabinoid receptor (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4621983/
CB1 receptor antagonism blocks stress-potentiated reinstatement of cocaine seeking in rats (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4703460/
Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists (full–2015) http://journals.sagepub.com/doi/full/10.1177/1074248415612593
The effects of endocannabinoid receptor agonist anandamide and antagonist rimonabant on opioid analgesia and tolerance in rats (link to download–2015) http://www.elis.sk/index.php?page=shop.product_details&flypage=flypage.tpl&product_id=4378&category_id=119&option=com_virtue mart&vmcchk=1&Itemid=1
Anxiety, Stress, and Fear Response in Mice with Reduced Endocannabinoid Levels (link through Elsevier to get full-2015) http://www.ncbi.nlm.nih.gov/pubmed/25981172
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (full–2015) http://www.cps.org.tw/files/201503160252300.pdf
Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (click Full Text Links for PDF–2015) http://www.ncbi.nlm.nih.gov/pubmed/25687494
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism (link to PDF–2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases (link to PDF–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0055/jbcpp-2015-0055.xml
Role of the endocannabinoid 2-arachidonoylglycerol in aversive responses mediated by the dorsolateral periaqueductal grey (link to PDF–2015) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(15)00364-8/abstract
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory (link to PDF–2015) http://www.eurekaselect.com/137770/article
Endocannabinoids (article–2015) http://emedicine.medscape.com/article/1361971-overview#showall
CB1 cannabinoid receptors mediate endochondral skeletal growth attenuation by Δ9- tetrahydrocannabinol (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/25573322
Dissecting the cannabinergic control of behavior: The where matters (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26260530
Active endocannabinoids are secreted on extracellular membrane vesicles (abst–2015) http://embor.embopress.org/content/early/2015/01/07/embr.201439668
Intra-visceral insular cortex 2-arachidonoylglycerol, but not Narachidonoylethanolamide, suppresses acute nausea-induced conditioned gaping in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25499318
Peripherally Restricted Cannabinoids for the Treatment of Pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497478
The endocannabinoid system within the dorsal lateral geniculate nucleus of the vervet monkey (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25575947
Cannabinoid agonists rearrange synaptic vesicles at excitatory synapses and depress motoneuron activity in vivo (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595101
Cannabinoid CB1 receptors in the dorsal hippocampus and prelimbic medial prefrontal cortex modulate anxiety-like behavior in rats: additional evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595265
Endocannabinoid-mediated modulation of Gq/11 protein-coupled receptor signalinginduced vasoconstriction and hypertension (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25595485
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at transient receptor potential vanilloid type-1 channels (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25598150
Modulation of the effects of the cannabinoid agonist, ACPA, on spatial and non-spatial novelty detection in mice by dopamine D1 receptor drugs infused into the basolateral amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25476564
A Synthetic Cannabinoid MAM-2201 Potently Suppresses Synaptic Transmission via Activation of Presynaptic CB1 Receptors and Reduces Synaptically-Evoked Intracellular Ca2+ Transients in Cerebellar Purkinje Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25747605
Phenotype-dependent inhibition of glutamatergic transmission on nucleus accumbens medium spiny neurons by the abused inhalant toluene (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25752326
Involvement of the serotonergic system of the ventral hippocampus (CA3) on amnesia induced by ACPA in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25771207
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25545473
[268-POS]: Placental expression of the endocannabinoid system in preeclampsia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25787618
The effects of beta-arrestin1 deletion on acute cannabinoid activity, brain cannabinoid receptors and tolerance to cannabinoids in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25779032
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788026
Acute administration of a cannabinoid CB1 receptor antagonist impairs stress-induced antinociception in fish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25656689
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Effects of cannabinoid and glutamate receptor antagonists and their interactions on learning and memory in male rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684318
Anandamide Drives Cell Cycle Progression through CB1 Receptors in a Rat Model of Synchronized Liver Regeneration (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25684344
Cannabinoid Receptor 1 and Acute Resistance Exercise – In vivo and In vitro Studies in Human Skeletal Muscle (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796352
Inhibition of monoacylglycerol lipase mediates a cannabinoid 1-receptor dependent delay of kindling progression in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25796567
Antidepressant-like effects of the cannabinoid receptor ligands in the forced swimming test in mice: Mechanism of action and possible interactions with cholinergic system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25660201
A multi-target approach for pain treatment – dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25719612
Cannabinoids to treat spinal cord injury (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25805333
Analysis of calretinin early expression in the rat hippocampus after beta amyloid (1-42) peptide injection (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25813826
Monoacylglycerol Lipase Inhibitor Protects Primary Cultured Neurons Against Homocysteine-induced Impairments in Rat Caudate Nucleus through COX-2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25818189
Localization and production of peptide endocannabinoids in the rodent CNS and adrenal medulla (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25839900
Major urinary protein 1 interacts with cannabinoid receptor type 1 in fatty acid-induced hepatic insulin resistance in a mouse hepatocyte model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843798
Cannabinoid CB1 receptors mediate the effects of dipyrone (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25430877
The interactive role of cannabinoid and vanilloid systems in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25843413
Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: The role of CB1-endoccannabinoid receptor in the ventral mesencephalon (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25841876
The role of the endocannabinoid system in pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846617
CB1 receptors modulate affective behaviour induced by neuropathic pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863168
CB 1Cannabinoid Receptor Agonist Inhibits Matrix Metalloproteinase Activity in Spinal Cord Injury: A Possible Mechanism of Improved Recovery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25881484
Weeding out bad waves: towards selective cannabinoid circuit control in epilepsy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25891509
Anti Proliferative and Pro Apoptotic Effects of Flavonoid Quercetin Are Mediated by CB1 Receptor in Human Colon Cancer Cell Lines (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25893829
Influence of arachidonyl-2′-chloroethylamide, a selective cannabinoid CB1 receptor agonist, on the anticonvulsant and acute side-effect potentials of clobazam, lacosamide and pregabalin in the maximal electroshock-induced seizure model and chimney test in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25904357
Role of cannabinoidergic system on food intake in neonatal layer-type chicken (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25902906
The complex modulation of lysosomal degradation pathways by cannabinoid receptor 1 and 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25908257
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912803
Distinct roles of the endocannabinoids anandamide and 2-arachidonoylglycerol in social behavior and emotionality at different developmental ages in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25914159
Endocannabinoids regulate the activity of astrocytic hemichannels and the microglial response against an injury: In vivo studies (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/25917763
Enhanced function of inhibitory presynaptic cannabinoid CB1 receptors on sympathetic nerves of DOCA-salt hypertensive rats (abst–2015)
http://www.sciencedirect.com/science/article/pii/S0024320515002155
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
Chronic ethanol exposure decreases CB1 receptor function at GABAergic synapses in the rat central amygdala (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25940135
Lipopolysaccharide-induced murine embryonic resorption involves changes in endocannabinoid profiling and alters progesterone secretion and inflammatory response by a CB1-mediated fashion (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25958042
The endocannabinoid system and associative learning and memory in zebrafish (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25956869
Astroglial type-1 cannabinoid receptors (CB1): A new player in the tripartite synapse (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25967266
AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25974027
Synthetic and endogenous cannabinoids protect retinal neurons from AMPA excitotoxicity in vivo, via activation of CB1 receptors: Involvement of PI3K/Akt and MEK/ERK signaling pathways (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25989217
JWH-018 impairs sensorimotor functions in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25987201
Repeated forced swim stress differentially affects formalin-evoked nociceptive behaviour and the endocannabinoid system in stress normo-responsive and stress hyper-responsive rat strains (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25988529
Layer-specific endocannabinoid-mediated LTD of GABAergic neurotransmission onto principal neurons in mouse visual cortex (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25997857
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Combined neuroprotective action of adenosine A1 and cannabinoid CB1 receptors against NMDA-induced excitotoxicity in the hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26065937
Increased tonic cannabinoid CB1R activity and brain region-specific desensitization of CB1R Gi/o signaling axis in mice with global genetic knockout of monoacylglycerol lipase (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26070239
ENP11, a potential CB1R antagonist, induces anorexia in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26072692
Endocannabinoids drive the acquisition of an alternative phenotype in microglia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26086345
The influence of cannabinoids on learning and memory processes of the dorsal striatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092091
Evidence against a critical role of CB1 receptors in adaptation of the hypothalamicpituitary-adrenal axis and other consequences of daily repeated stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26092203
Colocalization of cannabinoid receptor 1 with somatostatin and neuronal nitric oxide synthase in rat brain hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26115586
Endocannabinoid signaling mechanisms in the substantia nigra pars reticulata modulate GABAergic nigrotectal pathways in mice threatened by urutu-cruzeiro venomous pit viper snake (abst–2015) http://www.sciencedirect.com/science/article/pii/S0306452215005898
Cannabinoid and nitric oxide signaling interplay in the modulation of hippocampal hyperexcitability: Study on electrophysiological and behavioral models of temporal lobe epilepsy in the rat (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26135674
Modulatory effects by CB1 receptors on rat spinal locomotor networks after sustained application of agonists or antagonists (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26126926
Sperm Release from the Oviductal Epithelium Depends on Ca2+ Influx Upon Activation of CB1 and TRPV1 by Anandamide (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26129689
Roles for the endocannabinoid system in ethanol-motivated behavior (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26123153
A comprehensive patents review on cannabinoid 1 receptor antagonists as antiobesity agents (abst–2015)  http://www.ncbi.nlm.nih.gov/pubmed/26161824
Changes over time of cannabinoid receptor 1 in hippocampus of status epilepticus rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26168676
Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26173564
Effect of Homocysteine on Voltage-Gated Sodium Channel Currents in Primary Cultured Rat Caudate Nucleus Neurons and Its Modulation by 2-Arachidonylglycerol (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179279
Morphine-induced locomotor sensitization produces structural plasticity in the mesocorticolimbic system dependent on CB1-R activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179931
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179998
The endocannabinoid, endovanilloid and nitrergic systems could interact in the rat dorsolateral periaqueductal gray matter to control anxiety-like behaviors (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815300863
Functional interaction between the orexin-1 and CB1 receptors within the nucleus accumbens in the conditioned place preference induced by the lateral hypothalamus stimulation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25735491
Genetic deletion of monoacylglycerol lipase (MAGL) leads to impaired cannabinoid receptor CB1 R signaling and anxiety-like behavior (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26223500
Cannabinoid receptor expression in the bladder is altered in detrusor overactivity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26224382
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
The role of the peripheral cannabinoid system in the pathogenesis of detrusor overactivity evoked by increased intravesical osmolarity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26243021
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254701
The endocannabinoid system role in the pathogenesis of obesity and depression (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26277182
GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26287693
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297326
Effects of CB1 receptor agonism and antagonism on behavioural fear and physiological stress responses in adult intact, ovariectomized, and estradiol-replaced female rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26311003
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Effect of nucleus accumbens shell 5-HT4 receptors on the impairment of ACPA-induced emotional memory consolidation in male Wistar rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26340366
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26343919
Enhanced Glutamatergic Synaptic Plasticity in the Hippocampal CA1 Field of Food Restricted Rats: Involvement of CB1 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26354043
Repeated administration of phytocannabinoid Δ9-THC or synthetic cannabinoids JWH- 018 and JWH-073 induces tolerance to hypothermia but not locomotor suppression in mice, and reduces CB1 receptor expression and function in a brain region-specific manner (abst–2015) http://www.sciencedirect.com/science/article/pii/S1043661815002108
Endocannabinoid regulation of amyloid-induced neuroinflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26362942
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26370914
New insights on the role of the endocannabinoid system in the regulation of energy balance. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26374449
Δ-9-Tetrahydrocannabinol discriminative stimulus effects of AM2201 and related aminoalkylindole analogs in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26397760
Biosynthesis and Fate of Endocannabinoids (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_2
Distribution of the Endocannabinoid System in the Central Nervous System (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_3
Genetic Manipulation of the Endocannabinoid System (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_5
Endocannabinoids and Metabolic Disorders (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_10
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
The Endocannabinoid System: Pivotal Orchestrator of Obesity and Metabolic Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26412154
Audiograms, gap detection thresholds, and frequency difference limens in cannabinoid receptor 1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0378595515301489
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Reduced Brain Cannabinoid Receptor Availability In Schizophrenia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26432420
Cannabinoids, cannabinoid receptors and tinnitus (abst–2015) http://www.sciencedirect.com/science/article/pii/S0378595515300368
Neuroprotective Effect Is Driven Through the Upregulation of CB1 Receptor in Experimental Autoimmune Encephalomyelitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26411568
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300959
Evaluation of the abuse potential of AM281, a new synthetic cannabinoid CB1 receptor antagonist (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26450088
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
Further Characterization of Hemopressin Peptide Fragments in the Opioid and Cannabinoid Systems (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465932
Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26470810
Excitatory drive from the subthalamic nucleus attenuates GABAergic transmission in the Substantia Nigra pars compacta via endocannabinoids (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26472124
The CCDC55 couples cannabinoid receptor CNR1 to a putative DISC1 schizophrenia pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26475744
The type-1 cannabinoid receptor modulates the hydroelectrolytic balance independently of the energy homeostasis during salt load (abst–2015) http://www.sciencedirect.com/science/article/pii/S0018506X15301252
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26513129
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors (abst–2015) http://www.sciencedirect.com/science/article/pii/S1043661815002583
Dopamine-dependent CB1 receptor dysfunction at corticostriatal synapses in homozygous PINK1 knockout mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301441
Endocannabinoid regulation of nausea is mediated by 2-arachidonoylglycerol (2-AG) in the rat visceral insular cortex (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301623
MIMICKING ISCHEMIC PRECONDITIONING PHENOMENON THROUGH THE IMPACT ON THE CANNABINOID RECEPTORS: ROLE OF PROTEIN KINASE AND NO-SYNTHASE (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26591586
Involvement of opioid system in antidepressant-like effect of the cannabinoid CB1 receptor inverse agonist AM-251 after physical stress in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26609670
The interactive role of CB1 and GABAB receptors in hippocampal synaptic plasticity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26611204
Cannabinoid Receptor Agonists Modulate Calcium Channels in Rat Retinal Müller Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26621126
The Endocannabinoid Signaling System in the CNS: A Primer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638763
The Role of the Brain’s Endocannabinoid System in Pain and Its Modulation by Stress (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26638768
Allosteric Modulators: A Side Door (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26645411
Cannabinoid Transmission in the Hippocampus Activates Nucleus Accumbens Neurons and Modulates Reward and Aversion-Related Emotional Salience. (abst – 2015) http://www.ncbi.nlm.nih.gov/pubmed/26681496
Native CB1 receptor affinity, intrisic activity and accumbens shell dopamine stimulant properties of third generation SPICE/K2 cannabinoids: BB-22, 5F-PB-22, 5F-AKB-48 and STS-135 (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815301817
Involvement of the infralimbic cortex and CA1 hippocampal area in reconsolidation of a contextual fear memory through CB1 receptors: effects of CP55,940 (abst–2015) http://www.sciencedirect.com/science/article/pii/S1074742715002257
An Introduction to the Endogenous Cannabinoid System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26698193
Modulation of cannabinoid signaling by amygdala α2-adrenergic system in fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303259
Disruption of social cognition in the sub-chronic PCP rat model of schizophrenia: Possible involvement of the endocannabinoid system (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26706691
CB1 receptors in the formation of the different phases of memory-related processes in the inhibitory avoidance test in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815303326
Blockade of Cannabinoid 1 Receptor Improves GLP-1R Mediated Insulin Secretion in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0303720715301714
Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815302161
Cannabinoid Receptors Modulate Rod-Cone Gap Junctional Coupling In The Day And Night (abst–2015) http://iovs.arvojournals.org/article.aspx?articleid=2336723&resultClick=1
THC exerts neuroprotective effect in glutamate affected murine primary mesencephalic cultures and neuroblastoma N18TG2 cells (abst–2015) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0035-1565754
Dietary Carbohydrates that Modulate the Immune System (abst–2015) http://www.ingentaconnect.com/content/ben/ciemd/2015/00000002/00000001/art00009?crawler=true
Effects of metabolites of the analgesic agent dipyrone (metamizol) on rostral ventromedial medulla cell activity in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014299914008929
The disease-modifying effects of a Sativex-like combination of phytocannabinoids in mice with experimental autoimmune encephalomyelitis are preferentially due to Δ(9)- tetrahydrocannabinol acting through CB1 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26590655
Cannabinoids-Induced Vasodilation in Rat Mesenteric Artery: Possible Mechanisms of Action (abst–2015) http://www.fasebj.org/content/29/1_Supplement/948.6.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
CB1 receptor transgenic mice in the cannabinoid triad: a novel approach to assess in vivo efficacy of CB1 ligands (abst–2015) http://www.fasebj.org/content/29/1_Supplement/LB490.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Evaluation of FAAH- and MGL-Inhibition in Cannabinoid Drug Discrimination (abst–2015) http://www.fasebj.org/content/29/1_Supplement/1019.16.abstract? sid=edf921ac-0690-4aa6-ac81-0546314dd384
CB1 receptors into the Prelimbic Cortex modulate food intake in rats (abst–2015) http://www.fasebj.org/content/29/1_Supplement/655.1.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Allosteric Modulation of CB1 by Pregnenolone (abst–2015) http://www.fasebj.org/content/29/1_Supplement/LB60.abstract?sid=edf921ac-0690-4aa6-ac81- 0546314dd384
Δ9-Tetrahydrocannabinol alone and combined with cannabidiol mitigate fear memory through reconsolidation disruption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25799920
Cannabinoid Receptors May Control Aversive Memories (news & abstract-2015) http://neurosciencenews.com/habenula-cb1-receptors-memory-2742/
Runner’s high linked to cannabinoid receptors in mice (news & abstract–2015) http://medicalxpress.com/news/2015-10-runner-high-linked-cannabinoid-receptors.html
Oxytocin Enhances Pleasure of Social Interactions by Stimulating Production of “Bliss Molecule” (news & abstract–2015) http://neurosciencenews.com/oxytocin-anandamide-2926/
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
Endocannabinoid regulation in white and brown adipose tissue following thermogenic activation (full–2016) http://www.jlr.org/content/early/2016/01/14/jlr.M065227.full.pdf+html?sid=da020ee7-4e2e-40b6-a400- 27301739341e
Neuromodulation of Aerobic Exercise—A Review (full–2016) http://journal.frontiersin.org/article/10.3389/fpsyg.2015.01890/full
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
CB1 receptor blockade counters age-induced insulin resistance and metabolic dysfunction (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4783351/
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7042&path[]=20008
Selective Cannabinoid Receptor-1 Agonists Regulate Mast Cell Activation in an Oxazolone-Induced Atopic Dermatitis Model (full–2016) http://anndermatol.org/DOIx.php?id=10.5021/ad.2016.28.1.22
GABABR-Dependent Long-Term Depression at Hippocampal Synapses between CB1- Positive Interneurons and CA1 Pyramidal Cells (full – 2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00004/full
GABA and Endocannabinoids Mediate Depotentiation of Schaffer Collateral Synapses Induced by Stimulation of Temperoammonic Inputs. (full – 2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0149034
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
A collaboration investigating endocannabinoid signalling in brain and bone (full–2016) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0125/jbcpp-2015-0125.xml
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
Sustained Endocannabinoid Signaling Compromises Decidual Function and Promotes Inflammation-induced Preterm Birth (full–2016) http://www.jbc.org/content/early/2016/02/21/jbc.M115.707836.long
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling (full–2016) http://www.nature.com/articles/srep21931
Study the Effect of Endocannabinoid System on Rat Behavior in Elevated Plus-Maze (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4656987/
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
2-arachidonoylglycerol signaling impairs short-term fear extinction (full–2016) http://www.nature.com/tp/journal/v6/n3/full/tp201626a.html
Modulation of Fear Extinction by Stress, Stress Hormones and Estradiol: A Review (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4726806/
Exogenous hepatitis B virus envelope proteins induce endoplasmic reticulum stress: involvement of cannabinoid axis in liver cancer cells. (full – 2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7950&path%5B%5D=23319
Cannabinoids Regulate Bcl-2 and Cyclin D2 Expression in Pancreatic β Cells (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0150981
New insights into the yin and yang of the endocannabinoid system in health and disease (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13451/full
A Comparative Analysis of the Endocannabinoid System in the Retina of Mice, Tree Shrews, and Monkeys (full–2016) http://www.hindawi.com/journals/np/2016/3127658/
Monoacylglycerol lipase inhibitors produce pro- or antidepressant responses via hippocampal CA1 GABAergic synapses (full–2016) http://www.nature.com/mp/journal/vaop/ncurrent/full/mp201622a.html
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full
Behavioral Characterization of the Effects of Cannabis Smoke and Anandamide in Rats (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0153327
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys (full–2016) http://www.hindawi.com/journals/np/2016/1253245/
Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons of Metestrous Mice: An Acute Slice Electrophysiological Study (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00077/full
δ-Ctenitoxin-Pn1a, a Peptide from Phoneutria nigriventer Spider Venom, Shows Antinociceptive Effect Involving Opioid and Cannabinoid Systems, in Rats (full–2016) http://www.mdpi.com/2072-6651/8/4/106/htm
A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase (full–2016) http://mpx.sagepub.com/content/12/1744806916649192.long
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (full–2016) https://www.dovepress.com/modulation-of-breast-cancer-cell-viability-by-a-cannabinoid-receptor-2-peerreviewed-fulltext-article-BCTT
Impaired Ethanol-Induced Sensitization and Decreased Cannabinoid Receptor-1 in a Model of Posttraumatic Stress Disorder (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0155759#pone.0155759.ref024
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854499/
Neuronal and Astrocytic Monoacylglycerol Lipase Limit the Spread of Endocannabinoid Signaling in the Cerebellum (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4865651/
Cannabinoid 1 receptor knockout mice display cold allodynia, but enhanced recovery from spared-nerve injury-induced mechanical hypersensitivity (full–2016) http://mpx.sagepub.com/content/12/1744806916649191.long
Tolerance to the diuretic effects of cannabinoids and cross-tolerance to a kappa-opioid agonist in THC-treated mice (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/26/jpet.116.232132.long
Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1
Docosahexaenoic acid-supplementation prior to fasting prevents muscle atrophy in mice (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/jcsm.12103/full
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156693
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model (full–2016) http://www.nature.com/articles/srep27316
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4907698/
Endocannabinoid Modulation of Orbitostriatal Circuits Gates Habit Formation (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273%2816%2930157-X
Unmasking roles of the peripheral endocannabinoid system associated with bladder overactivity (full – 2016) http://onlinelibrary.wiley.com/doi/10.1111/bju.13336/full
Beyond Cannabis: Plants and the Endocannabinoid System (full–2016) http://ge.tt/3Rgtrsa2
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Endocannabinoid Signaling Regulates Sleep Stability (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0152473
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full–2016) http://carcin.oxfordjournals.org/content/31/9/1584.long
Rapid Changes in Cannabinoid 1 Receptor Availability in Cannabis-Dependent Male Subjects After Abstinence From Cannabis (full–2016) http://www.sciencedirect.com/science/article/pii/S2451902215000099
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016300192
Enkephalin levels and the number of neuropeptide Y-containing interneurons in the hippocampus are decreased in female cannabinoid-receptor 1 knock-out mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016301689
Estradiol impacts the endocannabinoid system in female rats to influence behavioral and structural responses to cocaine (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816302428
Cannabinoid CB1 receptor inhibition blunts adolescent-typical increased binge alcohol and sucrose consumption in male C57BL/6J mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0091305716300089
Dissociating the role of endocannabinoids in the pleasurable and motivational properties of social play behaviour in rats (full–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303917
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858820/
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells (full–2016) http://www.nature.com/pcan/journal/vaop/ncurrent/full/pcan201619a.html
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679742/
Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction (full–2016) http://www.sciencedirect.com/science/article/pii/S2214647416300137
Endocannabinoid control of glutamate NMDA receptors: the therapeutic potential and consequences of dysfunction. (full – 2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10095&path%5B%5D=31745
Expression of the endocannabinoid receptors in human fascial tissue. (full – 2016) http://www.ejh.it/index.php/ejh/article/view/2643/2590
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803149/
Immunohistochemical analysis of cannabinoid receptor 1 expression in steatotic rat livers (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812478/
Effects of Neuroendocrine CB1 Activity on Adult Leydig Cells (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891325/
Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4899471/
Harnessing the Endocannabinoid 2-Arachidonoylglycerol to Lower Intraocular Pressure in a Murine Model (full–2016) http://iovs.arvojournals.org/article.aspx? articleid=2530714
Pharmacological characterization of repeated administration of the first generation abused synthetic cannabinoid CP47,497 (full–2016) http://www.degruyter.com/view/j/jbcpp.2016.27.issue-3/jbcpp-2015-0118/jbcpp-2015-0118.xml
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927043/
Association between cerebral cannabinoid 1 receptor availability and body mass index in patients with food intake disorders and healthy subjects: a [(18)F]MK-9470 PET study (full–2016) http://www.nature.com/tp/journal/v6/n7/full/tp2016118a.html Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-
OTT The Orphan Nuclear Receptor ERRγ Regulates Hepatic CB1 Receptor-Mediated Fibroblast Growth Factor 21 Gene Expression (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0159425
Crucial Roles of the Endocannabinoid 2-Arachidonoylglycerol in the Suppression of Epileptic Seizures (full–2016) http://www.cell.com/cell-reports/fulltext/S2211-1247(16)30852-X
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929166/
Orexins contribute to restraint stress-induced cocaine relapse by endocannabinoidmediated disinhibition of dopaminergic neurons (full–2016) http://www.nature.com/ncomms/2016/160722/ncomms12199/full/ncomms12199.html
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Mice Expressing a “Hyper-Sensitive” Form of the Cannabinoid Receptor 1 (CB1) Are Neither Obese Nor Diabetic (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0160462
Hybrid inhibitor of peripheral cannabinoid-1 receptors and inducible nitric oxide synthase mitigates liver fibrosis (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4979564/
Orchestrated activation of mGluR5 and CB1 promotes neuroprotection (full–2016) http://molecularbrain.biomedcentral.com/articles/10.1186/s13041-016-0259-6
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Interaction between interleukin-1β and type-1 cannabinoid receptor is involved in anxiety-like behavior in experimental autoimmune encephalomyelitis (full–2016) http://jneuroinflammation.biomedcentral.com/articles/10.1186/s12974-016-0682-8
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full – 2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism. (full – 2016) http://www.nature.com/articles/srep33302
Targeting anandamide metabolism rescues core and associated autistic-like symptoms in rats prenatally exposed to valproic acid (full–2016) http://www.nature.com/tp/journal/v6/n9/full/tp2016182a.html
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full
Involvement of Endocannabinoids in Alcohol “Binge” Drinking: Studies of Mice with Human Fatty Acid Amide Hydrolase Genetic Variation and After CB1 Receptor Antagonists. (full – 2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4962692/
Crystal Structure of the Human Cannabinoid Receptor CB1 (full–2016) http://www.cell.com/cell/fulltext/S0092-8674(16)31385-X
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries (full–2016) http://www.sciencedirect.com/science/article/pii/S104366181630113X
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Adverse Social Experiences in Adolescent Rats Result in Enduring Effects on Social Competence, Pain Sensitivity and Endocannabinoid Signaling (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00203/full
PTSD: from neurobiology to pharmacological treatments (full–2016) http://www.ejpt.net/index.php/ejpt/article/view/31858
Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance (full–2016) http://link.springer.com/article/10.1007%2Fs12020-016-1172-6
Turning Up the Heat on Endocannabinoid Signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5106110/
Presynaptic G Protein-Coupled Receptors: Gatekeepers of Addiction? (full–2016) http://journal.frontiersin.org/article/10.3389/fncel.2016.00264/full
Anti-inflammatory effect of cannabinoid agonist WIN55, 212 on mouse experimental colitis is related to inhibition of p38MAPK (full–2016) http://www.wjgnet.com/1007-9327/full/v22/i43/9515.htm
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Regional Influence of Cannabinoid CB1 Receptors in the Regulation of Ethanol Self Administration by Wistar Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5152943/
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats (full–2016) http://ijnp.oxfordjournals.org/content/early/2016/12/19/ijnp.pyw102.long
Cannabinoids reverse the effects of early stress on neurocognitive performance in adulthood (full–2016) http://learnmem.cshlp.org/content/23/7/349.long
Orexin-A represses satiety-inducing POMC neurons and contributes to obesity via stimulation of endocannabinoid signaling (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4855580/
Rescue of Impaired mGluR5-Driven Endocannabinoid Signaling Restores Prefrontal Cortical Output to Inhibit Pain in Arthritic Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4719019/
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis (full–2016) http://gut.bmj.com/content/65/10/1721.long
Endocannabinoid regulation of β-cell functions: Implications for glycemic control and diabetes (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5045244/
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (full–2016) http://journals.sagepub.com/doi/full/10.1177/1933719116630414
Modulation of cannabinoid signaling by hippocampal 5-HT4 serotonergic system in fear conditioning (full–2016) http://journals.sagepub.com/doi/full/10.1177/0269881116652584
Bisphenol A Induces Fatty Liver by an Endocannabinoid-Mediated Positive Feedback Loop (full–2016) http://press.endocrine.org/doi/10.1210/en.2015-1384?url_ver=Z39.88- 2003&rfr_id=ori:rid:crossref.org&rfr_dat=cr_pub%3dpubmed
Identification of N-arachidonoyl dopamine as a highly biased ligand at cannabinoid CB1 receptors (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4813372/
Alteration of SLP2‐like immunolabeling in mitochondria signifies early cellular damage in developing and adult mouse brain (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4784115/
Does modulation of the endocannabinoid system have potential therapeutic utility in cerebellar ataxia? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4983615/
Mechanisms of biased beta-arrestin mediated signaling downstream from the cannabinoid 1 receptor (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4885504/
The multiple waves of cannabinoid 1 receptor signaling (full–2016) http://molpharm.aspetjournals.org/content/90/5/620.long
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model (full–2016) http://www.mdpi.com/2073-4425/7/9/56/htm
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167240
Modulation of Long-Term Potentiation of Cortico-Amygdala Synaptic Responses and Auditory Fear Memory by Dietary Polyunsaturated Fatty Acid (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993868/
Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032030/
A spider derived peptide, PnPP-19, induces central antinociception mediated by opioid and cannabinoid systems (full–2016) https://jvat.biomedcentral.com/articles/10.1186/s40409-016-0091-6
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00503/full
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit. (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559
Cannabinoid WIN-55,212-2 mesylate inhibits ADAMTS-4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan-1. (link to PDF-2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5137
Δ9-Tetrahydrocannabinol decreases willingness to exert cognitive effort in male rats. (link to PDF–2016) http://jpn.ca/articles-in-press/41-6-150363/
Dissecting the signaling pathways involved in the crosstalk between mGlu5 and CB1 receptors (link to PDF–2016) http://molpharm.aspetjournals.org/content/early/2016/06/23/mol.116.104372.long
Cannabinoid Receptor Interacting Protein (CRIP) 1a competition with β-arrestin for CB1 receptor binding sites (link to PDF–2016) http://molpharm.aspetjournals.org/content/early/2016/11/28/mol.116.104638.long
Two Janus cannabinoids that are both CB2 agonists and CB1 antagonists. (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/12/07/jpet.116.236539.long
Effects of activation of endocannabinoid system on myocardial metabolism (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333924
Getting into the weed: the role of the endocannabinoid system in the brain-gut axis (link to full via ELSEVIER–2016) http://www.ncbi.nlm.nih.gov/pubmed/27133395
Harvesting Benefits from Cannabinoids (article–2016) http://www.cell.com/cell/fulltext/S0092-8674(16)31675-0
Letter to the editor re Sredni et al.: spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (2016) (letter–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3333-6
Disruption of hippocampal synaptic transmission and long-term potentiation by psychoactive synthetic cannabinoid ‘Spice’ compounds: comparison with Δ9 -tetrahydrocannabinol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26732435 Physiological impact of CB1 receptor expression by hippocampal GABAergic interneurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26739712 The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.eurekaselect.com/138448/article
Ligands for cannabinoid receptors, promising anticancer agents (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320515301521
Major dorsoventral differences in the modulation of the local CA1 hippocampal network by NMDA, mGlu5, adenosine A2A and cannabinoid CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26762803
Adverse effects after the use of JWH-210 – a case series from the EU Spice II plus project (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26768345
The endocannabinoid system in the human granulosa cell line KGN (abst–2016) http://www.sciencedirect.com/science/article/pii/S0303720716300065
Effects of fatty acid amide hydrolase (FAAH) inhibitors on working memory in rats (abst– 016) http://www.ncbi.nlm.nih.gov/pubmed/26558620
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26778127
Impaired cued and spatial learning performance and altered cannabinoid CB1 receptor functionality in the substantia nigra in a rat model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300249
Endocannabinoids, through opioids and prostaglandins, contribute to fever induced by key pyrogenic mediators (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26291402
Chronic alcohol exposure disrupts CB1 regulation of GABAergic transmission in the rat basolateral amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26786379
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0969996116300146
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex – possible involvement of 5-HT1A and CB1 receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300298
Involvement of the orexin/hypocretin system in the pharmacological effects induced by Δ9-tetrahydrocannabinol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26799708
CB1 Cannabinoid Agonist (WIN55,212-2) Within the Basolateral Amygdala Induced Sensitization to Morphine and Increased the Level of μ-Opioid Receptor and c-fos in the Nucleus Accumbens (abst–2016) http://link.springer.com/article/10.1007/s12031-016-0716-9
Self-administration of the anandamide transport inhibitor AM404 by squirrel monkeys (abst–2016) http://link.springer.com/article/10.1007/s00213-016-4211-3
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia (abst–2016) http://link.springer.com/article/10.1007/s12035-016-9697-5
Mn-SOD Upregulation by Electroacupuncture Attenuates Ischemic Oxidative Damage via CB1R-Mediated STAT3 Phosphorylation (abst–2016) http://link.springer.com/article/10.1007/s12035-014-8971-7
Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors (abst–2016) http://link.springer.com/article/10.1007/s00210-015-1181-7
Dentate cannabinoid-sensitive interneurons undergo unique and selective strengthening of mutual synaptic inhibition in experimental epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26804027
Opioid and Cannabinoid System in Food Intake (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26806346
Cocaine-induced behavioral sensitization decreases the expression of endocannabinoid signaling-related proteins in the mouse hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26811312
Social defeat leads to changes in the endocannabinoid system; an overexpression of calreticulin and motor impairment in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300328
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Arachidonyl-2-Chloroethylamide Alleviates Cerebral Ischemia Injury Through Glycogen Synthase Kinase-3β-Mediated Mitochondrial Biogenesis and Functional Improvement (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26820679
A systematic review of plant-derived natural compounds for anxiety disorders (abst–2016) http://www.eurekaselect.com/139238/article
Cannabinoid receptor type 1 mediates high-fat diet-induced insulin resistance by increasing forkhead box O1 activity in a mouse model of obesity (abst–2016) http://www.spandidos-publications.com/10.3892/ijmm.2016.2475
Cannabinoids for the Treatment of Schizophrenia: An Overview (abst–2016) http://www.eurekaselect.com/139245/article
Attenuation of cue-induced reinstatement of nicotine seeking by URB597 through cannabinoid CB1 receptor in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26864774
Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Involvement of M1 and CB1 receptors in the anxiogenic-like effects induced by neostigmine injected into the rat prelimbic medial prefrontal cortex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26873081
Blockade of Nicotine and Cannabinoid Reinforcement and Relapse by a Cannabinoid CB1-Receptor Neutral Antagonist AM4113 and Inverse Agonist Rimonabant in Squirrel Monkeys (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26888056
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
Investigation of receptor binding and functional characteristics of hemopressin(1-7) (abst–2016) http://www.neuropeptidesjournal.com/article/S0143-4179(16)00020-2/abstract
Stimulation of cannabinoid CB1 receptors prevents nerve-mediated airway hyperreactivity in NGF-induced inflammation in mouse airways (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26896777
Sex and age specific effects of delta-9-tetrahydrocannabinol during the periadolescent period in the rat: The unique susceptibility of the prepubescent animal. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26898326
Cannabinoid Control of Learning and Memory through HCN Channels (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00048-9?_returnURL=http%3A%2F %2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316000489%3Fshowall%3Dtrue
Immunohistochemical distribution of the cannabinoid receptor 1 and fatty acid amide hydrolase in the dog claustrum (abst–2016) http://www.sciencedirect.com/science/article/pii/S0891061815300405
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (abst–2016) http://www.eurekaselect.com/140045/article
The Hyperpolarization-Activated Cation Current Ih: The Missing Link Connecting Cannabinoids to Cognition (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273(16)00144-6?_returnURL=http%3A%2F%2Flinkinghub.elsevier.com%2Fretrieve%2Fpii%2FS0896627316001446%3Fshowall%3Dtrue
Regulation of Growth Hormone by the Splanchnic Area (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26940386
Sex differences in hippocampal response to endocannabinoids after exposure to severe stress (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26928784
Anandamide interferes with human endometrial stromal-derived cell differentiation: An effect dependent on inhibition of cyclooxygenase-2 expression and prostaglandin E2 release (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945481
Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945822
Dynamic of expression and localization of cannabinoid-degrading enzymes FAAH and MGLL in relation to CB1 during meiotic maturation of human oocytes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26948343
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965148
Role of cannabinoid receptors in renal diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26968477
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320516301643 SGIP1
Alters Internalization and Modulates Signaling of Activated Cannabinoid Receptor 1 in Biased Manner (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300806
Lack of hippocampal CB1 receptor desensitization by Δ9-tetrahydrocannabinol in aged mice and by low doses of JZL 184 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26984820
Sevoflurane Prevents Stroke-induced Depressive and Anxiety Behaviors by Promoting Cannabinoid Receptor Subtype I-dependent Interaction Between β-Arrestin 2 and ERK1/2 in the Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26991409
Central administrations of hemopressin and related peptides inhibit gastrointestinal motility in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26991932
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26993829
Computational analysis of the CB1 carboxyl-terminus in the receptor-G protein complex (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26994549
Marine Metabolites Modulating CB Receptors and TRP Channels (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-101352
Genetically reduced FAAH activity may be a risk for the development of anxiety and depression in persons with repetitive childhood trauma (abst–2016) http://www.europeanneuropsychopharmacology.com/article/S0924-977X(16)00077-8/abstract
Functional effects of cannabinoids during dopaminergic specification of human neural precursors derived from induced pluripotent stem cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27027565
Cannabinoid Receptor 1 Mediates Homing of Bone Marrow-Derived Mesenchymal Stem Cells Triggered by Chronic Liver Injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27028843
Antagonism of dopamine receptor 2 long (D2L) affects cannabinoid receptor 1 (CB1) signaling in a cell culture model of striatal medium spiny projection neurons (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27053685
Toxicological impact of JWH-018 and its phase I metabolite N-(3-hydroxypentyl) on human cell lines (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27054591
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Sustained glucocorticoid exposure recruits cortico-limbic CRH signaling to modulate endocannabinoid function (abst–2016) http://www.psyneuen-journal.com/article/S0306-4530(16)30003-8/abstract
Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100518
Crosstalk between liver antioxidant and the endocannabinoid systems after chronic administration of the FAAH inhibitor, URB597, to hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0041008X1630076X
Because difficulty is not the same for everyone: the impact of complexity in working memory is associated with cannabinoid 1 receptor genetic variation in young adults (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27108777
Broad impact of deleting endogenous cannabinoid hydrolyzing enzymes and the CB1 cannabinoid receptor on the endogenous cannabinoid-related lipidome in eight regions of the mouse brain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303449
WHERE’s MY ENTOURAGE? THE CURIOUS CASE OF 2-oleoylglycerol, 2- linolenoylglycerol and 2-palmitoylglycerol (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303346
Endocannabinoid 2-Arachidonoylglycerol Suppresses LPS-Induced Inhibition of A-Type Potassium Channel Currents in Caudate Nucleus Neurons Through CB1 Receptor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27129498
Stimulated CB1 Cannabinoid Receptor Inducing Ischemic Tolerance and Protecting Neuron from Cerebral Ischemia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27142423
Adolescent social rejection alters pain processing in a CB1 receptor dependent manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27157075
Reversal effect of simvastatin on the decrease in cannabinoid receptor 1 density in 6- hydroxydopamine lesioned rat brains (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27155397
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production (abst–2016) http://www.jrijournal.org/article/S0165-0378%2816%2930026-2/abstract
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27167970
Direct presynaptic and indirect astrocyte-mediated mechanisms both contribute to endocannabinoid signaling in the pedunculopontine nucleus of mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27169390
MicroRNA let-7d is a target of cannabinoid CB1 receptor and controls cannabinoid signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816302052
Phytocannabinoids and cannabimimetic drugs: recent patents in central nervous system disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27184693
Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27193072
Neural endocannabinoid CB1 receptor expression, social status, and behavior in male European starlings (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27206544
The effect of cannabinoids on dinitrofluorobenzene-induced experimental asthma in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27216000
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27208730
Activity of muscarinic, galanin and cannabinoid receptors in the prodromal and advanced stages in the triple transgenic mice model of Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27223629
TRPV1-FAAH-COX: The Couples Game in Pain Treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27240888
Positron Emission Tomography Studies on Cannabinoid Receptor Type 1 in Schizophrenia (abst–2016) http://www.biologicalpsychiatryjournal.com/article/S0006-3223%2816%2932303-4/abstract
Assay of CB1 Receptor Binding (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27245890
Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_11
Assay of DAGLα/β Activity (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_16
Assay of Endocannabinoid Oxidation by Cyclooxygenase-2 (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_21
Western Blotting of the Endocannabinoid System (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_25
Prefrontal activity during working memory is modulated by the interaction of variation in CB1 and COX2 coding genes and correlates with frequency of cannabis use (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261878
Effect of synthetic cannabinoids on spontaneous neuronal activity: Evaluation using Ca2+ spiking and multi-electrode arrays (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262380
CB1 Receptor Antagonism Prevents Long-Term Hyperexcitability after Head Injury by of Dynorphin-KOR System and mGluR5 in Rat Hippocampus (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27262683
Discriminative Stimulus Properties of Phytocannabinoids, Endocannabinoids, and Synthetic Cannabinoids (abst–2016) http://link.springer.com/chapter/10.1007%2F7854_2016_24
Activation of cannabinoid CB1 receptors in the ventral hippocampus improved stress induced amnesia in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27282634
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
A High Efficacy Cannabinergic Ligand (AM4054) used as a Discriminative Stimulus: Generalization to other Adamantyl Analogs and Δ9-THC in Rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301022
Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30133-8/abstract
Autophagy activation by novel inducers prevents BECN2-mediated drug tolerance to cannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27305347
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449
Basolateral amygdala CB1 cannabinoid receptors are involved in cross state-dependent memory retrieval between morphine and ethanol (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716301083
Activation of cannabinoid CB1 receptors suppresses the ROS-induced hypersensitivity of rat vagal lung C-fiber afferents (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27328978
An update on PPAR activation by cannabinoids (abst–2016) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=6
PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase (abst–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13448/abstract
Anatomical characterization of the cannabinoid cb1 receptor in cell type-specific mutant mouse rescue models (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27339436
Cannabinoid receptors in the kidney (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27367912
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action (abst–2016) https://www.researchgate.net/publication/304669756_Coadministration_of_cannabidiol_and_capsazepine_ reduces_L-DOPA-induced_dyskinesia_in_mice_Possible_mechanism_of_action
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst–2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Mechanical and material properties of cortical and trabecular bone from cannabinoid receptor-1-null (Cnr1-/-) mice (abst–2016) http://www.medengphys.com/article/S1350-4533(16)30148-5/abstract
Effects of the cannabinoid 1 receptor peptide ligands hemopressin, (m)RVDhemopressin(α) and (m)VD-hemopressin(α) on memory in novel object and object location recognition tasks in normal young and Aβ1-42-treated mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1074742716301307
Blockade of Cannabinoid CB1 receptor attenuates the acquisition of morphine-induced conditioned place preference along with a downregulation of ERK, CREB phosphorylation, and BDNF expression in the nucleus accumbens and hippocampus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305419
Deficient adolescent social behavior following early-life inflammation is ameliorated by augmentation of anandamide signaling (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453335
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305353
Cannabinoid Receptor 1 (CNR1) Gene Variant Moderates Neural Index of Cognitive Disruption during Nicotine Withdrawal (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27453054
A study of cannabinoid-1 receptors during the early phase of excitotoxic damage to rat spinal locomotor networks in vitro (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450568
Expression of the Endocannabinoid Receptor 1 in Human Stroke: An Autoptic Study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27425766
Cannabinoid receptor agonist WIN55,212-2 and fatty acid amide hydrolase inhibitor URB597 may protect against cognitive impairment in rats of chronic cerebral hypoperfusion via PI3K/AKT signaling (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816304375
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Evaluation of first generation synthetic cannabinoids on binding at non-cannabinoid receptors and in a battery of in vivo assays in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816303021
Involvement of endocannabinoid neurotransmission in the bed nucleus of stria terminalis in cardiovascular responses to acute restraint stress in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27441413
Endocannabinoids participate in placental apoptosis induced by hypoxia inducible factor- 1 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488203
Projection-Specific Dynamic Regulation of Inhibition in Amygdala Micro-Circuits (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27497223
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9- tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303395
Acute Stress Suppresses Synaptic Inhibition and Increases Anxiety via Endocannabinoid Release in the Basolateral Amygdala (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27511017
Cannabinoid Receptor Interacting Protein (CRIP1a) suppresses agonist-driven CB1 receptor internalization, and regulates receptor replenishment in an agonist-biased manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27513693
Metabolism of endocannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27516570
Peripheral and central CB1 cannabinoid receptors control stress-induced impairment of memory consolidation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27528659
Heterologous Regulation of the Cannabinoid Type 1 Receptor by Angiotensin II in Astrocytes of Spontaneously Hypertensive Rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27529509
Anandamide reverses depressive-like behavior, neurochemical abnormalities and oxidative-stress parameters in streptozotocin-diabetic rats: Role of CB1 receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27544303
Cannabinoid type 1 receptor antagonism ameliorates harmaline-induced essential tremor in rat (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27545646
The endocannabinoid anandamide impairs in vitro decidualization of human cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27568210
mGluR1/5 activation in the lateral hypothalamus increases food intake via the endocannabinoid system (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305997
Endocannabinoid mechanism for orofacial antinociception induced by electroacupuncture in acupoint St36 in rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S1734114016300913
Peltatoside Isolated from Annona crassiflora Induces Peripheral Antinociception by Activation of the Cannabinoid System (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27574895
Activation of cannabinoid CB1 receptor contributes to suppression of spinal nociceptive transmission and inhibition of mechanical hypersensitivity by Aβ-fiber stimulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27589093
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591408
CB1 cannabinoid receptor-mediated anandamide signalling mechanisms of the inferior colliculus modulate the haloperidol-induced catalepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27595886
Dorsal hippocampus cannabinoid type 1 receptors modulate the expression of contextual fear conditioning in rats: Involvement of local glutamatergic/nitrergic and GABAergic neurotransmissions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27591981
Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27600019
Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27606334
Spontaneous involution of pediatric low-grade gliomas: high expression of cannabinoid receptor 1 (CNR1) at the time of diagnosis may indicate involvement of the endocannabinoid system (abst–2016) http://link.springer.com/article/10.1007%2Fs00381-016-3243-7
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623929
Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623930
Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27630088
Sexually-dimorphic alterations in cannabinoid receptor density depend upon prenatal / early postnatal history (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27634313
Seeing through the smoke: human and animal studies of cannabis use and endocannabinoid signalling in corticolimbic networks (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763415303638
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Bisphenol A induces hypothalamic down-regulation of CB1 and anorexigenic effects in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27641926
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Endocannabinoid receptor blockade increases vascular endothelial growth factor and inflammatory markers in obese women with polycystic ovary syndrome (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27651218
The Synthetic Cannabinoids Phenomenon (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27655416
Expression of Cannabinoid Type 1 Receptors in Human Odontoblast Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27989582
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Phytocannabinoids: a growing family of plant natural products with increasing pharmacological and clinical importance (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596088
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28011441
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites (abst–2016) http://link.springer.com/chapter/10.1007%2F7854_2016_60
Circulating levels of endocannabinoids respond acutely to voluntary exercise, are altered in mice selectively bred for high voluntary wheel running, and differ between the sexes (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28017680
The CB1 receptor is required for the establishment of the hyperlocomotor phenotype in developmentally-induced hypothyroidism in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816305822
Phytochemical and biological evaluation of Salvia apiana (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28025900
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext
Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
Synaptic Reorganization of the Perisomatic Inhibitory Network in Hippocampi of Temporal Lobe Epileptic Patients (full–2017) https://www.hindawi.com/journals/bmri/2017/7154295/
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216056/
Singular Location and Signaling Profile of Adenosine A2A-Cannabinoid CB1 Receptor Heteromers in the Dorsal Striatum (link to download–2017) http://www.nature.com/npp/journal/vaop/naam/abs/npp201712a.html
Peripheral endocannabinoid signaling controls hyperphagia in western diet-induced obesity (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28065722
Developmental Role of Macrophage Cannabinoid-1 Receptor Signaling in Type-2 Diabetes (abst–2017) http://diabetes.diabetesjournals.org/content/early/2017/01/11/db16-1199.long
Design, Synthesis and Biological Evaluation of Novel, Non-Brain Penetrant, Hybrid Cannabinoid CB1R Inverse Agonist/Inducible Nitric Oxide Synthase (iNOS) Inhibitors for the Treatment of Liver Fibrosis (abst–2017) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b01504
Pharmacology of cannabinoids in the treatment of epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28087250
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28100744
N-Oleoylglycine-induced hyperphagia was associated with the activation of AgRP neuron by CB1R (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28102080
Enantio-specific Allosteric Modulation of Cannabinoid 1 Receptor (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28103441
Chemical Proteomics Maps Brain Region Specific Activity of Endocannabinoid Hydrolases (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28106377
Endocannabinoid activation of CB1 receptors contributes to long-lasting reversal of neuropathic pain by repetitive spinal cord stimulation (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107590
Role of cannabis in digestive disorders (abst–2017) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=3
A preliminary study of endocannabinoid system regulation in psychosis: Distinct alterations of CNR1 promoter DNA methylation in patients with schizophrenia (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28108228
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Molecular Targets of the Phytocannabinoids: A Complex Picture (abst–2017) http://link.springer.com/chapter/10.1007%2F978-3-319-45541-9_4
Antihyperalgesic effect of CB1 receptor activation involves the modulation of P2X3 receptor in the primary afferent neuron (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28131783 Decreased expression of fatty acid amide hydrolase in women with polycystic ovary syndrome (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28132572 Endocannabinoid Signaling and the Hypothalamic-Pituitary-Adrenal Axis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28134998


CBR-CB1b CANNABINOID RECEPTOR
Co-expression of Human Cannabinoid receptor coding region splice variants (hCB₁) affects the function of hCB₁ receptor complexes (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24091169
Effects of dietary nucleotides on acute stress response and cannabinoid receptor 1 mRNAs in sole, Solea solea (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23261992
Human CB1 Receptor Isoforms, present in Hepatocytes and β-cells, are Involved in Regulating Metabolism (full–2016) http://www.nature.com/articles/srep33302
Targeted proteomics of cannabinoid receptor CB1 and the CB1b isoform (abst–2016) http://www.sciencedirect.com/science/article/pii/S0731708516310317


CBR-CB2 CANNABINOID RECEPTOR
Paradoxical effects of the cannabinoid CB2 receptor agonist GW405833 on rat osteoarthritic knee joint pain (full–2010) http://www.oarsijournal.com/article/S1063-4584%2810%2900315-8/fulltext
CB2: a cannabinoid receptor with an identity crisis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931549/?tool=pubmed
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2893662/
Cannabinoid-mediated modulation of neuropathic pain and microglial accumulation in a model of murine type I diabetic peripheral neuropathic pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2845559/?tool=pmcentrez
Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2869084/?tool=pubmed
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full–2010) http://www.biomedcentral.com/1471-2202/11/44
Tonic modulation of spinal hyperexcitability by the endocannabinoid receptor system in a rat model of osteoarthritis pain (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132591/?tool=pubmed
Small intestinal cannabinoid receptor changes following a single colonic insult with oil of mustard in mice (full–2010) http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00132/full
Cannabinoid inhibition of macrophage migration to the trans-activating (Tat) protein of HIV-1 is linked to the CB(2) cannabinoid receptor (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2846023/?tool=pubmed
The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2970523/?tool=pubmed
Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2930808/?tool=pubmed
Immunoregulation of a CB2 receptor agonist in a murine model of neuroAIDS (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109320/
Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone (SAB378), a peripherally restricted cannabinoid CB1/CB2 receptor agonist, inhibits gastrointestinal motility but has no effect on experimental colitis in mice (full–2010) http://jpet.aspetjournals.org/content/334/3/973.long
Oxidation of the Endogenous Cannabinoid Arachidonoyl Ethanolamide by the Cytochrome P450 Monooxygenases: Physiological and Pharmacological Implications (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2835397/?tool=pubmed
The expression level of CB1 and CB2 receptors determines their efficacy at inducing apoptosis in astrocytomas (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2806825/?tool=pubmed
The levels of the endocannabinoid receptor CB2 and its ligand 2-arachidonoylglycerol are elevated in endometrial carcinoma (full–2010) http://press.endocrine.org/doi/full/10.1210/en.2009-0883
Interaction between anandamide and sphingosine-1-phosphate in mediating vasorelaxation in rat coronary artery (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2962826/?tool=pubmed
Cannabinoid Receptors are Coupled to Stimulation of Insulin Secretion from Mouse MIN6 β-cells (full–2010) http://www.karger.com/Article/Pdf/320527
Depression-resistant endophenotype in mice overexpressing cannabinoid CB2 receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936848/?report=classic
Patent 7741365 Peripheral cannabinoid receptor (CB2) selective ligands (full–2010) http://www.freepatentsonline.com/7741365.html
CB2 Cannabinoid Receptor Targets Mitogenic Gi Protein–Cyclin D1 Axis in Osteoblasts (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3179350/
Cannabinoid Receptors, CB1 and CB2, as Novel Targets for Inhibition of Non-Small Cell Lung Cancer Growth and Metastasis (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/
Patent 7741365 Peripheral cannabinoid receptor (CB2) selective ligands (full–2010) http://www.freepatentsonline.com/7741365.html
Cannabinoid (JWH-133) therapy could be effective for treatment of corneal neovascularization (link to PDF–2010) http://ijmhi.tums.ac.ir/index.php/ijmhi/article/view/72/72
Brain CB2 Receptors: Implications for Neuropsychiatric Disorders (link to PDF–2010) http://www.mdpi.com/1424-8247/3/8/2517
Endocannabinoids and Schizophrenia (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3101
Endocannabinoids and Human Sperm Cells (link to PDF–2010) http://www.mdpi.com/1424-8247/3/10/3200
The development of cannabinoid CBII receptor agonists for the treatment of central neuropathies (link to PDF–2010) http://www.eurekaselect.com/85808/article
The Role of Cannabinoid Receptors in the Descending Modulation of Pain (link to PDF-2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72
Activation of cannabinoid 2 receptors protects against cerebral ischemia by inhibiting neutrophil recruitment (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19884325
Altered expression of cannabinoid receptors 1 and 2 and activated endocannabinoid system in patients with severe chronic heart failure (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0029-1246924
A nonsynonymous polymorphism in cannabinoid CB2 receptor gene is associated with eating disorders in humans and food intake is modified in mice by its ligands (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19768813
Expression of cannabinoid receptor 2 in squamous cell carcinoma (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20335147
Brain cannabinoid CB2 receptor in schizophrenia (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931854
Dronabinol for the treatment of unspecific pain, restlessness and spasticity in neuropaediatrics (abst–2010) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0030-1265622
The cannabinoid receptor type 2 is time-dependently expressed during skeletal muscle wound healing in rats (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20535492
Cannabinoid subtype-2 receptors modulate the antihyperalgesic effect of WIN 55,212-2 in rats with neuropathic spinal cord injury pain (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20920894
Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19931541
Localization and function of cannabinoid receptors in the corpus cavernosum: basis for modulation of nitric oxide synthase nerve activity (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19147270
Functionally selective cannabinoid receptor signalling: Therapeutic implications and opportunities (abst–2010) http://www.sciencedirect.com/science/article/pii/S0006295210001553
Role of the endocannabinoid system in alcoholic liver disease (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21525760
Histomorphometric evaluation of cannabinoid receptor and anandamide modulating enzyme expression in the human endometrium through the menstrual cycle (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20369362
Activation of cannabinoid receptor CB2 regulates osteogenic and osteoclastogenic gene expression in human periodontal ligament cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20412420
CB1 and CB2 cannabinoid receptor expression during development and in epileptogenic developmental pathologies (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20621164
Studies demonstrate analgesic properties of synthetic cannabinoid (news–2010) http://www.news-medical.net/news/20100702/Studies-demonstrate-analgesic-properties-of-syntheticcannabinoid.aspx
Transient receptor potential A1 and cannabinoid receptor activity in human normal and hyperplastic prostate: relation to nerves and interstitial cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/19733001
Electroacupuncture increases CB2 receptor expression on keratinocytes and infiltrating inflammatory cells in inflamed skin tissues of rats (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20627823
Peripheral cannabinoid type 2 receptor regulates osteoclast formation, MDA-MB-231 breast cancer cell migration and bone marrow/tumour cell interaction via PI3 kinase/AKT and P38 pathways (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2901828-4/abstract
Loss of the cannabinoid receptor CB2 alters the mechanical but not the material properties of bone (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2900716-7/abstract
The type 2 cannabinoid receptor protects against age-related bone loss and ovariectomy induced bone loss by stimulating bone formation (abst–2010) http://www.thebonejournal.com/article/S8756-3282%2810%2900619-8/abstract
Novel natural and synthetic ligands of the endocannabinoid system (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20166928
Deletion of CB2 Cannabinoid Receptor Induces Schizophrenia-Related Behaviors in Mice (full–2011) http://www.nature.com/npp/journal/v36/n7/full/npp201134a.html
Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3025486/?tool=pubmed
Endocannabinoids and traumatic brain injury (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165950/?tool=pubmed
Cannabinoid receptor 2 signaling does not modulate atherogenesis in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3082575/?tool=pubmed
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070571/
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3223692/
New blood brothers: the GPR55 and CB2 partnership (full–2011) http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html
Functional selectivity in CB2 cannabinoid receptor signaling and regulation: implications for the therapeutic potential of CB2 ligands (full–2011) http://molpharm.aspetjournals.org/content/early/2011/11/07/mol.111.074013.long
The Antinociceptive Effects of JWH-015 in Chronic Inflammatory Pain Are Produced by Nitric Oxide-cGMP-PKG-KATP Pathway Activation Mediated by Opioids (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3198780/?tool=pubmed
Cannabinoid CB2 Receptors Contribute to Upregulation of β-endorphin in Inflamed Skin Tissues by Electroacupuncture (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3281798/
Crosstalk between chemokine receptor CXCR4 and cannabinoid receptor CB2 in modulating breast cancer growth and invasion (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168464/?tool=pubmed
HIV-1 infection and alcohol abuse: neurocognitive impairment, mechanisms of neurodegeneration and therapeutic interventions (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3098312/
Endocannabinoid system in cardiovascular disorders – new pharmacotherapeutic opportunities (full–2011) http://www.jpbsonline.org/article.asp?issn=0975-7406;year=2011;volume=3;issue=3;spage=350;epage=360;aulast=Cunha
Cannabinoid Receptor 2 Deficiency in Haematopoietic cells Aggravates Early Atherosclerosis in LDL Receptor Deficient Mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3109635/?tool=pubmed
Regulatory effect of cannabinoid receptor agonist on chemokine-induced lymphocyte chemotaxis (full–2011) https://www.jstage.jst.go.jp/article/bpb/34/7/34_7_1090/_pdf
Protective Role of Cannabinoid Receptor Type 2 in a Mouse Model of Diabetic Nephropathy (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3161308/
Gadolinium-HU-308-incorporated micelles (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK54067/pdf/CB2R-Gd-Micelles.pdf
Is lipid signaling through cannabinoid 2 receptors part of a protective system? (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3062638/
Commentary: Functional Neuronal CB2 Cannabinoid Receptors in the CNS (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3137183/?tool=pubmed
Resolution of inflammation by N-arachidonoylglycine (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3196844/
Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating kupffer cell polarization in mice (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.24524/full
Activation of cannabinoid type 2 receptors inhibits HIV-1 envelope glycoprotein gp120-induced synapse loss (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164336/
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques (full–2011) http://eurheartj.oxfordjournals.org/content/33/7/846.full
CNR2 functional variant (Q63R) influences childhood immune thrombocytopenic purpura (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3232275/
The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief (full–2011) http://www.hindawi.com/isrn/anesthesiology/2011/593894/
Beneficial paracrine effects of cannabinoid receptor 2 on liver injury and regeneration (full–2011) http://onlinelibrary.wiley.com/doi/10.1002/hep.23779/full
Sex Differences in Cannabinoid 1 vs. Cannabinoid 2 Receptor-Selective Antagonism of Antinociception Produced by Δ9-Tetrahydrocannabinol and CP55,940 in the Rat (full–2011)  http://jpet.aspetjournals.org/content/340/3/787.full
Cannabinoid Receptor 2 Is Critical for the Homing and Retention of Marginal Zone B Lineage Cells and for Efficient T-Independent Immune Responses (full–2011) http://www.jimmunol.org/content/187/11/5720.full.pdf+html
N-arachidonoyl–serine is neuroprotective after traumatic brain injury by reducing apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3170948/
Cannabinoids and bone: endocannabinoids modulate human osteoclast function in vitro (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01519.x/full
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (full–2011) http://press.endocrine.org/doi/full/10.1210/en.2010-0930
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132458/pdf/cr201160a.pdf
Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3186912/pdf/fnbeh-05-00063.pdf
CB2 Cannabinoid Receptors Promote Neural Progenitor Cell Proliferation via mTORC1 Signaling (full–2011) http://www.jbc.org/content/287/2/1198.full
CNS effects of CB2 cannabinoid receptors: beyond neuro-immuno-cannabinoid activity (full–2011) http://jop.sagepub.com/content/26/1/92.full
Self-medication of a cannabinoid CB(2) agonist in an animal model of neuropathic pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3157548/pdf/nihms285774.pdf
Brain cannabinoid CB2 receptors modulate cocaine’s actions in mice (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3164946/
Increasing 2-arachidonoyl glycerol signaling in the periphery attenuates mechanical hyperalgesia in a model of bone cancer pain (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3104059/
Cannabinoid receptor 2 positions and retains marginal zone B cells within the splenic marginal zone (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3182059/
Cannabinoid receptor-2 (CB2) agonist ameliorates colitis in IL-10(-/-) mice by attenuating the activation of T cells and promoting their apoptosis (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4117838/
Deletion of cannabinoid receptors 1 and 2 exacerbates APC function to increase inflammation and cellular immunity during influenza infection (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3206470/
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21855337
Design and evaluation of a novel fluorescent CB2 ligand as probe for receptor visualization in immune cells (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3171627/
The highs and lows of cannabinoid receptor expression in disease: mechanisms and their therapeutic implications (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141881/
Expression of the cannabinoid system in muscle: effects of a high fat diet and CB1 receptor blockade (full–2011) http://www.biochemj.org/content/433/1/175
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21626285
Unraveling the complexities of cannabinoid receptor 2 (CB2) immune regulation in health and disease (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624216/
Cannabidiol decreases body weight gain in rats: Involvement of CB2 receptors (abst-2011) http://www.sciencedirect.com/science/article/pii/S0304394010015776
The role of central CB2 cannabinoid receptors on food intake in neonatal chicks (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21927979
Win 55,212-2 reduces cardiac ischaemia-reperfusion injury in zucker diabetic fatty rats: role of cb2 receptors and cardiac inos/enos expression (abst–2011) http://www.unboundmedicine.com/medline/ebm/record/21309057/abstract/Win_55212_2_reduces_cardiac_ischaemia_reperfusion_injury_in_zucker_diabetic_fatty_rats:_role_of_cb2_receptors_and_cardiac_inos/enos_expression_
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20980074
The endocannabinoid anandamide downregulates IL-23 and IL-12 subunits in a viral model of multiple sclerosis: evidence for a cross-talk between IL-12p70/IL-23 axis and IL-10 in microglial cells (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21310228
Genetic association between bipolar disorder and 524A>C (Leu133Ile) polymorphism of CNR2 gene, encoding for CB2 cannabinoid receptor (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21658778
Cloning and pharmacological characterization of the dog cannabinoid CB2 receptor (abst–2011) http://www.sciencedirect.com/science/article/pii/S0014299911008788
G-protein coupled receptors regulating cough (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21727026
Atheroprotection via cannabinoid receptor-2 is mediated by circulating and vascular cells in vivo (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21884703
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells (abst–2011) http://eprints.hud.ac.uk/16197/
Endocannabinoid pathways and their role in multiple sclerosis-related muscular dysfunction (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21449854
Regulation of hematopoietic stem cell trafficking and mobilization by the endocannabinoid system (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22074629 Antinociceptive effects induced through the stimulation of spinal cannabinoid type 2 receptors in chronically inflamed mice (abst-2011) http://www.unboundmedicine.com/medline/ebm/record/21771590/abstract/Antinociceptive_effects_induced_through_the_stimulation_of_spinal_cannabinoid_type_2_receptors_in_chronically_inflamed_mice_
New targets, new drugs for metastatic bone pain: a new philosophy (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21623686
Spinal cannabinoid CB2 receptors as a target for neuropathic pain: an investigation using chronic constriction injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22210507
Cannabinoid-2 Receptor Activation Protects against Infarct and Ischemia/Reperfusion Heart Injury (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22113346
Cannabinoid receptor type 2 activation yields delayed tolerance to focal cerebral ischemia. (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21443454
The endocannabinoid system in the cancer therapy: an overview (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21428888
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/22337285
The role of central CB2 cannabinoid receptors on food intake in neonatal chicks (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21927979
Comparison Of Rat And Human Eyes For The Presence And Distribution Of Cb1 And Cb2 Receptors (abst-2011) http://iovs.arvojournals.org/article.aspx?articleid=2357116&resultClick=1
Expression of cannabinoid receptors by human articular chondrocytes (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900386-3/abstract
The CB2 receptor regulates osteoclast formation, breast cancer cell migration and osteoclast/tumour cell interaction via the PI3 Kinase/AKT pathway (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900177-3/abstract
Cannabinoids and sepsis (abst–2011) http://www.trendsanaesthesiacriticalcare.com/article/S2210-8440%2811%2900049-9/fulltext
Cannabinoid receptors: nomenclature and pharmacological principles (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3378782/
Effects of a Selective Cannabinoid CB2 Agonist and Antagonist on Intravenous Nicotine Self Administration and Reinstatement of Nicotine Seeking (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266883/?tool=pubmed
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419612/
Endocannabinoids Stimulate Human Melanogenesis via Type-1 Cannabinoid Receptor (full–2012) http://www.jbc.org/content/early/2012/03/19/jbc.M111.314880.full.pdf+html
The role of CB2 receptor ligands in human eosinophil function (full–2012) http://www.biomedcentral.com/content/pdf/2050-6511-13-S1-A13.pdf
Cannabinoid Receptor 2-Mediated Attenuation of CXCR4-Tropic HIV Infection in Primary CD4+ T Cells (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0033961
Cannabinoids and atherosclerotic coronary heart disease (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/clc.21962/pdf
Targeting cannabinoid receptor CB2 in cardiovascular disorders: promises and controversies (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02042.x/pdf
Cannabinoid receptor 2 activation reduces intestinal leukocyte recruitment and systemic inflammatory mediator release in acute experimental sepsis (full–2012) http://ccforum.com/content/16/2/R47
Cannabinoid Receptor 2 Signaling in Peripheral Immune Cells Modulates Disease Onset and Severity in Mouse Models of Huntington’s Disease (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753072/
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
Disease modification of breast cancer-induced bone remodeling by cannabinoid 2 receptor agonists (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/jbmr.1732/full
The fatty acid amide hydrolase inhibitor URB597 exerts anti-inflammatory effects in hippocampus of aged rats and restores an age-related deficit in long-term potentiation (full–2012) http://www.jneuroinflammation.com/content/9/1/79
Cannabinoid modulation of neuroinflammatory disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3386505/
Functional Metabolomics Reveals Novel Active Products in the DHA Metabolome (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342038/?tool=pubmed
Therapeutic Potentials and uses of Cannabinoid Agonists in Health and Disease Conditions  (full–2012) http://maxwellsci.com/print/bjpt/v3-76-88.pdf
Role of cannabinoids in the regulation of bone remodeling (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/
Early Endogenous Activation of CB1 and CB2 Receptors after Spinal Cord Injury Is a Protective Response Involved in Spontaneous Recovery (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3496738/
The maintenance of cisplatin- and paclitaxel-induced mechanical and cold allodynia is suppressed by cannabinoid CB2 receptor activation and independent of CXCR4 signaling in models of chemotherapy-induced peripheral neuropathy (full–2012) http://www.molecularpain.com/content/8/1/71
Differences in the endocannabinoid system of sperm from fertile and infertile men (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0047704
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02019.x/full
Inhibitory effect of 4-O-methylhonokiol on lipopolysaccharide-induced neuroinflammation, amyloidogenesis and memory impairment via inhibition of nuclear factor-kappaB in vitro and in vivo models (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3323460/
The Therapeutic Potential of Cannabis and Cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3442177/
Inhibition of monoacylglycerol lipase attenuates vomiting in Suncus murinus and 2- arachidonoyl glycerol attenuates nausea in rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423233/
Cannabinoids Facilitate the Swallowing Reflex Elicited by the Superior Laryngeal Nerve Stimulation in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3507745/
Cannabinoid receptor type 2 functional variant influences liver damage in children with non-alcoholic Fatty liver disease (full–2012) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0042259
Therapeutic modulation of cannabinoid lipid signaling: Metabolic profiling of a novel antinociceptive cannabinoid-2 receptor agonist (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3493696/
Cannabinoid receptors in submandibular acinar cells: Functional coupling between saliva fluid and electrolytes secretion and Ca2+ signalling (full–2012) http://jcs.biologists.org/content/125/8/1884.full
Localization of mGluR5, GABA(B), GABA(A), and cannabinoid receptors on the vagovagal reflex pathway responsible for transient lower esophageal sphincter relaxation in humans: an immunohistochemical study (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01868.x/full
The CB(2)-preferring agonist JWH015 also potently and efficaciously activates CB(1) in autaptic hippocampal neurons (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3601544/
Sativex-like Combination of Phytocannabinoids is Neuroprotective in Malonate-Lesioned Rats, an Inflammatory Model of Huntington’s Disease: Role of CB(1) and CB(2) Receptors. (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382456/
Endocannabinoids in nervous system health and disease: the big picture in a nutshell (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3193.full
Betulinic Acid Targets YY1 and ErbB2 through Cannabinoid Receptor-Dependent Disruption of MicroRNA-27a:ZBTB10 in Breast Cancer (full–2012) http://www.ncbi.nlm.nih.gov/pubmed/22553354
Review article: Why do cannabinoid receptors have more than one endogenous ligand? (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3216.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Methylhonokiol attenuates neuroinflammation: a role for cannabinoid receptors? (full–2012) http://www.jneuroinflammation.com/content/9/1/135
Cannabinoid receptor 2 agonist ameliorates mesenteric angiogenesis and portosystemic collaterals in cirrhotic rats (full–2012) http://onlinelibrary.wiley.com/doi/10.1002/hep.25625/full
Δ(8)-Tetrahydrocannabivarin prevents hepatic ischaemia/reperfusion injury by decreasing oxidative stress and inflammatory responses through cannabinoid CB(2) receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423240/
β-Caryophyllene ameliorates cisplatin-induced nephrotoxicity in a cannabinoid 2 receptor-dependent manner (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3312970/
Dynamic changes to the endocannabinoid system in models of chronic pain (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3300.full?sid=1569c370-cd5c-4358-89ff-857201f5e069
Intrathecal cannabilactone CB(2)R agonist, AM1710, controls pathological pain and restores basal cytokine levels (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3603341/
Endocannabinoid signaling in female reproduction (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3382454/
Excitability of prefrontal cortical pyramidal neurons is modulated by activation of 98 intracellular type-2 cannabinoid receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3295302/
Activation of Cannabinoid Receptor 2 reduces inflammation in acute experimental pancreatitis via intra-acinar activation of p38 and MK2-dependent mechanisms (full–2012) http://ajpgi.physiology.org/content/304/2/G181
Ectopic pregnancy is associated with high anandamide levels and aberrant expression of FAAH and CB1 in fallopian tubes (full–2012) http://press.endocrine.org/doi/full/10.1210/jc.2012-1780
Cannabidiol for neurodegenerative disorders: important new clinical applications for this phytocannabinoid? (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3579248/
Review article: The endocannabinoid system in normal and pathological brain ageing (full–2012) http://rstb.royalsocietypublishing.org/content/367/1607/3326.full?sid=161e7b36-5055-448b-962e-697c782e901d
Inhibiting fatty acid amide hydrolase normalizes endotoxin-induced enhanced gastrointestinal motility in mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372737/
Prevention of Paclitaxel-Induced Neuropathy Through Activation of the Central Cannabinoid Type 2 Receptor System (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3334436/
Alteration of endocannabinoid system in human gliomas (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1471-4159.2011.07625.x/full
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
Cannabinoid type 2 receptor activation downregulates stroke-induced classic and alternative brain macrophage/microglial activation concomitant to neuroprotection (full–2012) http://stroke.ahajournals.org/content/43/1/211.long
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375509/
Cannabinoid CB(2) receptor-mediated regulation of impulsive-like behaviour in DBA/2 mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3252982/
Activation of cannabinoid receptor 2 attenuates leukocyte-endothelial cell interactions and blood-brain barrier dysfunction under inflammatory conditions (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3325902/
Signaling through cannabinoid receptor 2 suppresses murine dendritic cell migration by inhibiting matrix metalloproteinase 9 expression (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488886/
Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3936256/
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Nonsmall Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22578958
Anti-proliferative and Anti-angiogenic Effects of CB2R Agonist (JWH-133) in Nonsmall Lung Cancer Cells (A549) and Human Umbilical Vein Endothelial Cells: an in Vitro Investigation (full–2012) http://fb.cuni.cz/file/5640/FB2012A0013.pdf Psychopharmacology of the endocannabinoids: far beyond anandamide (full–2012) http://www.researchgate.net/publication/51201177_Psychopharmacology_of_the_endocannabinoids_far_be yond_anandamide
Targeting the endocannabinoid system with cannabinoid receptor agonists: pharmacological strategies and therapeutic possibilities (full – 2012) http://rstb.royalsocietypublishing.org/content/367/1607/3353.full?sid=1569c370-cd5c-4358-89ff- 857201f5e069
Local Peripheral Effects of β-Caryophyllene through CB2 Receptors in Neuropathic Pain in Mice (full–2012) http://file.scirp.org/Html/23613.html
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (abst–2012) http://jop.sagepub.com/content/26/10/1391
Genetic variability in the endocannabinoid system and 12-week clinical response to citalopram treatment: the role of the CNR1, CNR2 and FAAH genes (full–2012) http://journals.sagepub.com/doi/full/10.1177/0269881112454229
Cannabinoid Receptor CB2 Modulates Axon Guidance (link to PDF-2012) http://citeseerx.ist.psu.edu/viewdoc/summary? doi=10.1.1.727.7765&rank=63&q=cannabinoid&osm=&ossid=
The biochemical complexity of the endocannabinoid system with some remarks on stress and related disorders: a minireview (abst – 2012) http://www.ncbi.nlm.nih.gov/pubmed/22540859
Cannabinoid receptor type 2 is time-dependently expressed during skin wound healing in mice (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22814434
G protein-coupled receptor crosstalk and signaling in hematopoietic stem and progenitor cells (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22901257
Small-animal PET imaging of the type 1 and type 2 cannabinoid receptors in a photothrombotic stroke model (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22895861
4-O-methylhonokiol prevents memory impairment in the Tg2576 transgenic mice model of Alzheimer’s disease via regulation of β-secretase activity (abst–2012) https://www.ncbi.nlm.nih.gov/pubmed/22330831
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22795792
Effect of omega-3 polyunsaturated fatty acids on the endocannabinoid system in osteoblast-like cells and muscle (abst–2012) http://docs.lib.purdue.edu/dissertations/AAI3444794/
Behavioral effects of pulp exposure in mice lacking cannabinoid receptor 2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22152627
Role of cannabinoid 2 receptor in the development of bone cancer pain (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22490961
Overexpression of CB2 cannabinoid receptors results in neuroprotection against behavioral and neurochemical alterations induced by intracaudate administration of 6-hydroxydopamine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/20980074
Overexpression of cannabinoid CB2 receptor in the brain induces hyperglycaemia and a lean phenotype in adult mice (abst-2012) http://www.ncbi.nlm.nih.gov/pubmed/22487302
Cannabinoids and muscular pain. Effectiveness of the local administration in rat (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22354705
Platelet-rich plasma loaded hydrogel scaffold enhances chondrogenic differentiation and maturation with up-regulation of CB1 and CB2 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22366523
The Role of Cannabinoids In Inflammatory Modulation of Allergic Respiratory Disorders, Inflammatory Pain and Ischemic Stroke (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22420307
The Cannabinoid Receptor type 2 Q63R variant increases the risk of celiac disease: Implication for a novel molecular biomarker and future therapeutic intervention (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812000540
The therapeutic potential of the endocannabinoid system for Alzheimer’s disease (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22448595
Role of Lipid Rafts/Caveolae in the Anticancer Effect of Endocannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22625418
Cannabinoid receptor type 1 and 2 expression in the skin of healthy dogs and dogs with atopic dermatitis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22738050
THE CO-EXPRESSION OF THE ENDOCANNABINOID SYSTEM AND THE RANK/RANKL SIGNALLING PATHWAY IN HUMAN BONE AND OSTEOCLAST CULTURE (abst–2012) http://www.bjjprocs.boneandjoint.org.uk/content/94-B/SUPP_XVIII/7.abstract?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Cannabinoid receptor-2-selective agonists improve recovery in experimental autoimmune encephalomyelitis (abst–2012) http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/116.7?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22763024
Cannabinoid receptor 2 agonists inhibit migration of activated dendritic cells via modulation of MMP-9 (abst–2012) http://www.jimmunol.org/cgi/content/meeting_abstract/188/1_MeetingAbstracts/173.23?maxtoshow=&hits=25&RESULTFORMAT=&fulltext=cannabinoid&searchid=1&FIRSTINDEX=130&sortspec=date&resourcetype=HWCIT
Discovery and optimization of novel purines as potent and selective CB2 agonists (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22765893
Spinal Cord Fatty Acid Amide Hydrolase (FAAH) in Normal Micturition Control and Bladder Overactivity in Awake Rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23219540
A cannabinoid type 2 receptor agonist attenuates blood-brain barrier damage and neurodegeneration in a murine model of traumatic brain injury (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22903455
Expression of fatty acid amide hydrolase (FAAH) in human, mouse, and rat urinary bladder and effects of FAAH inhibition on bladder function in awake rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21930339
Neuroprotective agents: cannabinoids (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21420365
Electroacupuncture reduces the expression of proinflammatory cytokines in inflamed skin tissues through activation of cannabinoid CB2 receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22337285
Anandamide enhances expression of heat shock protein 72 to protect against ischemia reperfusion injury in rat heart (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23007622
Cannabinoid Receptor Subtypes 1 and 2 Mediate Long-Lasting Neuroprotection and Improve Motor Behaviour Deficits After Transient Focal Cerebral Ischemia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23069763
4-Oxo-1,4-dihydropyridines as Selective CB2 Cannabinoid Receptor Ligands Part 2: Discovery of New Agonists Endowed with Protective Effect Against Experimental Colitis (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23017078
Distribution and function of the endocannabinoid system in the rat and human bladder (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23081739
The cannabinoid receptor-2 is involved in allergic inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22525379
Involvement of peripheral cannabinoid and opioid receptors in β-caryophyllene-induced antinociception (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23138934
Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/and.12006/abstract
Anandamide Induces Matrix Metalloproteinase-2 Production through Cannabinoid-1 Receptor and Transient Receptor Potential Vanilloid-1 in Human Dental Pulp Cells in Culture (abst–2012) http://www.jendodon.com/article/PIIS0099239912002191/abstract?rss=yes
CD200-CD200R1 interaction contributes to neuroprotective effects of anandamide on experimentally induced inflammation (abst–2012) http://onlinelibrary.wiley.com/doi/10.1002/glia.22366/abstract
Role of CB1 and CB2 cannabinoid receptors in the development of joint pain induced by monosodium iodoacetate (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23199705
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23253273
Hind limb suspension and long-chain omega-3 PUFA increase mRNA endocannabinoid system levels in skeletal muscle (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22051448
A CB₁/CB₂ receptor agonist, WIN 55,212-2, exerts its therapeutic effect in a viral autoimmune model of multiple sclerosis by restoring self-tolerance to myelin (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22561283
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001980
Regulation of opioid and cannabinoid receptor genes in human neuroblastoma and T cells by the epigenetic modifiers trichostatin A and 5-aza-2′-deoxycytidine (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22262103
Involvement of the endogenous cannabinoid 2 ligand 2-arachidonyl glycerol in allergic inflammation (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22652530
Impact of reference gene selection for type 2 cannabinoid receptor gene expression studies in human spermatozoa (abst–2012) http://onlinelibrary.wiley.com/doi/10.1111/and.12006/abstract
Cannabinoid receptor 2 is upregulated in melanoma (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/23361273
Discovery of S-777469: an orally available CB2 agonist as an antipruritic agent (abst–2012) http://www.sciencedirect.com/science/article/pii/S0960894X12002739
Role of type 2 cannabinoid receptors in osteoarthritis (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900234-7/abstract
Combined deficiency of the CB1 and CB2 receptors enhances peak bone mass by inhibiting osteoclast differentiation but increases age-related bone loss by promoting adipocyte differentiation and reducing osteoblast differentiation (abst–2012) http://www.thebonejournal.com/article/S8756-3282%2812%2900153-6/abstract
A novel CB2 agonist, COR167, potently protects rat brain cortical slices against OGD and reperfusion injury (abst–2012) http://www.sciencedirect.com/science/article/pii/S1043661812001636
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
top
Endocannabinoid system and mood disorders: Priming a target for new therapies (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584612002801
A biophysical model of endocannabinoid-mediated short term depression in hippocampal inhibition (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0058926
Chronic activation of cannabinoid receptors in vitro does not compromise mouse islet function (full–2013) http://www.clinsci.org/cs/124/0467/1240467.pdf
Modulating the endocannabinoid system in human health and disease: successes and failures (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/febs.12260/pdf
CB2 Receptor Agonists Protect Human Dopaminergic Neurons against Damage from HIV-1 gp120 (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0077577
The Second Intracellular Loop of the Human Cannabinoid CB2 Receptor Governs G Protein Coupling in Coordination with the Carboxyl Terminal Domain (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063262
Δ9-tetrahydrocannabinol impairs the inflammatory response to influenza infection: role of antigen-presenting cells and the cannabinoid receptors 1 and 2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551428/
Cannabinoid Receptor 2 Protects against Acute Experimental Sepsis in Mice (full–2013) http://www.hindawi.com/journals/mi/2013/741303/
Altered expression of type-1 and type-2 cannabinoid receptors in celiac disease (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062078
Stabilization of Functional Recombinant Cannabinoid Receptor CB2 in Detergent Micelles and Lipid Bilayers (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0046290
Cannabinoids inhibit energetic metabolism and induce AMPK-dependent autophagy in pancreatic cancer cells (full–2013) http://www.nature.com/cddis/journal/v4/n6/pdf/cddis2013151a.pdf
Role of endogenous cannabinoid system in the gut (full–2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813752/
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice (full–2013) http://www.hindawi.com/journals/cdi/2013/263846/
The cannabinoid CB2 receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2013) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
The cannabinoid receptor type 2 as mediator of mesenchymal stromal cell immunosuppressive properties (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080022
Cannabinoid CB2 Receptors Regulate Central Sensitization and Pain Responses Associated with Osteoarthritis of the Knee Joint (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0080440
Rod Photoreceptors Express GPR55 in the Adult Vervet Monkey Retina (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081080
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907
Selective Activation of Cannabinoid Receptor 2 in Leukocytes Suppresses Their Engagement of the Brain Endothelium and Protects the Blood-Brain Barrier (full–2013) http://ajp.amjpathol.org/article/S0002-9440%2813%2900557-9/fulltext
Cannabinoid Receptor 2 (CB2) Plays a Role in the Generation of Germinal Center and Memory B Cells, but Not in the Production of Antigen-Specific IgG and IgM, in Response to T-dependent Antigens (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0067587
Anandamide Reduces Intracellular Ca2+ Concentration through Suppression of Na+/Ca2+ Exchanger Current in Rat Cardiac Myocytes (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0063386
Of mice and (wo)men: factors influencing successful implantation including endocannabinoids (full–2013) http://humupd.oxfordjournals.org/content/20/3/415.long
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
Effects on Immune Cells of a New 1,8-Naphthyridin-2-One Derivative and Its Analogues as Selective CB2 Agonists: Implications in Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0062511
Monoacylglycerol Lipase (MAGL) Inhibition Attenuates Acute Lung Injury in Mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808422/
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Cannabinoid Receptor 2: Potential Role in Immunomodulation and Neuroinflammation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3663904/
Roles of cannabinoid receptors type 1 and 2 on the retinal function of adult mice (full–2013) http://www.iovs.org/content/54/13/8079.long
Analgesic effect of a mixed T-type channel inhibitor/CB2 receptor agonist (full–2013) http://www.molecularpain.com/content/9/1/32
Attenuation of HIV-1 replication in macrophages by cannabinoid receptor 2 agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3629438/
Cannabinoid receptors and pain (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/wmts.83/full
Cannabinoid receptor 2 counteracts interleukin-17-induced immune and fibrogenic responses in mouse liver (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/hep.26598/full
The pharmacologic and clinical effects of medical cannabis (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/phar.1187/full
Irritable Bowel Syndrome and Migraine: Bystanders or Partners? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714407/
Towards a better Cannabis drug (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12400/full
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/nau.22442/full
CB1 and CB2 Cannabinoid Receptor Agonists Induce Peripheral Antinociception by Activation of the Endogenous Noradrenergic System (full–2013) http://journals.lww.com/anesthesiaanalgesia/Fulltext/2013/02000/CB1_and_CB2_Cannabinoid_Receptor_Agonists_Induce.31.aspx
Epithelial expression of vanilloid and cannabinoid receptors: a potential role in burning mouth syndrome pathogenesis (full–2013) http://www.hh.um.es/pdf/Vol_29/29_4/Borsani-29-523-533-2014.pdf
Chemical probes of endocannabinoid metabolism (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3639726/
The endocannabinoid system, cannabinoids, and pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820295/
The Influence of Cannabinoids on Generic Traits of Neurodegeneration (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12492/full
Activation of Cannabinoid Type 2 Receptor by JWH133 Protects Heart Against Ischemia / Reperfusion-Induced Apoptosis (full–2013) http://www.ncbi.nlm.nih.gov/pubmed/23711495
LiCABEDS II. Modeling of Ligand Selectivity for G-protein Coupled Cannabinoid Receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967758/
Bilateral changes of cannabinoid receptor type 2 protein and mRNA in the dorsal root ganglia of a rat neuropathic pain model (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3707359/
The cannabinoid TRPA1 agonist cannabichromene inhibits nitric oxide production in macrophages and ameliorates murine colitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3632250/
The role of endocannabinoids system in fatty liver disease and therapeutic potentials (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3745655/
Cannabinoid Receptor 2 Expression in Human Proximal Tubule Cells is Regulated by Albumin Independent of ERK1/2 Signaling (full–2013) http://www.karger.com/Article/Pdf/354529
Cannabinoid receptor 2 suppresses leukocyte inflammatory migration by modulating the JNK/c-Jun/Alox5 pathway (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3650391/
Application of HaloTag Technology to Expression and Purification of Cannabinoid Receptor CB2 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3627748/
Cannabinoid signaling and liver therapeutics (full–2013) http://www.journal-of-hepatology.eu/article/S0168-8278%2813%2900212-2/fulltext
Activation of Cannabinoid Receptor 2 Inhibits Experimental Cystitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3652164/
Endogenous Lipid Activated G Protein-Coupled Receptors: Emerging Structural Features From Crystallography and Molecular Dynamics Simulations (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4034697/
Childhood immune thrombocytopenia-who will spontaneously recover? (full–2013) http://www.seminhematol.org/article/S0037-1963%2813%2900032-2/fulltext
G-Protein Receptor Kinase 5 Regulates the Cannabinoid Receptor 2-Induced Upregulation of Serotonin 2A Receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3668730/
Differential Expression of Intracellular and Extracellular CB(2) Cannabinoid Receptor Protein by Human Peripheral Blood Leukocytes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3587044/
Human metabolites of synthetic cannabinoids JWH-018 and JWH-073 bind with high affinity and act as potent agonists at cannabinoid type-2 receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685885/
Characterization of cannabinoid receptor ligands in tissues natively expressing cannabinoid CB2 receptors (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687668/
Magnolia extract, magnolol and metabolites: activation of cannabinoid CB2 receptors and blockade of the related GPR55 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
Does the neuroprotective role of anandamide display diurnal variations? (link to PDF– 2013) http://www.mdpi.com/1422-0067/14/12/23341
Role of cannabinoid CB2 receptor in the reinforcing actions of ethanol (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/adb.12076/full
Differential expression and functional role of cannabinoid genes in alcohol users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818789/
Neuroimmmune interactions of cannabinoids in neurogenesis: focus on interleukin-1β (IL-1β) signalling (full–2013) http://www.biochemsoctrans.org/content/41/6/1577
CB1 and CB2 Receptors are Novel Molecular Targets for Tamoxifen and 4OHTamoxifen (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3860589/
Treatment with a Cannabinoid Receptor 2 Agonist Decreases Severity of Established Cystitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4163202/
Polymorphism rs3123554 in CNR2 reveals gender-specific effects on body weight and affects loss of body weight and cerebral insulin action (full–2013) http://onlinelibrary.wiley.com/doi/10.1002/oby.20573/full
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (full–2013) http://ajp.amjpathol.org/article/S0002-9440%2812%2900890-5/fulltext
The non-selective cannabinoid receptor agonist WIN 55,212-2 attenuates responses of Cfiber nociceptors in a murine model of cancer pain (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3753184/
Selective CB2 receptor activation ameliorates EAE by reducing Th17 differentiation and immune cell accumulation in the CNS (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3906668/
Association Between a Polymorphism in Cannabinoid Receptor 2 and Severe Necroinflammation in Patients With Chronic Hepatitis C. (full–2013) http://www.cghjournal.org/article/S1542-3565%2813%2900687-3/fulltext
Cannabinoids Inhibit T-cells via Cannabinoid Receptor 2 in an In Vitro Assay for Graft Rejection, the Mixed Lymphocyte Reaction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3864984/
CB2 cannabinoid agonist enhanced neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3904265/
Anti-inflammatory effects of Cannabinoid 2 Receptor activation in endotoxin-induced uveitis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954484/
Targeting the cannabinoid system for pain relief? (full – 2013) http://www.e-aat.com/article/S1875-4597%2813%2900119-7/fulltext
Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ9- THC: Mechanism underlying greater toxicity? (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3945037/
Peripheral endocannabinoid system dysregulation in first-episode psychosis (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3828529/
Role of CB2 Cannabinoid Receptor in the Rewarding, Reinforcing and Physical Effects of Nicotine (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3799072/
Cannabinoids: Do they have the potential to treat the symptoms of multiple sclerosis? (full–2013) http://www.wjgnet.com/2218-6212/full/v3/i4/87.htm Cannabinoid receptor modulation of the endothelial cell inflammatory response (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/
CB2 cannabinoid receptor is a novel target for third-generation selective estrogen receptor modulators bazedoxifene and lasofoxifene (full–2013) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5099082/
Natural Cannabinoids Improve Dopamine Neurotransmission and Tau and Amyloid Pathology in a Mouse Model of Tauopathy (link to PDF–2013) http://content.iospress.com/articles/journal-of-alzheimers-disease/jad130050
GPR55 and its interaction with membrane lipids: comparison with other endocannabinoid-binding receptors (link to PDF-2013) http://www.eurekaselect.com/105678/article
Different Classes of CB2 Ligands Potentially Useful in the Treatment of Pain (link to PDF–2013) http://www.eurekaselect.com/108399/article
Targeting the Endocannabinoid System to Treat Sepsis (review–2013) http://www.signavitae.com/articles/review-articles/222-targeting-the-endocannabinoid-system-to-treatsepsis
Endocannabinoid signaling in cancer: a rather complex puzzle (letter–2013) http://www.cell.com/trends/pharmacologicalsciences//retrieve/pii/S016561471300117X?_returnURL=http://linkinghub.elsevier.com/retrieve/pii/S016561471300117X?showall=true
The neuroprotective role of endocannabinoids against chemical-induced injury and other adverse effects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296873
Cannabinoid Receptors as Therapeutic Targets for Dialysis-Induced Peritoneal Fibrosis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296044
Activation of the CB(2) receptor system reverses amyloid-induced memory deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22795792
CB(2) receptor and amyloid pathology in frontal cortex of Alzheimer’s disease patients (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22763024
CB2 Cannabinoid Receptor Agonist Ameliorates Alzheimer-Like Phenotype in AβPP/PS1 Mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23515018
Evidence for the involvement of cannabinoid receptors’ polymorphisms in the pathophysiology of human diseases (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23293857
The 17-β-oestradiol inhibits osteoclast activity by increasing the cannabinoid CB2 receptor expression (abst–2013) http://www.sciencedirect.com/science/article/pii/S1043661812002046
Behavioral Responses to Acute and Sub-chronic Administration of the Synthetic Cannabinoid JWH-018 in Adult Mice Prenatally Exposed to Corticosterone (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296549
Cannabinoid CB2 receptor gene (CNR2) polymorphism is associated with chronic childhood immune thrombocytopenia in Egypt (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23406660
Novel antiobesity agents: Synthesis and pharmacological evaluation of analogues of Rimonabant and of LH21 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23434135
Activation of Cannabinoid CB2 Receptor-Mediated AMPK/CREB Pathway Reduces Cerebral Ischemic Injury (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23414569
Comparative proteomic and phosphoproteomic profiling of pancreatic adenocarcinoma cells treated with CB1 or CB2 agonists (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23463621
Endocannabinoid system and drug addiction: new insights from mutant mice approaches (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23490550
The complex effects of cannabinoids on insulin secretion from rat isolated islets of Langerhans (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23499687
Whole-Body Biodistribution and Radiation Dosimetry of the Cannabinoid Type 2 Receptor Ligand [11C]-NE40 in Healthy Subjects (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23508466
Antinociceptive effects of the selective CB2 agonist MT178 in inflammatory and chronic rodent pain models (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23518609
An ultra-low dose of tetrahydrocannabinol provides cardioprotection (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23537701
Cannabinoid Receptor Type 2, but not Type 1, is Up-Regulated in Peripheral Blood Mononuclear Cells of Children Affected by Autistic Disorders (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23585028
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst-2013) http://www.ncbi.nlm.nih.gov/pubmed/23587650
Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23601830
Identification of Raloxifene as a Novel CB2 Inverse Agonist (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23611779
Effect of cannabinoid CB2 receptor agonism on learning and memory in a mouse model of photothrombosis (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/1097.4?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Effects of the cannabinoid 2 receptor-selective agonist GW405833 in assays of acute pain-stimulated and paindepressed behavior in rats (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/886.9?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Inflammatory signaling as a therapeutic target for the treatment of breast cancer-induced bone pain (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/887.10?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
The omega and omega-1 monohydroxyl metabolites of the abused K2/Spice synthetic cannabinoids JWH-018 and JWH- 073 bind with high affinity and act as agonists at human cannabinoid 2 receptors (hCB2s) (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/26/1_MeetingAbstracts/660.8?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
Cannabinoid CB2 receptor activation attenuates cytokine-evoked mucosal damage in a human colonic explant model without changing epithelial permeability (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23706402
Modulation of anxiety-like behaviour by the endocannabinoid 2-arachidonoylglycerol (2-AG) in the dorsolateral periaqueductal gray (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23714073
Blockade of cannabinoid receptors reduces inflammation, leukocyte accumulation and neovascularization in a model of sponge-induced inflammatory angiogenesis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23722450
Müller cells express the cannabinoid CB2 receptor in the vervet monkey retina (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23630038
Activation of type 2 cannabinoid receptors (CB2R) promotes fatty acid oxidation through the SIRT1/PGC-1α pathway (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23747418
Synaptic plasticity alterations associated with memory impairment induced by deletion of CB2 cannabinoid receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23796670
Selective Cannabinoid Receptor Type 2 (CB2) Agonists: Optimization of a Series of Purines Leading to the Identification of a Clinical Candidate for the Treatment of Osteoarthritic Pain (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23795771
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23813098
Cannabinoid CB2 receptors as novel target for inhibiting house dust mite induced allergic airway inflammation (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/120.12?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Association of Single-Nucleotide Polymorphisms in the Cannabinoid Receptor 2 Gene with Schizophrenia in the Han Chinese Population (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23846977
CB1 and CB2 contribute to antinociceptive and anti-inflammatory effects of electroacupuncture on experimental arthritis of the rat temporomandibular joint (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23181276
3-Carboxamido-5-aryl-isoxazoles as new CB2 agonists for the treatment of colitis (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23849204
Interplay of cannabinoid 2 (CB2) receptors with nitric oxide synthases, oxidative and nitrative stress, and cell death during remote neurodegeneration (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22371074
Therapeutic Utility of Cannabinoid Receptor Type 2 (CB2) Selective Agonists (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23865723
Activation of spinal cannabinoid cb2 receptors inhibits neuropathic pain in streptozotocin-induced diabetic mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23892011
Characterization of bladder function in a cannabinoid receptor type 2 knockout mouse in vivo and in vitro (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23908133
Functional relevance of the cannabinoid receptor 2 – heme oxygenase pathway: A novel target for the attenuation of portal hypertension (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24007798
Cannabinoid receptor signaling in progenitor/stem cell proliferation and differentiation (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24076098
The endocannabinoid system mediates aerobic exercise-induced antinociception in rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148812
Endocannabinoids decrease neuropathic pain-related behavior in mice through the activation of one or both peripheral CB1 and CB2 receptors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24148808
Recent Development of CB2 Selective and Peripheral CB1/CB2 Cannabinoid Receptor Ligands (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24164198
Identification of CB1/CB2 Ligands from Zanthoxylum bungeanum (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24175626
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24304686
Unique effects of compounds active at both cannabinoid and serotonin receptors during stroke (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24323810
The inhibitory effect of anandamide on oxytocin and vasopressin secretion from neurohypophysis is mediated by nitric oxide (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24342802
Activation of type-2 cannabinoid receptor inhibits neuroprotective and anti-inflammatory actions of glucocorticoid receptor α: when one is better than two (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23296125
Spinal gene expression profiling and pathways analysis of a CB2 agonist (MDA7)-targeted prevention of paclitaxel-induced neuropathy (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24361916
Activation of endocannabinoid system in human myocardial hypertrophy (abst–2013) https://www.thieme-connect.com/ejournals/abstract/10.1055/s-0032-1332632
The agonist binding mechanism of human CB2 receptor studied by molecular dynamics simulation, free energy calculation and 3D-QSAR studies (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24358778
Cannabinoid agonists showing BuChE inhibition as potential therapeutic agents for Alzheimer’s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24378710
Modulation of Strain-Specific Differences in Gene Expression by Cannabinoid Type 2 Receptor Deficiency (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24370613
Inhibition of the cannabinoid 2 receptor in CNS-injury induced immunodeficiency syndrome (abst – 2013) http://www.medical-hypotheses.com/article/S0306-9877%2814%2900117-0/abstract
The role of Cannabinoid receptors on light-induced photoreceptor degeneration (abst – 2013) http://iovs.arvojournals.org/article.aspx?articleid=2149928&resultClick=1
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst – 2013) http://www.sciencedirect.com/science/article/pii/S0028390813003419
Cannabinoids for treatment of Alzheimer’s disease: moving toward the clinic (full-2014) http://journal.frontiersin.org/Journal/10.3389/fphar.2014.00037/full
Effect of melilotus extract on lung injury by upregulating the expression of cannabinoid CB2 receptors in septic rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3995869/
Activation of CB2 receptors as a potential therapeutic target for migraine: evaluation in an animal model (full–2014) http://www.thejournalofheadacheandpain.com/content/pdf/1129-2377-15-14.pdf
CB2 cannabinoid receptors as a therapeutic target – What does the future hold? (full–2014) http://molpharm.aspetjournals.org/content/early/2014/08/08/mol.114.094649.long
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
Polyunsaturated Fatty Acid-Derived Lipid Mediators and T Cell Function (full–2014) http://www.ncbi.nlm.nih.gov/pubmed/24611066
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Experimental cannabinoid 2 receptor-mediated immune modulation in sepsis (full–2014) http://www.hindawi.com/journals/mi/2014/978678/
CB2 Receptor Deficiency Increases Amyloid Pathology and Alters Tau Processing in a Transgenic Mouse Model of Alzheimer’s Disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3883962/
Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity (full–2014) http://www.plosone.org/article/fetchObject.action?uri=info%3Adoi%2F10.1371%2Fjournal.pone.0098079&representation=PDF
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
The in vitro GcMAF effects on endocannabinoid system transcriptionomics, receptor formation, and cell activity of autism-derived macrophages (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3996516/
Care and Feeding of the Endocannabinoid System: A Systematic Review of Potential Clinical Interventions that Upregulate the Endocannabinoid System (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3951193/
2012 Division of Medicinal Chemistry Award Address: Trekking the Cannabinoid Road: A Personal Perspective (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4064474/
The endocannabinoid system: a putative role in neurodegenerative diseases (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4070159/
CB2 Receptor Activation Ameliorates the Proinflammatory Activity in Acute Lung Injury Induced by Paraquat (full–2014) http://www.hindawi.com/journals/bmri/2014/971750/
Endocannabinoid Receptors Gene Expression in Morbidly Obese Women with Nonalcoholic Fatty Liver Disease (full–2014) http://www.hindawi.com/journals/bmri/2014/502542/
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Aminotransferase Serum Levels in Chronic Hepatitis C (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062424/
Validating Antibodies to the Cannabinoid CB2 Receptor: Antibody Sensitivity Is Not Evidence of Antibody Specificity (full–2014) http://jhc.sagepub.com/content/62/6/395.full
Cannabinoid Receptor 2-63 QQ Variant Is Associated with Persistently Normal Amino-transferase Serum Levels in Chronic Hepatitis C (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0099450
Prophylactic cannabinoid administration blocks the development of paclitaxel-induced neuropathic nociception during analgesic treatment and following cessation of drug delivery (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3998744/
Repositioning therapy for thyroid cancer: new insights on established medications (full–2014) http://erc.endocrinology-journals.org/content/21/3/R183.long
Cannabinoid receptor 2 as a potential therapeutic target in rheumatoid arthritis (full–2014) http://www.biomedcentral.com/1471-2474/15/275
Cannabinoid CB2 receptor (CB2R) stimulation delays rubrospinal mitochondrial dependent degeneration and improves functional recovery after spinal cord hemisection by ERK1/2 inactivation (full–2014) http://www.nature.com/cddis/journal/v5/n9/full/cddis2014364a.html
Cannabinoid Type 1 and Type 2 Receptor Antagonists Prevent Attenuation of Serotonin Induced Reflex Apneas by Dronabinol in Sprague-Dawley Rats (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0111412
Cannabinoid CB2 receptors modulate midbrain dopamine neuronal activity and dopamine-related behavior in mice (full–2014) http://www.pnas.org/content/early/2014/10/30/1413210111.long
Cannabinoid receptor 2 agonist attenuates pain related behavior in rats with chronic alcohol / high fat diet induced pancreatitis (full–2014) http://www.molecularpain.com/content/10/1/66
High hopes for CB(2) receptors in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12548/full
High hopes for cannabinoid agonists in the treatment of rheumatic diseases (full–2014) http://www.biomedcentral.com/content/pdf/1471-2474-15-410.pdf
NMP-7 inhibits chronic inflammatory and neuropathic pain via block of Cav3.2 T-type calcium channels and activation of CB2 receptors (full–2014) http://www.molecularpain.com/content/pdf/1744-8069-10-77.pdf
Antagonism of cannabinoid receptor 2 pathway suppresses IL-6-induced immunoglobulin IgM secretion (full–2014) http://www.biomedcentral.com/2050-6511/15/30
Antibodies to probe endogenous G protein-coupled receptor heteromer expression, regulation, and function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4253664/
Localization of diacylglycerol lipase alpha and monoacylglycerol lipase during postnatal development of the rat retina (full–2014) http://journal.frontiersin.org/Journal/10.3389/fnana.2014.00150/full
Are cannabidiol and Δ9 -tetrahydrocannabivarin negative modulators of the endocannabinoid system? A systematic review (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12944/full
Celastrol Attenuates Inflammatory and Neuropathic Pain Mediated by Cannabinoid Receptor Type 2 (full–2014) http://www.mdpi.com/1422-0067/15/8/13637/htm
Differential Expression of Brain Cannabinoid Receptors between Repeatedly Stressed Males and Females may Play a Role in Age and Gender-Related Difference in Traumatic Brain Injury: Implications from Animal Studies (full–2014) http://journal.frontiersin.org/article/10.3389/fneur.2014.00161/full
Differential modulation of endogenous cannabinoid CB1 and CB2 receptors in spontaneous and splice variants of ghrelin-induced food intake in conscious rats (full–2014) http://www.nutritionjrnl.com/article/S0899-9007%2814%2900297-4/fulltext
Expression of cannabinoid receptor 2 and its inhibitory effects on synovial fibroblasts in rheumatoid arthritis (full–2014) http://rheumatology.oxfordjournals.org/content/53/5/802.long
Cannabinoid receptor type-2 stimulation, blockade, and deletion alters the vascular inflammatory responses to traumatic brain injury (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4248435/
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (full–2014) http://www.jbc.org/content/early/2014/07/02/jbc.M114.561761.full.pdf+htm
Target-Selective Phototherapy Using a Ligand-Based Photosensitizer for Type 2 Cannabinoid Receptor (abst-2014) http://www.ncbi.nlm.nih.gov/pubmed/24583052
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (full–2014) http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12478/full
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice. (full – 2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243857/
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954486/
Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12488/full
Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities (full–2014) http://www.sciencedirect.com/science/article/pii/S0006291X14014636
The antitumor action of cannabinoids on glioma tumorigenesis (full–2014) http://www.hh.um.es/pdf/Vol_30/30_6/Zogopoulos-30-629-645-2015.pdf
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Cannabinoid inhibits HIV-1 Tat-stimulated adhesion of human monocyte-like cells to extracellular matrix proteins (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4089388/
The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: Involvement of both mitochondrial and death receptor pathways (full–2014) http://www.placentajournal.org/article/S0143-4004%2814%2900823-6/fulltext
The cannabinoid CB2 receptor agonist AM1241 enhances neurogenesis in GFAP/Gp120 transgenic mice displaying deficits in neurogenesis (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12478/full
Regulation of cannabinoid receptor gene expression and endocannabinoid levels in lymphocyte subsets by IFN-β: a longitudinal study in multiple sclerosis patients (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cei.12443/full
Regulatory role of the Cannabinoid-2 receptor in stress-induced neuroinflammation in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243857/
Changes in CB1 and CB2 receptors in the post-mortem cerebellum of humans affected by spinocerebellar ataxias (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3954486/
Peripheral interactions between cannabinoid and opioid systems contribute to the antinociceptive effect of crotalphine (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12488/full
Examining the critical roles of human CB2 receptor residues Valine 3.32 (113) and Leucine 5.41 (192) in ligand recognition and downstream signaling activities (full–2014) http://www.sciencedirect.com/science/article/pii/S0006291X14014636
The antitumor action of cannabinoids on glioma tumorigenesis (full–2014) http://www.hh.um.es/pdf/Vol_30/30_6/Zogopoulos-30-629-645-2015.pdf
The cannabinoid CB₂ receptor-selective phytocannabinoid beta-caryophyllene exerts analgesic effects in mouse models of inflammatory and neuropathic pain (full–2014) http://www.europeanneuropsychopharmacology.com/article/S0924-977X%2813%2900302-7/fulltext
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Changes in Endocannabinoid Receptors and Enzymes in the Spinal Cord of SOD1G93A Transgenic Mice and Evaluation of a Sativex® -like Combination of Phytocannabinoids: Interest for Future Therapies in Amyotrophic Lateral Sclerosis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24703394
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24642775
Endocannabinoid-Hydrolysing Enzymes in the Post-Mortem Cerebellum of Humans Affected by Hereditary Autosomal Dominant Ataxias (full–2014) http://www.karger.com/Article/FullText/358127
Cannabinoid type 2 receptor stimulation attenuates brain edema by reducing cerebral leukocyte infiltration following subarachnoid hemorrhage in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24819918
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice (full–2014) http://diabetes.diabetesjournals.org/content/64/3/808.long
Acute Activation of Cannabinoid Receptors by Anandamide Reduces Gastro-Intestinal Motility and Improves Postprandial Glycemia in Mice (full–2014) http://diabetes.diabetesjournals.org/content/64/3/808.long
Antibiotic-induced dysbiosis alters host-bacterial interactions and leads to colonic sensory and motor changes in mice (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4615720/
Cannabinoid Receptor Type 2 Agonist Attenuates Apoptosis by Activation of Phosphorylated CREB-Bcl-2 Pathway After Subarachnoid Hemorrhage in Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4194247/
JZL184 is anti-hyperalgesic in a murine model of cisplatin-induced peripheral neuropathy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4268146/ Activating Cannabinoid Receptor 2 Alleviates Pathogenesis of Experimental Autoimmune Encephalomyelitis Via Activation of Autophagy and Inhibiting NLRP3 Inflammasome (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
What we know and do not know about the cannabinoid receptor 2 (CB2) (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4567276/
Combined inhibition of FAAH and COX produces enhanced anti-allodynic effects in mouse neuropathic and inflammatory pain models (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4206939/
Treatment with a Heme Oxygenase 1 Inducer Enhances the Antinociceptive Effects of µ- Opioid, δ-Opioid, and Cannabinoid 2 Receptors during Inflammatory Pain (full–2014) http://jpet.aspetjournals.org/content/351/1/224.long
Cannabinoid receptor-dependent metabolism of 2-arachidonoylglycerol during aging (full–2014) http://www.sciencedirect.com/science/article/pii/S0531556514001296
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self Administration in Mice and Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330519/
Cannabis smoking and serum C-reactive protein: A quantile regressions approach based on NHANES 2005–2010 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4297696/
Prior stimulation of the endocannabinoid system prevents methamphetamine-induced dopaminergic neurotoxicity in the striatum through activation of CB2 receptors (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939842/
Chronic activation of CB2 cannabinoid receptors in the hippocampus increases excitatory synaptic transmission (full-2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4398527/
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signaling (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4294047/
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Effects of cannabinoid receptor type 2 on endogenous myocardial regeneration by activating cardiac progenitor cells in mouse infarcted heart (link to PDF–2014) http://life.scichina.com:8082/sciCe/EN/abstract/abstract513395.shtml#
Cannabinoids as therapeutic agents in cancer: current status and future implications (link to PDF – 2014) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=2233
Early increase of cannabinoid receptor density after experimental traumatic brain injury in the newborn piglet (link to PDF–2014) http://www.ncbi.nlm.nih.gov/pubmed/24993629
Cannabinoids as therapeutic agents in cancer: current status and future implications. (link to PDF-2014) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=2233
Blockade of cannabinoid CB1 and CB2 receptors does not prevent the antipruritic effect of systemic paracetamol (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24399199
Trans-Caryophyllene Suppresses Hypoxia-Induced Neuroinflammatory Responses by Inhibiting NF-κB Activation in Microglia (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24488604
A Role for Trans-caryophyllene in the Moderation of Insulin Secretion (abst–2014) http://www.sciencedirect.com/science/article/pii/S0006291X14001399
Switching cannabinoid response from CB2 agonists to FAAH inhibitors (abst–2014) http://www.sciencedirect.com/science/article/pii/S0960894X14000869
Detailed characterization of the endocannabinoid system in human macrophages and foam cells, and anti-inflammatory role of type-2 cannabinoid receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24529123
Evaluation of selective cannabinoid CB1 and CB2 receptor agonists in a mouse model of lipopolysaccharide-induced interstitial cystitis (abst–2014) http://www.sciencedirect.com/science/article/pii/S0014299914001423
Intrathecal Injection of JWH015 Attenuates Remifentanil-Induced Postoperative Hyperalgesia by Inhibiting Activation of Spinal Glia in a Rat Model (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24651239
The cannabinoid CB2 receptor agonist GW405833 does not ameliorate brain damage induced by hypoxia-ischemia in rats (abst–2014) http://www.sciencedirect.com/science/article/pii/S0304394014002766
Therapeutical Potential of CB2 Receptors in Immune-Related Diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24720538
Inhibition of Peripheral Fatty Acid Amide Hydrolase Depresses Activities of Bladder Mechanosensitive Nerve Fibers of the Rat (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24746881
Synthetic marijuana “K2” induced ITP (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24749892
Cannabinoid CB2 Receptor as a New Phototherapy Target for Inhibition of Tumor Growth (abst–2014) http://pubs.acs.org/doi/abs/10.1021/mp5001923
Endocannabinoid signaling in Alzheimer’s disease: current knowledge and future directions. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24813316
Deficiency of cannabinoid receptor of type 2 worsens renal functional and structural abnormalities in streptozotocin-induced diabetic mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24827776
Functionalization of β-Caryophyllene Generates Novel Polypharmacology in the Endocannabinoid System (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cb500177c
Cannabinoids in pain management: CB1, CB2 and non-classic receptor ligands (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24836296
Inhibition of colon carcinogenesis by a standardized Cannabis sativa extract with high content of cannabidiol (abst–2014) http://www.sciencedirect.com/science/article/pii/S0944711313004728
Functions of the CB1 and CB 2 Receptors in Neuroprotection at the Level of the Blood-Brain Barrier (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24929655
β-Caryophyllene, a CB2 Receptor agonist produces multiple behavioral changes relevant to anxiety and depression in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24930711
Cyclic ovarian hormone modulation of supraspinal Δ9-tetrahydrocannabinol-induced antinociception and cannabinoid receptor binding in the female rat (abst–2014) http://www.sciencedirect.com/science/article/pii/S0091305714001774
Anti-atherosclerosis role of N-oleoylethanolamine in CB2 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24961101
The endocannabinoid-CB2 receptor axis protects the ischemic heart at the early stage of cardiomyopathy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24980781
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington’s disease brain (abst–2014) http://www.sciencedirect.com/science/article/pii/S0891061814000453
Ligand Activation of Cannabinoid Receptors Attenuates Hypertrophy of Neonatal Rat Cardiomyocytes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24979612
The cannabinoid receptor 2 agonist, β-Caryophyllene, reduced voluntary alcohol intake and attenuated ethanol-induced place preference and sensitivity in mice (abst–2014) http://www.sciencedirect.com/science/article/pii/S0091305714001956
Genetic association analysis of CNR1 and CNR2 polymorphisms with schizophrenia in a Korean population (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25014618
Cannabinoid Receptor-2 and HIV-Associated Neurocognitive Disorders (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25015040
Reductions in Endocannabinoid Levels and Enhanced Coupling of Cannabinoid Receptors in the Striatum are Accompanied by Cognitive Impairments in the AβPPswe/PS1ΔE9 Mouse Model of Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24844690
Involvement of β-arrestin-2 and Clathrin in Agonist-Mediated Internalization of the Human Cannabinoid CB2 Receptor (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25023974
Cannabinoid receptor CB2 prevents development of heart failure in a murine model of pressure overload (abst–2014) http://www.freedomwares.ca/p80cannabinoid-receptor-cb2-prevents-development-heart-failure-murinemodel-pressure-overload/
Dual agonism of peripheral cannabinoid CB1/CB2 receptors suppresses cardiac myocyte hypertrophy (abst–2014) http://www.fasebj.org/content/28/1_Supplement/652.9.abstract?sid=db987fd0-3ef0-4796-aff6-4103f0c84daf
The Role of Endocannabinoid Signaling in the Molecular Mechanisms of Neurodegeneration in Alzheimer’s Disease (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25147120
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25171128
MicroRNA-665 is involved in the regulation of the expression of the cardioprotective cannabinoid receptor CB2 in patients with severe heart failure (abst–2014) http://www.sciencedirect.com/science/article/pii/S0006291X14014144
Stimulation of cannabinoid receptors by using Rubus coreanus extracts to control osteoporosis in aged male rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25136745
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
Oxidative stress and cannabinoid receptor expression in type-2 diabetic rat pancreas following treatment with Δ9 -THC (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25187240
Role of cannabinoid receptors in hepatic fibrosis and apoptosis associated with bile duct ligation in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25179573
Inhibition of endocannabinoid neuronal uptake and hydrolysis as strategies for developing anxiolytic drugs (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083569
Ultrapure ajulemic acid has improved CB2 selectivity with reduced CB1 activity (abst–2014) http://www.sciencedirect.com/science/article/pii/S0968089614003368
Cannabinoid receptor type 2 activation in atherosclerosis and acute cardiovascular diseases (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25245379
Type-2 cannabinoid receptor regulates proliferation, apoptosis, differentiation, and OPG/RANKL ratio of MC3T3-E1 cells exposed to Titanium particles (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25292314
Differences in receptor binding affinity of several phytocannabinoids does not explain their effects on neural cell cultures (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25311884
Interaction of a Cannabinoid-2 Agonist With Tramadol on Nociceptive Thresholds and Immune Responses in a Rat Model of Incisional Pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25370921
Protective effect of palmitoylethanolamide, a naturally-occurring molecule, in a rat model of cystitis (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25463999
Role of CB2 receptors and cGMP pathway on the cannabinoid-dependent antiepileptic effects in an in vivo model of partial epilepsy (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25458534
Post-status epilepticus treatment with the cannabinoid agonist WIN 55,212-2 prevents chronic epileptic hippocampal damage in rats (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25447228
Involvement of central and peripheral cannabinoid receptors on antinociceptive effect of tetrahydrocannabinol in muscle pain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446925
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
Cannabinoid receptor agonists reduce the short-term mitochondrial dysfunction and oxidative stress linked to excitotoxicity in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25446347
Identification of CB2 receptors in human nigral neurons that degenerate in Parkinson’s disease (abst–2014) http://www.sciencedirect.com/science/article/pii/S0304394014009318
The Activated Endocannabinoid System in Atherosclerosis: Driving Force or Protective Mechanism? (abst–2014) http://www.eurekaselect.com/126560/article
Identification of a highly potent and selective CB2 agonist, RQ-00202730, for the treatment of irritable bowel syndrome (abst–2014) http://www.sciencedirect.com/science/article/pii/S0960894X14012578
Genetic background modifies the effects of type 2 cannabinoid receptor deficiency on bone mass and bone turnover (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24036631
In vitro binding affinity to human CB1 and CB2 receptors and antimicrobial activity of volatile oil from high potency Cannabis sativa (abst–2014) https://www.thieme-connect.com/products/ejournals/abstract/10.1055/s-0034-1382491
Visual deficits in mice after mild traumatic brain injury produced by primary overpressure blast are alleviated by the novel CB2 drug SMM189 (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2271359&resultClick=1
Cannabinoids and the endocannabinoid system in lower urinary tract function and dysfunction (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24285567
Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington’s disease brain (abst–2014) http://www.sciencedirect.com/science/article/pii/S0891061814000453
Local uterine Ang-(1-7) infusion augments the expression of cannabinoid receptors and differentially alters endocannabinoid metabolizing enzymes in the decidualized uterus of pseudopregnant rats (full–2015) http://www.rbej.com/content/13/1/5
The spinal anti-inflammatory mechanism of motor cortex stimulation: cause of success and refractoriness in neuropathic pain? (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-014-0216-1.pdf
Activation of Cannabinoid Receptor 2 Enhances Osteogenic Differentiation of Bone Marrow Derived Mesenchymal Stem Cells (full–2015) http://www.hindawi.com/journals/bmri/2015/874982/
Cannabinoid Receptor CB2 Is Involved in Tetrahydrocannabinol-Induced AntiInflammation against Lipopolysaccharide in MG-63 Cells (full–2015) http://www.hindawi.com/journals/mi/2015/362126/
Motor, Visual and Emotional Deficits in Mice after Closed-Head Mild Traumatic Brain Injury Are Alleviated by the Novel CB2 Inverse Agonist SMM-189 (full–2015) http://www.mdpi.com/1422-0067/16/1/758/htm
Protective Role of CB2 Receptor Activation in Galactosamine/LPS-induced Acute Liver Failure Through Regulation of Macrophage Polarization and miRNAs (full–2015) http://jpet.aspetjournals.org/content/early/2015/03/06/jpet.114.220368.long
Interactions of the opioid and cannabinoid systems in reward: Insights from knockout studies (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4318341/
Activation of cannabinoid receptor 2 enhances osteogenic differentiation of bone marrow derived mesenchymal stem cells (full–2015) http://www.hindawi.com/journals/bmri/2015/874982/
Possible Immunosuppressive Effects of Drug Exposure and Environmental and Nutritional Effects on Infection and Vaccination (full–2015) http://www.hindawi.com/journals/mi/2015/349176/
4′-O-methylhonokiol increases levels of 2-arachidonoyl glycerol in mouse brain via selective inhibition of its COX-2-mediated oxygenation (full–2015) http://www.jneuroinflammation.com/content/pdf/s12974-015-0307-7.pdf
Changes in cannabinoid receptors, aquaporin 4 and vimentin expression after traumatic brain injury in adolescent male mice. Association with edema and neurological deficit (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0128782
Turning Over a New Leaf: Cannabinoid and Endocannabinoid Modulation of Immune Function (full–2015) http://link.springer.com/article/10.1007/s11481-015-9615-z/fulltext.html
Endocannabinoids modulate human blood-brain barrier permeability in vitro (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13106/full
Effects of pro-inflammatory cytokines on cannabinoid CB1 and CB2 receptors in immune cells (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/apha.12474/full
Cannabinoids receptor type 2, CB2, expression correlates with human colon cancer progression and predicts patient survival (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4381706/
Perturbations of the endocannabinoid system in mantle cell lymphoma: correlations to clinical and pathological features (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4278325/
Cannabis in cancer care (full–2015) http://onlinelibrary.wiley.com/doi/10.1002/cpt.108/full
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451551/
Gastric mucosal protection: from the periphery to the central nervous system (full–2015) http://www.jpp.krakow.pl/journal/archive/06_15/pdf/319_06_15_article.pdf
Cannabinoid CB2 Receptors in a Mouse Model of Aβ Amyloidosis: Immunohistochemical Analysis and Suitability as a PET Biomarker of Neuroinflammation (full-2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0129618
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
CB2R orchestrates fibrogenesis through regulation of inflammatory response during the repair of skeletal muscle contusion (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4466920/
Time-Dependent Protection of CB2 Receptor Agonist in Stroke (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0132487
Bone cell-autonomous contribution of type 2 cannabinoid receptor to breast cancer induced osteolysis (full–2015) http://www.jbc.org/content/early/2015/07/20/jbc.M115.649608.long
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Differential immune mechanism to HIV-1 Tat variants and its regulation by AEA (full–2015) http://www.nature.com/srep/2015/150505/srep09887/full/srep09887.html
Current Status and Future of Cannabis Research (full–2015) http://cannabisclinicians.org/wp-content/uploads/2015/05/Russo-et-al-Current-status-and-future-ofcannabis-research-Clin-Researcher-2015.pdf
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://www.arthritis-research.com/content/17/1/226
Expression Analysis of CB2-GFP BAC Transgenic Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0138986
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136546
The Cannabinoid Receptor 2 Q63R Variant Modulates the Relationship between Childhood Obesity and Age at Menarche (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140142
The skeletal endocannabinoid system: clinical and experimental insights (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0073/jbcpp-2015-0073.xml Bisdemethoxycurcumin
Induces Apoptosis in Activated Hepatic Stellate Cells via Cannabinoid Receptor 2 (full–2015) http://www.mdpi.com/1420-3049/20/1/1277/htm
Restoring homeostasis of CD4(+) T cells in hepatitis-B-virus-related liver fibrosis (full–2015) http://www.wjgnet.com/1007-9327/full/v21/i38/10721.htm
Pharmacological activation of CB2 receptors counteracts the deleterious effect of ethanol on cell proliferation in the main neurogenic zones of the adult rat brain (full–2015) http://journal.frontiersin.org/article/10.3389/fncel.2015.00379/full
Clinical Significance of Cannabinoid Receptors CB1 and CB2 Expression in Human Malignant and Benign Thyroid Lesions (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4619873/
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/26584135
Oxyradical Stress, Endocannabinoids, and Atherosclerosis. (full – 2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4686160/
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
Cannabinoid-Induced Chemotaxis in Bovine Corneal Epithelial Cells (full–2015) http://iovs.arvojournals.org/article.aspx?articleid=2297919&resultClick=1
A synergistic interaction of 17-β-estradiol with specific cannabinoid receptor type 2 antagonist/inverse agonist on proliferation activity in primary human osteoblasts (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487012/
Effects of deleting cannabinoid receptor-2 on mechanical and material properties of cortical and trabecular bone (full–2015) http://www.tandfonline.com/doi/full/10.1080/23311916.2014.1001015
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0140592
Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells (full–2015) http://www.spandidos-publications.com/10.3892/mmr.2015.4477
[Corrigendum] Cannabinoid WIN55, 212-2 induces cell cycle arrest and inhibits the proliferation and migration of human BEL7402 hepatocellular carcinoma cells (correction–2015) http://www.spandidos-publications.com/mmr/13/1/1054
Preclinical evaluation of SMM-189, a cannabinoid receptor 2-specific inverse agonist (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4506688/
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26124120
CB2 cannabinoid receptor agonist enantiomers HU-433 and HU-308: An inverse relationship between binding affinity and biological potency (full–2015) http://www.pnas.org/content/112/28/8774.long
Proapoptotic effect of endocannabinoids in prostate cancer cells (link to PDF–2015) http://www.spandidos-publications.com/10.3892/or.2015.3746
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25849525
Activation of Cannabinoid CB2 receptors Reduces Hyperalgesia in an Experimental Autoimmune Encephalomyelitis Mouse Model of Multiple Sclerosis (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/cns.12349/full
Role of the Endocannabinoid System in Diabetes and Diabetic Complications (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13226/full
Renal effects of chronic pharmacological manipulation of CB2 receptors in rats with dietinduced obesity (full–2015) http://onlinelibrary.wiley.com/enhanced/doi/10.1111/bph.13056
A runner’s high depends on cannabinoid receptors in mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4620874/
Role of the endocannabinoid system in the emotional manifestations of osteoarthritis pain (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770330/
The effect of phytocannabinoids on airway hyper-responsiveness, airway inflammation, and cough (full–2015) http://jpet.aspetjournals.org/content/353/1/169.long
Cannabinoid Receptor Type 2 (CB2) Dependent and Independent Effects of WIN55,212- 2 on Atherosclerosis in Ldlr-null Mice (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4581537/
Activation of Cannabinoid Type Two Receptors (CB2) Diminish Inflammatory Responses in Macrophages and Brain Endothelium (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4795159/
The Antitumor Activity of Plant-Derived Non-Psychoactive Cannabinoids (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470774/
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25931248
Cannabinoid Receptor-2 Regulates Embryonic Hematopoietic Stem Cell Development via PGE2 and P-selectin Activity (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781665/
CB1 Knockout Mice Unveil Sustained CB2-Mediated Anti-Allodynic Effects of the Mixed CB1/CB2 Agonist CP55,940 in a Mouse Model of Paclitaxel-Induced Neuropathic Pain (full–2015) http://molpharm.aspetjournals.org/content/88/1/64.long
Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia (full–2015) http://onlinelibrary.wiley.com/doi/10.1111/bph.13215/full
Effects of Cannabinoids on T-cell Function and Resistance to Infection (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4470840/
Sequelae of Cannabis as Medicine (full–2015) http://painmedicine.oxfordjournals.org/content/16/7/1447
A CB2-Selective Cannabinoid Suppresses T-Cell Activities and Increases Tregs and IL-10 (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4528965/
Cannabinoid Receptor‐2 Regulates Embryonic Hematopoietic Stem Cell Development via Prostaglandin E2 and P‐Selectin Activity (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4781665/
A potential role for cannabinoid receptors in the therapeutic action of fenofibrate (full–2015) http://www.fasebj.org/content/29/4/1446.full.pdf+html
The Endocannabinoid System and its Modulation by Phytocannabinoids (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604172/
The type 2 cannabinoid receptor regulates susceptibility to osteoarthritis in mice (full–2015) http://www.oarsijournal.com/article/S1063-4584(15)01140-1/fulltext
Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4917208/
Targeting cannabinoid receptor-2 pathway by phenylacetylamide suppresses the proliferation of human myeloma cells through mitotic dysregulation and cytoskeleton disruption (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504841/
Dynamics of expression and localization of the cannabinoid system in granulosa cells during oocyte nuclear maturation (full–2015) http://www.fertstert.org/article/S0015-0282(15)00440-9/fulltext
Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor (full–2015) http://www.reproduction-online.org/content/150/6/463.long
A selective cannabinoid CB2 agonist attenuates damage and improves memory retention following stroke in mice (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4552583/
The endocannabinoid system in renal cells: Regulation of Na+ transport by CB1 receptors through distinct cell signaling pathways (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25537261
The role of cannabinoids in adult neurogenesis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4543605/
An endocannabinoid system is present in the mouse olfactory epithelium but does not modulate olfaction (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4485596/
Prospects for Creation of Cardioprotective Drugs Based on Cannabinoid Receptor Agonists (full–2015) http://journals.sagepub.com/doi/full/10.1177/1074248415612593 Tonic Modulation of Nociceptive Behavior and Allodynia by Cannabinoid Receptors in Formalin Test in Rats (click Full Text Links for PDF–2015) http://www.ncbi.nlm.nih.gov/pubmed/25687494
Detection of cannabinoid receptors CB1 and CB2 within basal ganglia output neurons in macaques: changes following experimental parkinsonism (link to PDF–2015) http://link.springer.com/article/10.1007/s00429-014-0823-8
Cannabinoid receptor-specific mechanisms to ameliorate pain in sickle cell anemia via inhibition of mast cell activation and neurogenic inflammation (link to PDF–2015) http://www.haematologica.org/content/early/2015/12/21/haematol.2015.136523.long
The emerging role of the endocannabinoid system in the pathogenesis and treatment of kidney diseases (link to PDF–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0055/jbcpp-2015-0055.xml
The therapeutic aspects of the endocannabinoid system (ECS) for cancer and their development: from nature to laboratory (link to PDF–2015) http://www.eurekaselect.com/137770/article
Endocannabinoids (article–2015) http://emedicine.medscape.com/article/1361971-overview#showall
Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle postcontusion (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25588471
Beneficial effects of cannabinoid receptor type 2 (CB2R) in injured skeletal muscle postcontusion (full–2015) http://www.hh.um.es/pdf/Vol_30/30_6/Yu-30-737-749-2015.pdf
Type 2 cannabinoid receptor contributes to the physiological regulation of spermatogenesis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26671998
The anti-inflammatory mediator palmitoylethanolamide enhances the levels of 2-arachidonoyl-glycerol and potentiates its actions at transient receptor potential vanilloid type-1 channels (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25598150
Activation of cannabinoid receptor 2 attenuates synovitis and joint distruction in collagen-induced arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25601571
The cannabinoid receptor 2 is involved in acute rejection of cardiac allografts (abst–2015) http://www.sciencedirect.com/science/article/pii/S0024320515001290
Osseous Characteristics of Mice Lacking Cannabinoid Receptor 2 after Pulp Exposure (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25773059
S-777469, a Novel Cannabinoid Type 2 Receptor Agonist, Suppresses Itch-Associated Scratching Behavior in Rodents through Inhibition of Itch Signal Transmission (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25721168
Changes in the endocannabinoid signaling system in CNS structures of TDP-43 transgenic mice: relevance for a neuroprotective therapy in TDP-43-related disorders (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25819934
[268-POS]: Placental expression of the endocannabinoid system in preeclampsia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25787618
Spinal neuronal cannabinoid receptors mediate urodynamic effects of systemic fatty acid amide hydrolase (FAAH) inhibition in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25788026
Activation of murine microglial N9 cells is attenuated through cannabinoid receptor CB2 signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25637536
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Conformational Restriction Leading to a Selective CB2 Cannabinoid Receptor Agonist Orally Active Against Colitis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25699149
The endocannabinoid system and its therapeutic implications in rheumatoid arthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25791728
Design, syntheses, structure-activity relationships and docking studies of coumarin derivatives as novel selective ligands for the CB2 receptor (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25644673
Selective, Nontoxic CB2 Cannabinoid o-Quinone with in Vivo Activity against TripleNegative Breast Cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25671648
Cannabinoids to treat spinal cord injury (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25805333
Interaction of cannabinoid receptor 2 and social environment modulates chronic alcohol consumption (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25827923
Minocycline Attenuates Neonatal Germinal-Matrix-Hemorrhage-Induced Neuroinflammation and Brain Edema by Activating Cannabinoid Receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25833102
The role of the endocannabinoid system in pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25846617
Protective effect of paeoniflorin on the hippocampus in rats with cerebral ischemia reperfusion through activating cannabinoid receptor 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25854559
Potential of the cannabinoid CB2 receptor as a pharmacological target against inflammation in Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25863279
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014488615001211
Differential upregulation of the cannabinoid CB2 receptor in neurotoxic and inflammation-driven rat models of Parkinson’s disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25895887
Role of cannabinoidergic system on food intake in neonatal layer-type chicken (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25902906
The complex modulation of lysosomal degradation pathways by cannabinoid receptor 1 and 2 (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25908257
Inhibition of FAAH reduces nitroglycerin-induced migraine-like pain and trigeminal neuronal hyperactivity in mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25910421
The monoacylglycerol lipase inhibitor JZL184 decreases inflammatory response in skeletal muscle contusion in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912803
Role of CB2 receptors in social and aggressive behavior in male mice (abst–2015) http://link.springer.com/article/10.1007%2Fs00213-015-3939-5
Role of CB2 receptors in social and aggressive behavior in male mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921034
Differential role of cannabinoids in the pathogenesis of skin cancer (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25921771
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25935384
The effect of endocannabinoid system in ischemia-reperfusion injury: a friend or a foe? (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25936364
Cannabinoid receptor 2 attenuates microglial accumulation and brain injury following germinal matrix hemorrhage via ERK dephosphorylation in vivo and in vitro (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25963415
Neuroprotective Effect of JZL184 in MPP+-Treated SH-SY5Y Cells Through CB 2 Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25976369
Involvement of cannabinoid receptors in infrasonic noise-induced neuronal impairment (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26058582
Over-expression of cannabinoid receptor 2 induces the apoptosis of cervical carcinoma Caski cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26062417
Endocannabinoids drive the acquisition of an alternative phenotype in microglia (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26086345
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Whole-cell biosensor for label-free detection of GPCR-mediated drug responses in personal cell lines (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26143464
Enhanced vasorelaxation effect of endogenous anandamide on thoracic aorta in renal vascular hypertension rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26173564
Phytocannabinoids for Cancer Therapeutics: Recent Updates and Future Prospects (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26179998
Activation of CB2 receptor is required for the therapeutic effect of ABHD6 inhibition in experimental autoimmune encephalomyelitis (abst–2015)
http://www.ncbi.nlm.nih.gov/pubmed/26189763
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity (abst–2015) http://www.sciencedirect.com/science/article/pii/S1043661815001243
Biphasic effects of anandamide on behavioural responses: emphasis on copulatory behaviour (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26226145
Cannabinoid receptor 1 but not 2 mediates macrophage phagocytosis by G(α)i/o /RhoA/ROCK signaling pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25545473
Novel Triazolopyrimidine-Derived Cannabinoid Receptor 2 Agonists As Potential Treatment for Inflammatory Kidney Diseases (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26228928
The role of the peripheral cannabinoid system in the pathogenesis of detrusor over-activity evoked by increased intravesical osmolarity in rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26243021
Cannabinoids Regulate Intestinal Motor Function and Electrophysiological Activity of Myocytes in Rodents (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26254701
Association between cannabinoid receptor type 2 Q63R variant and oligo/polyarticular juvenile idiopathic arthritis (abst–2015) http://informahealthcare.com/doi/abs/10.3109/03009742.2015.1020863
Pro-inflammatory obesity in aged cannabinoid-2 receptor deficient mice (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26303348
Medical Marijuana and Chronic Pain: a Review of Basic Science and Clinical Evidence (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26325482
Effects of Chronic Alcohol Exposure on the Modulation of Ischemia-Induced Glutamate Release via Cannabinoid Receptors in the Dorsal Hippocampus (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26343919
Palmitoylethanolamide attenuates PTZ-induced seizures through CB1 and CB2 receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26370914
A Cannabinoid Receptor 2 Agonist Prevents Thrombin-Induced Blood-Brain Barrier Damage via the Inhibition of Microglial Activation and Matrix Metalloproteinase Expression in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26376816
Biosynthesis and Fate of Endocannabinoids (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_2
Endocannabinoids and the Immune System in Health and Disease (abst–2015) http://link.springer.com/chapter/10.1007%2F978-3-319-20825-1_2
Endocannabinoids and the Cardiovascular System in Health and Disease (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26408169
Cannabinoid receptor-2 expression modulates Gβ1γ2 protein interaction with the activator of G protein signalling 2/dynein light chain protein Tctex-1 (abst–2015) http://www.sciencedirect.com/science/article/pii/S0006295215006279
Cannabinoid 2 receptor activation reduces leukocyte adhesion and improves capillary perfusionin the iridial microvasculature during systemic inflammation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26410875
The effect of WIN 55,212-2 suggests a cannabinoid-sensitive component in the early toxicity induced by organic acids accumulating in glutaric acidemia type I and in related disorders of propionate metabolism in rat brain synaptosomes (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26431622
Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients’ survival (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26459312
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26463937
The Efficacy of Eslicarbazepine Acetate in Models of Trigeminal, Neuropathic, and Visceral Pain: The Involvement of 5-HT1B/1D Serotonergic and CB1/CB2 Cannabinoid Receptors (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26465930
Intracellular postsynaptic cannabinoid receptors link thyrotropin-releasing hormone receptors to TRPC-like channels in thalamic paraventricular nucleus neurons (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26470810
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26513129
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors (abst–2015) http://www.sciencedirect.com/science/article/pii/S1043661815002583
Pharmacological Preventions of Brain Injury Following Experimental Germinal Matrix Hemorrhage: an Up-to-Date Review (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26561051
Pharmacological benefits of selective modulation of cannabinoid receptor type 2 (CB2) in experimental Alzheimer’s disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S0091305715300952
Cannabinoid Receptor Agonists Modulate Calcium Channels in Rat Retinal Müller Cells (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26621126
Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase: New Targets for Future Antidepressants (abst–2015) http://www.eurekaselect.com/132200/article
Therapy with a Selective Cannabinoid Receptor Type 2 Agonist Limits Albuminuria and Renal Injury in Mice with Type 2 Diabetic Nephropathy (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26646377
An Introduction to the Endogenous Cannabinoid System (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26698193
Effects of bioactive fatty acid amide derivatives in zebrafish scale model of bone metabolism and disease (abst–2015) http://www.sciencedirect.com/science/article/pii/S104366181500287X
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26720619
Dietary Carbohydrates that Modulate the Immune System (abst–2015) http://www.ingentaconnect.com/content/ben/ciemd/2015/00000002/00000001/art00009?crawler=true
Signaling Mechanism of Cannabinoid Receptor-2 Activation-Induced β-Endorphin Release (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26108183
Cannabinoid receptor 2 deficiency results in reduced neuroinflammation in an Alzheimer’s disease mouse model (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25443294
Endocannabinoid Inhibition Of Airway Sensory Nerve Depolarisation (abst–2015) http://www.atsjournals.org/doi/abs/10.1164/ajrccm-conference.2015.191.1_MeetingAbstracts.A4114
Intrathecal Injection of JWH-015 Attenuates Bone Cancer Pain Via Time-Dependent Modification of Pro-inflammatory Cytokines Expression and Astrocytes Activity in Spinal Cord (abst–2015) http://link.springer.com/article/10.1007/s10753-015-0168-3
The cannabinoid CB2 receptor-specific agonist AM1241 increases pentylenetetrazole induced seizure severity in Wistar rats (abst–2015) http://www.epires-journal.com/article/S0920-1211(16)30131-0/abstract
Runner’s high linked to cannabinoid receptors in mice (news & abstract–2015) http://medicalxpress.com/news/2015-10-runner-high-linked-cannabinoid-receptors.html
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Correlations between the Memory-Related Behavior and the Level of Oxidative Stress Biomarkers in the Mice Brain, Provoked by an Acute Administration of CB Receptor Ligands (full–2016) http://www.hindawi.com/journals/np/2016/9815092/
CB2 Cannabinoid Receptor Knockout in Mice Impairs Contextual Long-Term Memory and Enhances Spatial Working Memory (full–2016) http://www.hindawi.com/journals/np/2016/9817089/
Cannabinoid CB2 Receptor Mediates Nicotine-Induced Anti-Inflammation in N9 Microglial Cells Exposed to β Amyloid via Protein Kinase C (full–2016) http://www.hindawi.com/journals/mi/2016/4854378/
Cannabinoid Ligands and Alcohol Addiction: A Promising Therapeutic Tool or a Humbug? (full–2016) http://link.springer.com/article/10.1007/s12640-015-9555-7/fulltext.html
Myeloid-Specific Deletion of Diacylglycerol Lipase α Inhibits Atherogenesis in ApoEDeficient Mice (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0146267
Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice (full–2016) http://www.sciencedirect.com/science/article/pii/S0021915015301933
Up-regulation of immunomodulatory effects of mouse bone-marrow derived mesenchymal stem cells by tetrahydrocannabinol pre-treatment involving cannabinoid receptor CB2 (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=7042&path%5B%5D=20008
Simultaneous Activation of Induced Heterodimerization between CXCR4 Chemokine Receptor and Cannabinoid Receptor 2 (CB2) Reveal a Mechanism for Regulation of Tumor Progression (full–2016) http://www.jbc.org/content/early/2016/02/03/jbc.M115.712661.long
A collaboration investigating endocannabinoid signalling in brain and bone (full–2016) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0125/jbcpp-2015-0125.xml
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
New insights into the yin and yang of the endocannabinoid system in health and disease (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13451/full
A Comparative Analysis of the Endocannabinoid System in the Retina of Mice, Tree Shrews, and Monkeys (full–2016) http://www.hindawi.com/journals/np/2016/3127658/ CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury (full–2016) http://www.sciencedirect.com/science/article/pii/S0014488616300619
Editorial: Lung macrophages high on cannabinoids: jamming PAMs and taming TAMs? (full–2016) http://www.jleukbio.org/content/99/4/518.full
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys (full–2016) http://www.hindawi.com/journals/np/2016/1253245/
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (full–2016) https://www.dovepress.com/modulation-of-breast-cancer-cell-viability-by-a-cannabinoid-receptor-2-peerreviewed-fulltext-article-BCTT Functional selectivity of CB2 cannabinoid receptor ligands at a canonical and noncanonical pathway (full–2016) http://jpet.aspetjournals.org/content/early/2016/05/18/jpet.116.232561.long
Cannabinoid receptor type-1: breaking the dogmas (full–2016) http://f1000research.com/articles/5-990/v1
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156693
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
CB2 Cannabinoid Receptor As Potential Target against Alzheimer’s Disease (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00243/full#B36
Unmasking roles of the peripheral endocannabinoid system associated with bladder overactivity (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bju.13336/full Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
Stimulation of brain glucose uptake by cannabinoid CB2 receptors and its therapeutic potential in Alzheimer’s disease (full–2016) http://www.sciencedirect.com/science/article/pii/S0028390816300879
The cannabinoid quinol VCE-004.8 alleviates bleomycin-induced scleroderma and exerts potent antifibrotic effects through peroxisome proliferator-activated receptor-γ and CB2 pathways (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4757881/ Cannabinoid receptor-dependent and -independent anti-proliferative effects of omega-3 ethanolamides in androgen receptor-positive and -negative prostate cancer cell lines (full–2016) http://carcin.oxfordjournals.org/content/31/9/1584.long
Genetic Versus Pharmacological Assessment of the Role of Cannabinoid Type 2 Receptors in Alcohol Reward-Related Behaviors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4886733/
Opposite regulation of cannabinoid CB1 and CB2 receptors in the prefrontal cortex of rats treated with cocaine during adolescence (full–2016) http://www.sciencedirect.com/science/article/pii/S0304394016300192
The Cannabinoid Receptor 2 Protects Against Alcoholic Liver Disease Via a Macrophage Autophagy-Dependent Pathway (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4921859/
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858820/
Impaired Excitatory Neurotransmission in the Urinary Bladder from the Obese Zucker Rat: Role of Cannabinoid Receptors (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902197/
The cannabinoid WIN 55,212-2 prevents neuroendocrine differentiation of LNCaP prostate cancer cells (full–2016) http://www.nature.com/pcan/journal/vaop/ncurrent/full/pcan201619a.html
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679742/
Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4679742/
Prolonged activation of human islet cannabinoid receptors in vitro induces adaptation but not dysfunction (full–2016) http://www.sciencedirect.com/science/article/pii/S2214647416300137
Expression of the endocannabinoid receptors in human fascial tissue (full–2016) http://www.ejh.it/index.php/ejh/article/view/2643/2590
Effects of various cannabinoid ligands on choice behaviour in a rat model of gambling (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4803149/
Cannabinoid CB2 receptors are involved in the regulation of fibrogenesis during skin wound repair in mice (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4805070/
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation  (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927043/
Endocannabinoid system as a regulator of tumor cell malignancy – biological pathways and clinical significance (full–2016) https://www.dovepress.com/endocannabinoid-system-as-a-regulator-of-tumor-cell-malignancy-ndash-bpeer-reviewed-fulltext-article-
OTT Cannabinoid receptor subtype 2 (CB2R) agonist, GW405833 reduces agonist-induced Ca(2+) oscillations in mouse pancreatic acinar cells (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949433/
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929166/
Endocannabinoids and Heterogeneity of Glial Cells in Brain Function (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4932105/
Sulfation of the FLAG epitope is affected by co-expression of G protein-coupled receptors in a mammalian cell model (full–2016) http://www.nature.com/articles/srep27316
Spontaneous Cannabinoid Receptor 2 (CB2) Expression in the Cochlea of Adult Albino Rat and Its Up-Regulation after Cisplatin Treatment (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0161954
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice (full–2016) http://www.karger.com/Article/FullText/447855
CB2 cannabinoid receptor activation promotes colon cancer progression via AKT/GSK3β signaling pathway (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=11968&path%5B%5D=37882
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Turning Down the Thermostat: Modulating the Endocannabinoid System in Ocular Inflammation and Pain (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00304/full
The CB2 receptor and its role as a regulator of inflammation (full–2016) http://link.springer.com/article/10.1007%2Fs00018-016-2300-4
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Role of cannabinoid receptor 1 in human adipose tissue for lipolysis regulation and insulin resistance (full–2016) http://link.springer.com/article/10.1007%2Fs12020-016-1172-6
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Tamoxifen Isomers and Metabolites Exhibit Distinct Affinity and Activity at Cannabinoid Receptors: Potential Scaffold for Drug Development (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0167240
Cannabinoid 2 Receptor Agonist Improves Systemic Sensitivity to Insulin in High-Fat Diet/Streptozotocin-Induced Diabetic Mice (full–2016) https://www.karger.com/Article/FullText/453171
Attenuation of Cocaine-Induced Conditioned Place Preference and Motor Activity via Cannabinoid CB2 Receptor Agonism and CB1 Receptor Antagonism in Rats (full–2016) http://ijnp.oxfordjournals.org/content/early/2016/12/19/ijnp.pyw102.long
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Cannabinoid Type 2 (CB2) Receptors Activation Protects against Oxidative Stress and Neuroinflammation Associated Dopaminergic Neurodegeneration in Rotenone Model of Parkinson’s Disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4969295/
Mild Traumatic Brain Injury Produces Neuron Loss That Can Be Rescued by Modulating Microglial Activation Using a CB2 Receptor Inverse Agonist (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5052277/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
CB2 receptor activation prevents glial-derived neurotoxic mediator production, BBB leakage and peripheral immune cell infiltration and rescues dopamine neurons in the MPTP model of Parkinson’s disease (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4892852/
Synthesis, Biodistribution and In vitro Evaluation of Brain Permeable High Affinity Type 2 Cannabinoid Receptor Agonists [11C]MA2 and [18F]MA3 (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5031696/
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis (full–2016) http://gut.bmj.com/content/65/10/1721.long
Activation of Cannabinoid Receptor 2 Ameliorates DSS-Induced Colitis through Inhibiting NLRP3 Inflammasome in Macrophages (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5017608/
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (full–2016) http://journals.sagepub.com/doi/full/10.1177/1933719116630414
Antipsychotic-like Effects of M4 Positive Allosteric Modulators Are Mediated by CB2 Receptor-Dependent Inhibition of Dopamine Release (full–2016) http://www.cell.com/neuron/fulltext/S0896-6273(16)30509-8
Role of the endocannabinoid system in the control of mouse myometrium contractility during the menstrual cycle (full–2016) http://www.sciencedirect.com/science/article/pii/S0006295216304452
Dietary olive oil induces cannabinoid CB2 receptor expression in adipose tissue of ApcMin/+ transgenic mice (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5166557/
Selective Estrogen Receptor Modulators: Cannabinoid Receptor Inverse Agonists with Differential CB1 and CB2 Selectivity (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00503/full
Long-Term Effects of Prenatal Exposure to Undernutrition on Cannabinoid Receptor Related Behaviors: Sex and Tissue-Specific Alterations in the mRNA Expression of Cannabinoid Receptors and Lipid Metabolic Regulators (full–2016) http://journal.frontiersin.org/article/10.3389/fnbeh.2016.00241/full
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
Cannabinoid WIN-55,212-2 mesylate inhibits ADAMTS-4 activity in human osteoarthritic articular chondrocytes by inhibiting expression of syndecan-1 (link to PDF-2016) https://www.spandidos-publications.com/10.3892/mmr.2016.5137
Cannabinoid receptor 2 as anti-obesity target: inflammation, fat storage and browning modulation. (link to PDF-2016) http://press.endocrine.org/doi/10.1210/jc.2015-4381?url_ver=Z39.88-2003&rfr_id=ori%3Arid %3Acrossref.org&rfr_dat=cr_pub%3Dpubmed&
Two affinity sites of cannabinoid CB2 receptor identified by a novel homogeneous binding assay (link to PDF-2016) http://jpet.aspetjournals.org/content/early/2016/06/28/jpet.116.234948.long
Two Janus cannabinoids that are both CB2 agonists and CB1 antagonists (link to PDF–2016) http://jpet.aspetjournals.org/content/early/2016/12/07/jpet.116.236539.long
Effects of activation of endocannabinoid system on myocardial metabolism (click “ICI” for download–2016) http://www.ncbi.nlm.nih.gov/pubmed/27333924
Cannabinoid receptor-2 agonist inhibits macrophage induced EMT in non-small cell lung cancer by downregulation of EGFR pathway (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26741322
Cannabinoid Receptor Type 2 Agonist Attenuates Acute Neurogenic Pulmonary Edema by Preventing Neutrophil Migration after Subarachnoid Hemorrhage in Rats (abst-2016) http://link.springer.com/chapter/10.1007/978-3-319-18497-5_24
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26758668
Ligands for cannabinoid receptors, promising anticancer agents (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320515301521
Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394015303517
The endocannabinoid system in the human granulosa cell line KGN (abst–2016) http://www.sciencedirect.com/science/article/pii/S0303720716300065
Role of hypothalamic cannabinoid receptors in post-stroke depression in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26778127
Role of the Endocannabinoid System in the Pathophysiology of Schizophrenia (abst-2016) http://link.springer.com/article/10.1007/s12035-016-9697-5
Curcumin and hemopressin treatment attenuates cholestasis-induced liver fibrosis in rats: role of CB1 receptors (abst–2016) http://link.springer.com/article/10.1007/s00210-015-1181-7
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Expression of functional cannabinoid CB2 receptor in VTA dopamine neurons in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26833913
The molecular mechanism and effect of cannabinoid-2 receptor agonist on the blood spinal cord barrier permeability induced by ischemia-reperfusion injury (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26835555
A systematic review of plant-derived natural compounds for anxiety disorders (abst–2016) http://www.eurekaselect.com/139238/article
Anti-Inflammatory and Osteoprotective Effects of Cannabinoid-2 Receptor Agonist Hu- 308 in a Rat Model of Lipopolysaccharide-Induced Periodontitis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26846967
Cannabinoid receptor 2 augments eosinophil responsiveness and aggravates allergen induced pulmonary inflammation in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26850094 Cannabinoids and autoimmune diseases: A systematic review (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26876387
Development and Pharmacological Characterization of Selective Blockers of 2- Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.5b01812
Cannabinoid Receptor 2 Participates in Amyloid-β Processing in a Mouse Model of Alzheimer’s Disease but Plays a Minor Role in the Therapeutic Properties of a CannabisBased Medicine (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26890764
A Single Intrathecal or Intraperitoneal Injection of CB2 Receptor Agonist Attenuates Bone Cancer Pain and Induces a Time-Dependent Modification of GRK2 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26935064
Role of cannabinoids in gastrointestinal mucosal defense and inflammation (abst–2016) http://www.eurekaselect.com/140045/article
Cannabinoid receptors are involved in the protective effect of a novel curcumin derivative C66 against CCl4-induced liver fibrosis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26945822
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965148
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: a Dietary Phytocannabinoid of Pharmaceutical Promise (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965491
Role of cannabinoid receptors in renal diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26968477
Marine Metabolites Modulating CB Receptors and TRP Channels (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-101352
The role of carbon monoxide on the anti-nociceptive effects and expression of cannabinoid 2 receptors during painful diabetic neuropathy in mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27020787
Targeting the cannabinoid CB2 receptor to attenuate the progression of motor deficits in LRRK2-transgenic mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816302663
Endocannabinoids signaling: Molecular mechanisms of liver regulation and diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27100518
Cannabinoid Type 2 Receptors Mediate a Cell Type-Specific Plasticity in the Hippocampus (abst–2016) http://www.cell.com/neuron/abstract/S0896-6273%2816%2930025-3
Expression analysis of cannabinoid receptors 1 and 2 in B cells during pregnancy and their role on cytokine production (abst–2016) http://www.jrijournal.org/article/S0165-0378%2816%2930026-2/abstract
Synthetic cannabinoid receptor agonists and antagonists: implication in CNS disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27193072
Cannabinoid receptor 2 (CB2) agonists and antagonists: a patent update (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27215781
β-Caryophyllene attenuates palmitate-induced lipid accumulation through AMPK signaling by activating CB2 receptor in human HepG2 hepatocytes (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27234712
Endocannabinoid system: a promising therapeutic target for the treatment of haematological malignancies? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27237820
The Displacement Binding Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27245891
The Cyclic AMP Assay Using Human Cannabinoid CB2 Receptor-Transfected Cells (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27245894
Protocol to Study β-Arrestin Recruitment by CB1 and CB2 Cannabinoid Receptors (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_11
Assay of DAGLα/β Activity (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_16
Assay of Endocannabinoid Oxidation by Cyclooxygenase-2 (abst–2016) http://link.springer.com/protocol/10.1007%2F978-1-4939-3539-0_21
Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1/M2 polarization through the cAMP/PKA pathway in an experimental GMH rat model (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27261088
Cannabinoid 2 (CB2) receptor agonism reduces lithium chloride-induced vomiting in Suncus murinus and nausea-induced conditioned gaping in rats (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27263826
Pharmacological activation of cannabinoid 2 receptor attenuates inflammation, fibrogenesis, and promotes re-epithelialization during skin wound healing (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27268717
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27281236
Reduced Noradrenergic Signaling in the Spleen Capsule in the Absence of CB1 and CB2 Cannabinoid Receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27287619
Chromenopyrazole, a Versatile Cannabinoid Scaffold with in Vivo Activity in a Model of Multiple Sclerosis (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00397
Upregulation of the cannabinoid CB2 receptor in environmental and viral inflammation driven rat models of Parkinson’s disease (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014488616301790
Cannabinoid receptor agonism suppresses tremor, cognition disturbances and anxiety-like behaviors in a rat model of essential tremor (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27317835
Ischemic Stroke, Excitatory Amino Acids Toxicity and the Adjustment of Acupuncture Intervention (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27323449
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
Docosahexaenoic acid attenuates in endocannabinoid synthesis in RAW 264.7 macrophages activated with benzo(a)pyrene and lipopolysaccharide (abst–2016) http://www.sciencedirect.com/science/article/pii/S0378427416301667
An update on PPAR activation by cannabinoids (abst–2016) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=6
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise (abst–2016) http://www.ingentaconnect.com/search/article? option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=8
New ursane triterpenoids from Ficus pandurata and their binding affinity for human cannabinoid and opioid receptors (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27350550
Cannabinoid receptors in the kidney (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27367912
Endocannabionoid System in Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27364363
Microglia activation states and cannabinoid system: Therapeutic implications (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27373505
The cannabinoid 2 receptor agonist β-caryophyllene modulates the inflammatory reaction induced by Mycobacterium bovis BCG by inhibiting neutrophil migration (abst–2016) http://link.springer.com/article/10.1007%2Fs00011-016-0969-3
Inhibitors of diacylglycerol lipases in neurodegenerative and metabolic disorders (abst-2016) http://www.sciencedirect.com/science/article/pii/S0960894X16306874
Decreased in vivo availability of the cannabinoid type 2 receptor in Alzheimer’s disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488857
Selective activation of CB2 receptor improves efferocytosis in cultured macrophages (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27474129
Type-2 cannabinoid receptors in neurodegeneration (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816306983
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9- tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303395
The Effect of Muscarinic Receptor Modulators on the Antinociception Induced by CB2 Receptor Agonist, JWH133 in Mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27504865
Cannabinoid 2 receptor is a novel anti-inflammatory target in experimental proliferative vitreoretinopathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816303665
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Characterization of peripheral cannabinoid receptor expression and clinical correlates in schizophrenia. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/27591408
Experimental Cannabinoid 2 Receptor Inhibition in CNS Injury-Induced Immunodeficiency Syndrome. (abst – 2016) http://www.ncbi.nlm.nih.gov/pubmed/26999797
Selective modulator of cannabinoid receptor type 2 (CB2) against biochemical alterations and brain damage in chronic cerebral hypoperfusion induced vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27599483
Selective modulator of cannabinoid receptor type 2 reduces memory impairment and infarct size during cerebral hypoperfusion and vascular dementia (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27586843
Progress in study on endocannabinoids and cannabinoid receptors in the treatment for neuropathic pain (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27600019 Cannabinoid receptor signaling induces proliferation but not neurogenesis in the mouse olfactory epithelium (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27606334 Beyond the Direct Activation of Cannabinoid Receptors: New Strategies to Modulate the Endocannabinoid System in CNS-Related Diseases (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27630088
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Δ9-Tetrahydrocannabinol Reverses TNFα-induced Increase in Airway Epithelial Cell Permeability through CB2 Receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006295216302878
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681
The endocannabinoid system and bone (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27734700
Hemopressin peptides as modulators of the endocannabinoid system and their potential applications as therapeutic tools (abst–2016) http://www.eurekaselect.com/146167/article
Endocannabinoids and sleep (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416302640
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00538
Cannabinoid Receptor 2 Activation Restricts Fibrosis and Alleviates Hydrocephalus after Intraventricular Hemorrhage (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27769788
Decreased CB receptor binding and cannabinoid signaling in three brain regions of a rat model of schizophrenia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016306930
Cannabinoid derivatives exert a potent anti-myeloma activity both in vitro and in vivo (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27778331
Overlapping molecular pathways between cannabinoid receptors type 1 and 2 and estrogens/androgens on the periphery and their involvement in the pathogenesis of common diseases (Review) (abst–2016) https://www.spandidos-publications.com/10.3892/ijmm.2016.2779
Role of cannabis in digestive disorders (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27792038
Exocannabinoids effect on in vitro bovine oocyte maturation via activation of AKT and ERK1/2 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27798282
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
The combination of β-caryophyllene, baicalin and catechin synergistically suppresses the proliferation and promotes the death of RAW267.4 macrophages in vitro (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27840942
The central cannabinoid receptor type-2 (CB2) and chronic pain (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27842450
Application of Strep-Tactin XT for affinity purification of Twin-Strep-tagged CB2, a G protein-coupled cannabinoid receptor (abst–2016) http://www.sciencedirect.com/science/article/pii/S1046592816303321
The cannabinoid beta-caryophyllene (BCP) induces neuritogenesis in PC12 cells by a cannabinoid-receptor-independent mechanism (abst–2016) http://www.sciencedirect.com/science/article/pii/S0009279716305920
Cannabinoid receptors and TRPA1 on neuroprotection in a model of retinal ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014483516304791
Functional selectivity at G-protein coupled receptors: Advancing cannabinoid receptors as drug targets (abst–2016) http://www.sciencedirect.com/science/article/pii/S0006295216304014
Cannabimimetic phytochemicals in the diet – an evolutionary link to food selection and metabolic stress adaptation? (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27891602
Sex-dependent influence of chronic mild stress (CMS) on voluntary alcohol consumption; study of neurobiological consequences (abst–2016) http://www.sciencedirect.com/science/article/pii/S0091305716302465
Cannabinoid Type-2 Receptor Drives Neurogenesis and Improves Functional Outcome After Stroke (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27899748
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816310994
From adolescent to elder rats: Motivation for palatable food and cannabinoids receptors (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27935269
CB2 receptors regulate natural killer cells that limit allergic airway inflammation in a murine model of asthma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27992060
The role of mifamurtide in chemotherapy-induced osteoporosis of children with osteosarcoma (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27993113
Phytocannabinoids: a growing family of plant natural products with increasing pharmacological and clinical importance (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596088
Cannabinoid receptors on peripheral leukocytes from patients with schizophrenia: Evidence for defective immunomodulatory mechanisms (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28011441
Pharmacological and Toxicological Effects of Synthetic Cannabinoids and Their Metabolites (abst–2016) http://link.springer.com/chapter/10.1007%2F7854_2016_60 Protective effects of trans-caryophyllene on maintaining osteoblast function (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28026135
Up-regulation of CB2 receptors in reactive astrocytes in canine degenerative myelopathy, a disease model of amyotrophic lateral sclerosis (full–2017) http://dmm.biologists.org/content/early/2017/01/06/dmm.028373.long
Targeting Cutaneous Cannabinoid Signaling in Inflammation – A “High”-way to Heal? (full–2017) http://www.ebiomedicine.com/article/S2352-3964(17)30003-8/fulltext Cannabinoid Receptors in the Central Nervous System: Their Signaling and Roles in Disease (full–2017) http://journal.frontiersin.org/article/10.3389/fncel.2016.00294/full
The Impact of CB2 Receptor Ligands on the MK-801-Induced Hyperactivity in Mice (full–2017) http://link.springer.com/article/10.1007%2Fs12640-017-9702-4
Cannabinoid CB2 receptor ligand profiling reveals biased signalling and off-target activity (full–2017) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5216056/
Brain cannabinoid receptor 2: expression, function and modulation (abst-2017) https://www.ncbi.nlm.nih.gov/pubmed/28065934
Pharmacology of cannabinoids in the treatment of epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28087250
Compensatory Activation of Cannabinoid CB2 Receptor Inhibition of GABA Release in the Rostral Ventromedial Medulla in Inflammatory Pain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28100744
Cannabinoid receptor type 2 (CB2) as one of the candidate genes in human carotid plaque imaging: Evalulation of the novel radiotracer [11C]RS-016 targeting CB2 in atherosclerosis (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28104528
β-Caryophyllene promotes osteoblastic mineralization, and suppresses osteoclastogenesis and adipogenesis in mouse bone marrow cultures in vitro (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/28105093
Beta-caryophyllene protects against alcoholic steatohepatitis by attenuating inflammation and metabolic dysregulation in mice (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28107775
Role of cannabis in digestive disorders (abst–2017) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10&index=3
Endocannabinoid 2-arachidonoylglycerol protects inflammatory insults from sulfur dioxide inhalation via cannabinoid receptors in the brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28115138
Molecular Targets of the Phytocannabinoids: A Complex Picture (abst–2017) http://link.springer.com/chapter/10.1007%2F978-3-319-45541-9_4
Regulation of cannabinoid CB2 receptor constitutive activity in vivo: repeated treatments with inverse agonists reverse the acute activation of JNK and associated apoptotic signaling in mouse brain (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28127623


CB2a
Cannabinoid receptors are widely expressed in goldfish: molecular cloning of a CB2-like receptor and evaluation of CB1 and CB2 mRNA expression profiles in different organs (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3776019
Species Differences in Cannabinoid Receptor 2 and Receptor Responses to Cocaine Self Administration in Mice and Rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4330519/


CBR-CBe
Endothelium-dependent mechanisms of the vasodilatory effect of the endocannabinoid, anandamide, in the rat pulmonary artery (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22627170
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Mechanisms of endothelium-dependent relaxation evoked by anandamide in isolated human pulmonary arteries (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984660/
Endothelial atypical cannabinoid receptor: do we have enough evidence? (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12866/full
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Role of Endothelium in Abnormal Cannabidiol-Induced Vasoactivity in Retinal Arterioles (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26098470
The endocannabinoid anandamide causes endothelium-dependent vasorelaxation in human mesenteric arteries (full–2016) http://www.sciencedirect.com/science/article/pii/S104366181630113X
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMPdependent vasorelaxant (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27890711
top


CBR-GPR18 / CANNABINOID RECEPTOR
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2865488/
2-Arachidonoylglycerol (2-AG) Induces Corneal Epithelial Cell Migration via Cannabinoid CB1 Receptors (abst–2011) http://iovs.arvojournals.org/article.aspx? articleid=2352973&resultClick=1
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2012.02019.x/full
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration (full–2012) http://www.jmolecularsignaling.com/content/7/1/10
So what do we call GPR18 now? (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01731.x/full
Δ9-Tetrahydrocannabinol and N-arachidonyl glycine are full agonists at GPR18 receptors and induce migration in human endometrial HEC-1B cells (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1476-5381.2011.01497.x/full
N-arachidonoyl glycine induces macrophage apoptosis via GPR18 (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22266325
Evidence That A Functional Gpr18-based Signaling System In The Anterior Murine Eye Modulates Intraocular Pressure (abst–2012) http://iovs.arvojournals.org/article.aspx?articleid=2358806&resultClick=1
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
Do N-arachidonyl-glycine (NA-glycine) and 2-arachidonoyl glycerol (2-AG) share mode of action and the binding site on the β2 subunit of GABAA receptors? (full–2013) https://peerj.com/articles/149/
N-Arachidonyl glycine does not activate G protein-coupled receptor 18 signaling via canonical pathways (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3533477/
N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3734775/
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813752/
A GPR18-based signaling system regulates IOP in murine eye (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687663/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/
Mechanism of Central Atypical Cannabinoid Receptor GPR18-Mediated Hypotension in Conscious Rats (abst–2013) http://www.fasebj.org/cgi/content/meeting_abstract/27/1_MeetingAbstracts/654.15?sid=eea722c0-971c-4daa-8b8c-38c0c63c19ad
G-protein coupled receptor 18 (GPR18) in channel catfish: expression analysis and efficacy as immunostimulant against Aeromonas hydrophila infection (abst–2013) http://www.sciencedirect.com/science/article/pii/S1050464813006554
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full–2014) http://jpet.aspetjournals.org/content/early/2014/01/15/jpet.113.209213.long
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood- Brain Barrier (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
Δ(9)-THC and N-arachidonoyl glycine regulate BV-2 microglial morphology and cytokine release plasticity: implications for signaling at GPR18 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3877838/
Neuronal Nitric Oxide Synthase Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies GPR18-mediated Hypotension in Conscious Rats (full–2014) http://jpet.aspetjournals.org/content/early/2014/08/06/jpet.114.216036.long
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24762058
GPR18 is required for a normal CD8αα intestinal intraepithelial lymphocyte compartment (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4235638/
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451551/
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
GPR18 Inhibiting Amauromine and the Novel Triterpene Glycoside Auxarthonoside from the Sponge-Derived Fungus Auxarthron reticulatum (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26287693
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929166/
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18 (full–2016) http://www.nature.com/articles/srep32255
Evidence for a GPR18 Role in Diurnal Regulation of Intraocular Pressure (full–2016) http://iovs.arvojournals.org/article.aspx?articleid=2588572
GPR18 undergoes a high degree of constitutive trafficking but is unresponsive to NArachidonoyl Glycine (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4806671/
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
G protein-coupled receptor 18: A potential role for endocannabinoid signalling in metabolic dysfunction (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26337420
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.eurekaselect.com/138448/article
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
The Effect of Chronic Activation of the Novel Endocannabinoid Receptor GPR18 on Myocardial Function and Blood Pressure in Conscious Rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27676325
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
The endogenous lipid N-arachidonoyl glycine is hypotensive and nitric oxide-cGMP dependent vasorelaxant (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27890711
top


CBR-GPR35 / CXCR8
Expression of functional GPR35 in human iNKT cells (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20599711
Small Molecule Agonists for the Neurotensin 1 Receptor (NTR1 Agonists) (full–2013) http://www.ncbi.nlm.nih.gov/books/NBK184496/
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25926795


CBR-GPR40 / CANNABINOID RECEPTOR / FFAR1
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
TAK-875, an orally available G protein-coupled receptor 40/free fatty acid receptor 1 agonist, enhances glucose-dependent insulin secretion and improves both postprandial and fasting hyperglycemia in type 2 diabetic rats (full–2011) http://jpet.aspetjournals.org/content/339/1/228.long
A Multiple-Ascending-Dose Study to Evaluate Safety, Pharmacokinetics, and Pharmacodynamics of a Novel GPR40 Agonist, TAK-875, in Subjects With Type 2 Diabetes (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22669289
Optimization of (2,3-dihydro-1-benzofuran-3-yl)acetic acids: discovery of a non-free fatty acid-like, highly bioavailable G protein-coupled receptor 40/free fatty acid receptor 1 agonist as a glucose-dependent insulinotropic agent (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22490067
TAK-875 versus placebo or glimepiride in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22374408
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
A Novel Antidiabetic Drug, Fasiglifam/TAK-875, Acts as an Ago-Allosteric Modulator of FFAR1 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3794927/
Randomized, double-blind, dose-ranging study of TAK-875, a novel GPR40 agonist, in Japanese patients with inadequately controlled type 2 diabetes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3554318/
Pharmacometric Approaches to Guide Dose Selection of the Novel GPR40 Agonist TAK-875 in Subjects With Type 2 Diabetes Mellitus (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3600727/
Activation of GPR40 as a therapeutic target for the treatment of type 2 diabetes (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3920793/
TAK-875, a GPR40/FFAR1 agonist, in combination with metformin prevents progression of diabetes and β-cell dysfunction in Zucker diabetic fatty rats (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23848179
Fasiglifam as a new potential treatment option for patients with type 2 diabetes (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24195772
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
The G-Protein-Coupled Long-Chain Fatty Acid Receptor GPR40 and Glucose Metabolism (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4176464/
Activation of GPR40 attenuates chronic inflammation induced impact on pancreatic β- cells health and function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4083038/
A novel GPR40 agonist, CNX-011-67, suppresses glucagon secretion in pancreatic islets under chronic glucolipotoxic conditions in vitro (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4161845/
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24576779
Docosahexaenoic acid, G protein-coupled receptors, and melanoma: is G protein-coupled receptor 40 a potential therapeutic target? (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057893/
Optimization of GPR40 Agonists for Type 2 Diabetes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24900872
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Activation of G-protein-coupled receptor 40 attenuates the cisplatin-induced apoptosis of human renal proximal tubule epithelial cells (full–2014) http://www.spandidos-publications.com/ijmm/34/4/1117
Evaluation of the pharmacokinetics and safety of a single oral dose of fasiglifam in subjects with normal or varying degrees of impaired renal function (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4269813/
Physiology and therapeutics of the free fatty acid receptor GPR40 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24373235
G-protein coupled receptor 40 agonists as novel therapeutics for type 2 diabetes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24234912
High-resolution structure of the human GPR40 receptor bound to allosteric agonist TAK-875 (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25043059
Overexpression of g-protein-coupled receptor 40 enhances the mitogenic response to epoxyeicosatrienoic acids (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0113130
A Gut Microbial Metabolite of Linoleic Acid, 10-Hydroxy-cis-12-octadecenoic Acid, Ameliorates Intestinal Epithelial Barrier Impairment Partially via GPR40-MEK-ERK Pathway (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25505251
Vascular, but not luminal, activation of FFAR1 (GPR40) stimulates GLP-1 secretion from isolated perfused rat small intestine (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4600392/
Deficiency of G-protein coupled receptor 40, a lipid-activated receptor, heightens in vitro- and in vivo-induced murine osteoarthritis (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935402/
Dual effects of the non-esterified fatty acid receptor ‘GPR40’ for human health (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25615413
GPR40 agonists for the treatment of type 2 diabetes: life after “TAKing” a hit (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25604916
Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs (abst-2015) http://www.ncbi.nlm.nih.gov/pubmed/25576830
G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26739335
GPR40 Agonists for the Treatment of Type 2 Diabetes Mellitus: Benefits and Challenges (abst–2015) http://www.eurekaselect.com/137697/article
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854499/
Fasiglifam/TAK-875, a Selective GPR40 Agonist, Improves Hyperglycemia in Rats Unresponsive to Sulfonylureas and Acts Additively with Sulfonylureas (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26813930
Long-term safety and efficacy of fasiglifam (TAK-875), a G-protein-coupled receptor 40 agonist, as monotherapy and combination therapy in Japanese patients with type 2 diabetes: a 52-week open-label phase III study (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27178047
top


CBR-GPR55 / CB3 CANNABINOID RECEPTOR
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
GPR55 ligands promote receptor coupling to multiple signalling pathways (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931561/?tool=pubmed
A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2931574/
Pharmacological characterization of GPR55, a putative cannabinoid receptor (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2874616/pdf/nihms189321.pdf
Endocannabinoid-like N-arachidonoyl serine is a novel pro-angiogenic mediator (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2936832/
GPR55: Current Knowledge and Future Perspectives of a Purported “Type-3” Cannabinoid Receptor (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20166924
Cannabinoids and the gut: new developments and emerging concepts (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20117132
Cannabinoids and Bone: Friend or Foe? (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20532878
Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist (full–2011) http://jpet.aspetjournals.org/content/337/1/236.long
The Type 2 Cannabinoid Receptor Regulates Bone Mass and Ovariectomy-Induced Bone Loss by Affecting Osteoblast Differentiation and Bone Formation (full–2011) http://press.endocrine.org/doi/full/10.1210/en.2010-0930
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116968/
Lipid bilayer molecular dynamics study of lipid-derived agonists of the putative cannabinoid receptor, GPR55 (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3086297/?tool=pubmed
Screening for Selective Ligands for GPR55 (full–2011) http://www.ncbi.nlm.nih.gov/books/NBK66153/
GPR55 regulates cannabinoid 2 receptor-mediated responses in human neutrophils (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132458/pdf/cr201160a.pdf
New blood brothers: the GPR55 and CB2 partnership (full–2011) http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201177a.html
A role for the putative cannabinoid receptor GPR55 in the islets of Langerhans (full–2011) http://joe.endocrinology-journals.org/content/211/2/177.long
The atypical cannabinoid O-1602 protects against experimental colitis and inhibits neutrophil recruitment (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3116968/
A novel CB receptor GPR55 and its ligands are involved in regulation of gut movement in rodents (full–2011) http://onlinelibrary.wiley.com/doi/10.1111/j.1365-2982.2011.01742.x/full
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21464819
Modulation of the novel cannabinoid receptor – GPR55 – during rat fetoplacental development (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21497900
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
L-α-lysophosphatidylinositol meets GPR55: a deadly relationship (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/21367464
Pharmacology, Signaling and Physiological Relevance of the G Protein-coupled Receptor 55 (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/21907912
The novel cannabinoid receptor GPR55, inhibits cholangiocarcinoma growth (abst–2011) http://www.fasebj.org/content/25/1_Supplement/1117.3.abstract?sid=c25fb29d-4fe2-4875-8a21- 80afcada4527
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst–2011) http://www.sciencedirect.com/science/article/pii/S0304394011008986
Functional polymorphism in the GPR55 gene is associated with anorexia nervosa (abst–2011) http://www.ncbi.nlm.nih.gov/pubmed/20506567
Endocannabinoids inhibit release of nerve growth factor by inflammation-activated mast cells (abst–2011) http://www.sciencedirect.com/science/article/pii/S0006295211002978
Expression of cannabinoid receptors by human articular chondrocytes (abst–2011) http://www.thebonejournal.com/article/S8756-3282%2811%2900386-3/abstract
Off-Target Cannabinoid Effects Mediated by GPR55 (full–2012) http://content.karger.com/produktedb/produkte.asp?DOI=000336872&typ=pdf
Role of cannabinoids in the regulation of bone remodeling (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3499879/
The L-α-lysophosphatidylinositol/GPR55 system and its potential role in human obesity (full–2012) http://diabetes.diabetesjournals.org/content/61/2/281.long
Effects of Palmitoylethanolamide on Aqueous Humor Outflow(full–2012) http://www.iovs.org/content/53/8/4416.long
The Endocannabinoids Anandamide and Virodhamine Modulate the Activity of the Candidate Cannabinoid Receptor GPR55 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3669693/
Cannabinoid 2 (CB2) Receptor Involvement in the Down-regulation but not Upregulation of Serum IgE Levels in Immunized Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3419805/
The cannabinoid receptor CB1 modulates the signaling properties of the lysophosphatidylinositol receptor GPR55 (full–2012) http://www.jbc.org/content/early/2012/11/16/jbc.M112.364109.long
Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3249141/
Cannabinoid Receptors CB1 and CB2 Form Functional Heteromers in Brain (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3375509/
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Evidence for the Putative Cannabinoid Receptor (GPR55)-Mediated Inhibitory Effects on Intestinal Contractility in Mice (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3548934/
Magnolia Extract, Magnolol, and Metabolites: Activation of Cannabinoid CB2 Receptors and Blockade of the Related GPR55 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55 (full-2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4384340/
Psychopharmacology of the endocannabinoids: far beyond anandamide (full–2012) http://www.researchgate.net/publication/51201177_Psychopharmacology_of_the_endocannabinoids_far_be yond_anandamide
The atypical cannabinoid O-1602 increases hind paw sensitisation in the chronic constriction injury model of neuropathic pain (abst–2012) http://www.sciencedirect.com/science/article/pii/S0304394011016612
The interaction between intrathecal administration of low doses of palmitoylethanolamide and AM251 in formalin-induced pain related behavior and spinal cord IL1-β expression in rats (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22201038
GPR55 and GPR35 and their relationship to cannabinoid and lysophospholipid receptors (abst–2012) http://www.sciencedirect.com/science/article/pii/S0024320512003670
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
GPR55, a G-Protein Coupled Receptor for Lysophosphatidylinositol, Plays a Role in Motor Coordination (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0060314
Cannabinoid- and lysophosphatidylinositol-sensitive receptor GPR55 boosts neuro-transmitter release at central synapses (full–2013) http://www.pnas.org/content/early/2013/03/06/1211204110.full.pdf+html
Role of endogenous cannabinoid system in the gut (full–2013) http://www.actaps.com.cn/qikan/manage/wenzhang/2013-4-12.pdf
A potential role for GPR55 in gastrointestinal functions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660623/
The Natural Product Magnolol as a Lead Structure for the Development of Potent Cannabinoid Receptor Agonists (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3813752/
A role for O-1602 and G protein-coupled receptor GPR55 in the control of colonic motility in mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3677091/
Rod Photoreceptors Express GPR55 in the Adult Vervet Monkey Retina (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0081080
Genetic Background Can Result in a Marked or Minimal Effect of Gene Knockout (GPR55 and CB2 Receptor) in Experimental Autoimmune Encephalomyelitis Models of Multiple Sclerosis (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0076907
Magnolia extract, magnolol and metabolites: activation of cannabinoid CB2 receptors and blockade of the related GPR55 (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4027495/
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function (full–2013) http://jpet.aspetjournals.org/content/346/1/54.long
Of mice and (wo)men: factors influencing successful implantation including endocannabinoids (full–2013) http://humupd.oxfordjournals.org/content/20/3/415.long
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
A potential role for GPR55 in gastrointestinal functions (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3660623/
Orphan G protein receptor GPR55 as an emerging target in cancer therapy and management (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3706254/
Differential expression and functional role of cannabinoid genes in alcohol users (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3818789/
(R,R’)-4′-Methoxy-1-naphthylfenoterol Targets GPR55-mediated Ligand Internalization and Impairs Cancer Cell Motility (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3935314/
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3949647/
Identification of the GPR55 Antagonist Binding Site Using a Novel Set of High Potency GPR55 Selective Ligands (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3970910/
A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function (full–2013) http://jpet.aspetjournals.org/content/346/1/54.long
Cannabinoid receptor modulation of the endothelial cell inflammatory response (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2791499/
GPR55 and its Interaction with Membrane Lipids: Comparison with Other Endocannabinoid-Binding Receptors (link to PDF–2013) http://www.eurekaselect.com/105678/article
The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55 (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23714700
Regulation of cell proliferation by GPR55/cannabinoid receptors using (R,R’)-4’-methoxy-1-naphthylfenoterol in rat C6 glioma cell line (abst–2013) http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=695437a2-7613-4bef-8697-2294df2da859&cKey=18ba6eb0-2c5f-4004-a56f-2d1f450e2ed1&mKey=9b2d28e7-24a0-466f-a3c9-07c21f6e9bc9
Anti-inflammatory role of cannabidiol and O-1602 in cerulein-induced acute pancreatitis in mice (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22850623
The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia dependent neuroprotection after excitotoxic lesion (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24038453
(R,R’)-4’-methoxy-1-naphthylfenoterol Inhibits GPR55 signaling and the modulation of motility in human cancer cells (abst–2013) http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=25370896-7d13-4f15-be76-f664d79b577d&cKey=87b7fec1-45cc-42b7-aca7-48c6b1d42773&mKey=9b2d28e7-24a0-466f-a3c9-07c21f6e9bc9
Anticancer activity of anandamide in human cutaneous melanoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24041928
Increase of mesenchymal stem cell migration by Cannabidiol via activation of p42/44 MAPK (abst–2013) http://www.sciencedirect.com/science/article/pii/S0006295213007478
Regulation of GPR55 in rat white adipose tissue and serum LPI by nutritional status, gestation, gender and pituitary factors (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24378736
The endocannabinoid/endovanilloid N-arachidonoyl dopamine (NADA) and synthetic cannabinoid WIN55,212-2 abate the inflammatory activation of human endothelial cells (full–2014) http://www.jbc.org/content/early/2014/03/18/jbc.M113.536953.long
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/epi.12631/full
CB2 Receptor Activation Inhibits Melanoma Cell Transmigration through the Blood-Brain Barrier (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4057719/
GPR55 Deletion in Mice Leads to Age-Related Ventricular Dysfunction and Impaired Adrenoceptor-Mediated Inotropic Responses (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4183508/
Palmitoylethanolamide, a naturally-occurring lipid, is an orally effective intestinal antiinflammatory agent (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12907/full
Targeting CB2-GPR55 Receptor Heteromers Modulates Cancer Cell Signaling (full–2014) http://www.jbc.org/content/early/2014/07/02/jbc.M114.561761.full.pdf+html Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Role of Endocannabinoid Activation of Peripheral CB1 Receptors in the Regulation of Autoimmune Disease (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261058/
Heteromerization of GPR55 and cannabinoid CB2 receptors modulates signaling (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25048571
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
CB1 and GPR55 receptors are co-expressed and form heteromers in rat and monkey striatum. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24967683
Role of orphan G protein-coupled receptor 55 in diabetic gastroparesis in mice (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24964851
GPR55: From orphan to metabolic regulator? (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24972076
Consequences of early life stress on the expression of endocannabinoid-related genes in the rat brain (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25083571
The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25344934
Elevated CB1 and GPR55 receptor expression in proximal tubule cells and whole kidney exposed to diabetic conditions (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25545857
The therapeutic potential of orphan GPCRs, GPR35 and GPR55 (full–2015) http://www.ncbi.nlm.nih.gov/pubmed/25926795
Activation of GPR55 Receptors Exacerbates oxLDL-Induced Lipid Accumulation and Inflammatory Responses, while Reducing Cholesterol Efflux from Human Macrophages (ful  2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0126839
The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueduactal Grey (full–2015)
http://molpharm.aspetjournals.org/content/early/2015/05/12/mol.115.099333.long
Primary Macrophage Chemotaxis Induced by Cannabinoid Receptor 2 Agonists Occurs Independently of the CB2 Receptor (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451551/
Anandamide, Acting via CB2 Receptors, Alleviates LPS-Induced Neuroinflammation in Rat Primary Microglial Cultures (full–2015) http://www.hindawi.com/journals/np/2015/130639/
The G-protein coupled receptor 55-agonist L-α-lysophosphatidylinositol mediates ovarian carcinoma cell induced angiogenesis (full–2015) http://www.actaps.com.cn/qikan/manage/wenzhang/2014-3-10.pdf
Homeostatic regulation of brain functions by endocannabinoid signaling (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468750/
Pathogenesis of Systemic Sclerosis (full–2015) http://journal.frontiersin.org/article/10.3389/fimmu.2015.00272/full
Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach (full–2015)
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4492759/
The skeletal endocannabinoid system: clinical and experimental insights (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0073/jbcpp-2015-0073.xml
GPR55 – a putative “type 3” cannabinoid receptor in inflammation (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0080/jbcpp-2015-0080.xml
Alcohol Versus Cannabinoids: A Review of Their Opposite Neuro-Immunomodulatory Effects and Future Therapeutic Potentials (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4607066/
A role for GPR55 in human placental venous endothelial cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4487816/
The GPR55 agonist lysophosphatidylinositol mediates vasorelaxation of the rat mesenteric resistance artery and induces calcium release in rat mesenteric artery endothelial cells (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4459022/
Co-Localization of Alpha1-Adrenoceptors and GPR55: A Novel Prostate Cancer Paradigm? (full–2015) http://file.scirp.org/Html/2-2500616_55349.htm
The GPR55 antagonist CID16020046 protects against intestinal inflammation (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4587547/
Molecular Targets of Cannabidiol in Neurological Disorders (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4604182/
Cannabinoids and Epilepsy (full–2015) http://link.springer.com/article/10.1007%2Fs13311-015-0375-5
The role of cannabinoids in regulation of nausea and vomiting, and visceral pain (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25715910
Blockade of GPR55 in the dorsolateral striatum impairs performance of rats in a T-maze paradigm (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26292188
Mechanisms of vasorelaxation induced by the cannabidiol analogue compound O-1602 in the rat small mesenteric artery (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297305
Deletion of G-protein coupled receptor 55 promotes obesity by reducing physical activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26447738
Potent and selective N-(4-sulfamoylphenyl)thiourea-based GPR55 agonists (abst–2015) http://www.sciencedirect.com/science/article/pii/S0223523415303329
G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26739335
Expression and Function of the Endocannabinoid System in the Retina and the Visual Brain (full–2016) http://www.hindawi.com/journals/np/2016/9247057/
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
Cannabinoid Receptors CB1 and CB2 Modulate the Electroretinographic Waves in Vervet Monkeys (full–2016) http://www.hindawi.com/journals/np/2016/1253245/
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (full–2016) https://www.dovepress.com/modulation-of-breast-cancer-cell-viability-by-a-cannabinoid-receptor-2-peerreviewed-fulltext-article-BCTT
Cannabinoid Receptors Are Overexpressed in CLL but of Limited Potential for Therapeutic Exploitation (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0156693
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
The effect of O-1602, an atypical cannabinoid, on morphine-induced conditioned place preference and physical dependence (full–2016) http://www.sciencedirect.com/science/article/pii/S1734114016000037
Activation of the orphan receptor GPR55 by lysophosphatidylinositol promotes metastasis in triple-negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10206&path%5B%5D=32116
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927043/
Pharmacological evaluation of synthetic cannabinoids identified as constituents of spice (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929166/
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
CB2 and GPR55 Receptors as Therapeutic Targets for Systemic Immune Dysregulation (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00264/full
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Deletion of Gpr55 Results in Subtle Effects on Energy Metabolism, Motor Activity and Thermal Pain Sensation (full–2016) http://journals.plos.org/plosone/article? id=10.1371/journal.pone.0167965
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
The emerging role of the cannabinoid receptor family in peripheral and neuro-immune interactions (abst–2016) http://www.eurekaselect.com/138448/article
The endocannabinoid system in the human granulosa cell line KGN (abst–2016) http://www.sciencedirect.com/science/article/pii/S0303720716300065
Role of the lysophosphatidylinositol/GPR55 axis in cancer (abst–2016) http://www.sciencedirect.com/science/article/pii/S2212492615300105
Advances towards the Discovery of GPR55 Ligands (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27109575
A Functional Assay for GPR55: Envision Protocol (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27245893
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667 Advances in the Physiology of GPR55 in the Central Nervous (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27488130
Scotopic vision in the monkey is modulated by the G protein-coupled receptor 55 (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27485069
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Treatment with the GPR55 antagonist CID16020046 increases neutrophil activation in mouse atherogenesis (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27465665 Metabolism of endocannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27516570
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561953
Cannabinoid receptor ligand bias: implications in the central nervous system (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27835801
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence (abst–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00422/full
top


CBR-GPR109 / CANNABINOID RECEPTOR
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells (full–2011) http://tinyurl.com/pfeyx9h
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome (full–2011) http://ajpendo.physiology.org/content/300/4/E681.long
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
Central GPR109A Activation Mediates Glutamate-Dependent Pressor Response in Conscious Rats (abst–2015) http://jpet.aspetjournals.org/content/356/2/456.abstract?sid=97527854-e2fb-4d74-ad96-6ab0744dc240
top


CBR-GPR119 / CANNABINOID RECEPTOR
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full–2010) http://pharmrev.aspetjournals.org/content/62/4/588.full.pdf+html
N-oleoyldopamine enhances glucose homeostasis through the activation of GPR119 (full–2010) http://mend.endojournals.org/content/24/1/161.long
GPR119 agonists for the potential treatment of type 2 diabetes and related metabolic disorders (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/21094910
American Diabetes Association–70th scientific sessions–research on novel therapeutics: part 2 (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20799137
Novel GPR119 agonist AS1535907 contributes to first-phase insulin secretion in rat perfused pancreas and diabetic db/db mice (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20937249
AS1907417, a novel GPR119 agonist, as an insulinotropic and β-cell preservative agent for the treatment of type 2 diabetes (abst–2010) http://www.ncbi.nlm.nih.gov/pubmed/20816753
GPR119 Regulates Murine Glucose Homeostasis Through Incretin Receptor-Dependent and Independent Mechanisms (full–2011) http://endo.endojournals.org/content/152/2/374.full?sid=c7413b30-1046-4f9c-b028-c46f78f293d9
The cytoprotective effects of oleoylethanolamide in insulin-secreting cells do not require activation of GPR119 (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3423238/
G-Protein-Coupled Receptors in Intestinal Chemosensation (full–2012) http://www.sciencedirect.com/science/article/pii/S1550413112000198
Stimulating beta cell replication and improving islet graft function by GPR119 agonists (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/j.1432-2277.2011.01332.x/full
GPR119 as a fat sensor (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22560300
The Endocannabinoid System and Sex Steroid Hormone-Dependent Cancers (full–2013) http://www.hindawi.com/journals/ije/2013/259676/
Cannabinoid receptor modulation of the endothelial cell inflammatory response (abst–2013) http://www.jimmunol.org/cgi/content/meeting_abstract/190/1_MeetingAbstracts/112.29?sid=c3422dd2-7ad0-42e4-a862-845dc670f7cf
Vascular targets for cannabinoids: animal and human studies (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bph.12560/full
Molecular matchmaking between the popular weight-loss herb Hoodia gordonii and GPR119, a potential drug target for metabolic disorder (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4210048/
Dietary Non-Esterified Oleic Acid Decreases the Jejunal Levels of Anorectic Nacylethanolamines (full–2014) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0100365
Cannabinoids: New Promising Agents in the Treatment of Neurological Diseases (full–2014) http://www.mdpi.com/1420-3049/19/11/18781/htm
Classical endocannabinoid-like compounds and their regulation by nutrients (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24677570
Gastrointestinal hormonal responses on GPR119 activation in lean and diseased rodent models of type 2 diabetes (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24451185
Circumventing seizure activity in a series of G protein coupled receptor 119 (GPR119) agonists (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25286150
Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity (abst–2015) http://www.sciencedirect.com/science/article/pii/S0303720715000106
Direct activation of the proposed anti-diabetic receptor, GPR119 in cardiomyoblasts decreases markers of muscle metabolic activity (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25578601
G protein-coupled receptors: signalling and regulation by lipid agonists for improved glucose homoeostasis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26739335
Dose-response estrogen promotes osteogenic differentiation via GPR40 (FFAR1) in murine BMMSCs (abst-2015) http://www.sciencedirect.com/science/article/pii/S0300908415000036
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
A Lower Olfactory Capacity Is Related to Higher Circulating Concentrations of Endocannabinoid 2-Arachidonoylglycerol and Higher Body Mass Index in Women (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0148734
Mechanisms underlying glucose‐dependent insulinotropic polypeptide and glucagon‐like peptide‐1 secretion (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4854499/
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Endocannabinoid System: the Direct and Indirect Involvement in the Memory and Learning Processes—a Short Review (full–2016) http://link.springer.com/article/10.1007%2Fs12035-016-0313-5
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130


CBR-GPR135 CANNABINOID RECEPTOR
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18 (full–2016) http://www.nature.com/articles/srep32255


CBR-GPR137 CANNABINOID RECEPTOR
Characterization of non-olfactory GPCRs in human sperm with a focus on GPR18 (full–2016) http://www.nature.com/articles/srep32255


CBR-GPR158 / CANNABINOID RECEPTOR
GPR158/179 regulate G protein signaling by controlling localization and activity of the RGS7 complexes (full–2012) http://jcb.rupress.org/content/197/6/711.long
Genome-wide association study of antibody response to smallpox vaccine (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3367131/
GPR158, an Orphan Member of G Protein-Coupled Receptor Family C: Glucocorticoid-Stimulated Expression and Novel Nuclear Role (full–2013) http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0057843
The Concise Guide to PHARMACOLOGY 2013/14: G Protein-Coupled Receptors (full–2013) http://onlinelibrary.wiley.com/doi/10.1111/bph.12445/full
top


CBR – 5-HT1A
Cannabidiol ameliorates cognitive and motor impairments in bile-duct ligated mice via 5-HT1A receptor activation (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2829220/?tool=pubmed
Antidepressant-like effects of cannabidiol in mice: possible involvement of 5-HT1A receptors (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2823358/?tool=pubmed
Intra-dorsal periaqueductal gray administration of cannabidiol blocks panic-like response by activating 5-HT1A receptors (abst–2010) http://www.unboundmedicine.com/medline/ebm/record/20457188/abstract/Intra_dorsal_periaqueductal_gray_administration_of_cannabidiol_blocks_panic_like_response_by_activating_5_HT1A_receptors_
Cannabidiol injected into the bed nucleus of the stria terminalis modulates baroreflex activity through 5-HT1A receptors (abst–2010) http://www.sciencedirect.com/science/article/pii/S1043661810001192
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors (abst-2010) http://www.ncbi.nlm.nih.gov/pubmed/20695034
Cannabidiol inhibits the hyperphagia induced by cannabinoid-1 or serotonin-1A receptor agonists (full–2011) http://www.sciencedirect.com/science/article/pii/S0091305711000128
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors (abst-2011) http://www.ncbi.nlm.nih.gov/pubmed/20945065
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3481531/
Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22979992
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT1A receptors (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/21148020
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5- HT1A receptors activation in mice (full–2013) http://www.sciencedirect.com/science/article/pii/S0278584613001164
Similar anxiolytic effects of agonists targeting serotonin 5-HT1A or cannabinoid CB receptors on zebrafish behavior in novel environments (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3989442/
Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT(1A) receptor activation (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3596650/
The role of 5-HT1A receptors in the anti-aversive effects of cannabidiol on panic attack like behaviors evoked in the presence of the wild snake Epicrates cenchria crassus (Reptilia, Boidae) (full–2013) http://journals.sagepub.com/doi/full/10.1177/0269881113493363
Mechanisms Of Cannabidiol Neuroprotection In Hypoxic-Ischemic Newborn Pigs: Role Of 5HT1A And CB2 Receptors (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813001238
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003419
Cannabidiol inhibits the reward-facilitating effect of morphine: involvement of 5-HT1A receptors in the dorsal raphe nucleus (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/22862835
Cannabidiol administration into the bed nucleus of the stria terminalis alters cardiovascular responses induced by acute restraint stress through 5-HT₁A receptor. (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23041353
Effects of intra-prelimbic prefrontal cortex injection of cannabidiol on anxiety-like behavior: Involvement of 5HT1A receptors and previous stressful experience (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24321837
Cannabidiol inhibits paclitaxel-induced neuropathic pain through 5-HT1A receptors without diminishing nervous system function or chemotherapy efficacy (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3969077/
Cannabidiol: Pharmacology and potential therapeutic role in epilepsy and other neuropsychiatric disorders (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4707667/
Antidepressant-like and anxiolytic-like effects of cannabidiol: a chemical compound of Cannabis sativa (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24923339
Role of endocannabinoid signalling in the dorsolateral periaqueductal grey in the modulation of distinct panic-like responses (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881114566259
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygenglucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
Cannabidiol induces rapid-acting antidepressant-like effects and enhances cortical 5- HT/glutamate neurotransmission: role of 5-HT1A receptors (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815302136
Effects of intra-infralimbic prefrontal cortex injections of cannabidiol in the modulation of emotional behaviors in rats: contribution of 5HT₁A receptors and stressful experiences (abst–2015) http://www.sciencedirect.com/science/article/pii/S0166432815001023
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygen glucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927043/
Enhanced discriminative stimulus effects of Δ9-THC in the presence of cannabidiol and 8-OH-DPAT in rhesus monkeys (abst–2016) http://www.drugandalcoholdependence.com/article/S0376-8716(16)30133-8/abstract
Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex – possible involvement of 5-HT1A and CB1 receptors (abst–2016) http://www.sciencedirect.com/science/article/pii/S0166432816300298
Cannabidiol attenuates haloperidol-induced catalepsy and c-Fos protein expression in the dorsolateral striatum via 5-HT1A receptors in mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S016643281630256X
Cannabidiol Modulates Fear Memory Formation through Interactions with Serotonergic Transmission in the Mesolimbic System (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27296152
The CB1 antagonist, SR141716A, is protective in permanent photothrombotic cerebral ischemia (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394016305353
top


CBR-NPR19
Endocannabinoid signaling regulates regenerative axon navigation in Caenorhabditis elegans via the GPCRs NPR-19 and NPR-32 (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12377/full


CBR-NPR32
Endocannabinoid signaling regulates regenerative axon navigation in Caenorhabditis elegans via the GPCRs NPR-19 and NPR-32 (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/gtc.12377/full
top


CBR–PPARs
β-Caryophyllene inhibits dextran sulfate sodium-induced colitis in mice through CB2 receptor activation and PPARγ pathway (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3070571/
Cannabidiol Reduces Aβ-Induced Neuroinflammation and Promotes Hippocampal Neurogenesis through PPARγ Involvement (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3230631/?tool=pubmed
Inhibition of COX-2 expression by endocannabinoid 2-arachidonoylglycerol is mediated via PPAR-γ (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3165961/
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417461/
Multimodal stepped care approach with acupuncture and PPAR-α agonist palmitoylethanolamide in the treatment of a patient with multiple sclerosis and central neuropathic pain (full–2012) http://aim.bmj.com/content/30/1/53.long
Orally administered oleoylethanolamide protects mice from focal cerebral ischemic injury by activating peroxisome proliferator-activated receptor α (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001062
Effects of the anandamide uptake blocker AM404 on food intake depend on feeding status and route of administration (abst–2012) http://www.sciencedirect.com/science/article/pii/S0091305711003662
Investigation of endocannabinoid system genes suggests association between peroxisome proliferator activator receptor-α gene (PPARA) and schizophrenia (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22920733
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812005643
WIN55212-2 attenuates amyloid-beta-induced neuroinflammation in rats through activation of cannabinoid receptors and PPAR-γ pathway (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812001980
Inhibition of FAAH and activation of PPAR: New approaches to the treatment of cognitive dysfunction and drug addiction (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3662489/
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma (full–2013) http://www.jneuroinflammation.com/content/10/1/20
COX-2 and PPAR-γ Confer Cannabidiol-Induced Apoptosis of Human Lung Cancer Cells (full–2013) http://mct.aacrjournals.org/content/12/1/69.long
Involvement of PPARγ in the antitumoral action of cannabinoids on hepatocellular carcinoma (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3674350/
Evolution in pharmacologic thinking around the natural analgesic palmitoylethanolamide: from nonspecific resistance to PPAR-α agonist and effective nutraceutical (link to PDF–2013) http://www.dovepress.com/articles.php?article_id=13950
Cannabidiol Promotes Amyloid Precursor Protein Ubiquitination and Reduction of Beta Amyloid Expression in SHSY5YAPP+ Cells Through PPARγ Involvement (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24288245
Δ9-Tetrahydrocannabinol is protective through PPARγ dependent mitochondrial biogenesis in a cell culture model of Parkinson’s Disease (abst–2013) http://jnnp.bmj.com/content/84/11/e2.58.abstract
PPARγ mediates the effects of WIN55,212-2, an synthetic cannabinoid, on the proliferation and apoptosis of the BEL-7402 hepatocarcinoma cells (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24062073
Fatty Acid-binding Protein 5 (FABP5) Regulates Cognitive Function Both by Decreasing Anandamide Levels and by Activating the Nuclear Receptor Peroxisome Proliferatoractivated Receptor β/δ (PPARβ/δ) in the Brain (full–2014) http://www.jbc.org/content/289/18/12748.full.pdf+html
Activation of PPAR gamma receptors reduces levodopa-induced dyskinesias in 6-OHDAlesioned rats (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4323744/
Palmitoylethanolamide improves colon inflammation through an enteric glia/toll like receptor 4-dependent PPAR-α activation (abst–2014) http://gut.bmj.com/content/63/8/1300.abstract?sid=a8fb2a13-4493-4045-8855-9a0bae1e5d51
β-Caryophyllene Ameliorates the Alzheimer-Like Phenotype in APP/PS1 Mice through CB2 Receptor Activation and the PPARγ Pathway (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25171128
WIN induces apoptotic cell death in human colon cancer cells through a block of autophagic flux dependent on PPARγ down-regulation (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/24696378
Involvement of PPAR receptors in the anticonvulsant effects of a cannabinoid agonist, WIN 55,212-2 (abst–2014) http://www.sciencedirect.com/science/article/pii/S0278584614002218
Inhibition of FAAH confers increased stem cell migration via PPARα (full-2015) http://www.jlr.org/content/early/2015/08/11/jlr.M061473.long
Oleoylethanolamide, an endogenous PPAR-α ligand, attenuates liver fibrosis targeting hepatic stellate cells (full–2015) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=6466&path[]=17855
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297326
Cannabidiol protects an in vitro model of the blood brain barrier (BBB) from oxygenglucose deprivation via PPARγ and 5-HT1A (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26497782
Interference with acute nausea and anticipatory nausea in rats by fatty acid amide hydrolase (FAAH) inhibition through a PPARα and CB1 receptor mechanism, respectively: a double dissociation (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26297326
Effects of dietary CLA on n-3 HUFA score and N-acylethanolamides biosynthesis in the liver of obese Zucker rats (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25912618
Analysis of endocannabinoid signaling elements and related proteins in lymphocytes of patients with Dravet syndrome (full–2016) http://onlinelibrary.wiley.com/doi/10.1002/prp2.220/full
Delta-9-tetrahydrocannabinol protects against MPP+ toxicity in SH-SY5Y cells by restoring proteins involved in mitochondrial biogenesis (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path %5B%5D=10314&path%5B%5D=32486
Endocannabinoids in Feeding Behavior and Energy Homeostasis (full–2016) http://themedicalbiochemistrypage.org/endocannabinoids.php
A role of CB1R in inducing θ-rhythm coordination between the gustatory and gastrointestinal insula (full–2016) http://www.nature.com/articles/srep32529
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Exposure to a Highly Caloric Palatable Diet during the Perinatal Period Affects the Expression of the Endogenous Cannabinoid System in the Brain, Liver and Adipose Tissue of Adult Rat Offspring (full–2016) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0165432
Effects of Adolescent Intermittent Alcohol Exposure on the Expression of Endocannabinoid Signaling-Related Proteins in the Spleen of Young Adult Rats (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5035052/
Can Cannabinoids Modulate Fibrotic Progression in Systemic Sclerosis? (link to PDF–2016) http://www.ima.org.il/imaj/ViewArticle.aspx?aId=3850
Endocannabinoids and Endocannabinoid-Related Mediators: Targets, Metabolism and Role In Neurological Disorders (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26965148
An update on peroxisome proliferator-activated receptor (PPAR) activation by cannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27077495
N-Oleoylethanolamine reduces inflammatory cytokines and adhesion molecules in TNF- α-induced human umbilical vein endothelial cells by activating CB2 and PPAR-α (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27281236
An update on PPAR activation by cannabinoids (abst–2016) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=6
Polypharmacological Properties and Therapeutic Potential of β-Caryophyllene: A Dietary Phytocannabinoid of Pharmaceutical Promise (abst–2016) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=8
Co-administration of cannabidiol and capsazepine reduces L-DOPA-induced dyskinesia in mice: Possible mechanism of action (abst–2016) https://www.researchgate.net/publication/304669756_Coadministration_of_cannabidiol_and_capsazepine_ reduces_L-DOPA-induced_dyskinesia_in_mice_Possible_mechanism_of_action
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623929
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916306161
Palmitoylethanolamide reduces inflammation and itch in a mouse model of contact allergic dermatitis (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27720681
Endocannabinoids and sleep (abst–2016) http://www.sciencedirect.com/science/article/pii/S0149763416302640
Therapeutic potential of fatty acid amide hydrolase, monoacylglycerol lipase, and Nacylethanolamine acid amidase inhibitors (abst–2016) http://pubs.acs.org/doi/abs/10.1021/acs.jmedchem.6b00538
Pharmacokinetic-pharmacodynamic influence of N-palmitoylethanolamine, arachidonyl- 2′-chloroethylamide and WIN 55,212-2 on the anticonvulsant activity of antiepileptic drugs against audiogenic seizures in DBA/2 mice (abst–2016) http://www.sciencedirect.com/science/article/pii/S0014299916306161
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence (abst–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00422/full
Phytocannabinoids: a growing family of plant natural products with increasing pharmacological and clinical importance (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596088
Plasma palmitoylethanolamide (PEA) as a potential biomarker for impaired coronary function (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27989579
top


CBR-TRPV1 / TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 1 CHANNEL
Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells (full–2010) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2926165/
The Role of Cannabinoid Receptors in the Descending Modulation of Pain (link to PDF-2010) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.634.4866&rank=72
Multiple Changes in Peptide and Lipid Expression Associated with Regeneration in the Nervous System of the Medicinal Leech (link to PDF–2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.713.3790&rank=102
The effect of CBD (BDS) botanical cannabinoid extraction on MCF-7 human breast carcinoma cells (abst–2011) http://eprints.hud.ac.uk/16197/
Anandamide capacitates bull spermatozoa through CB1 and TRPV1 activation (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3037938/?tool=pubmed
Role of Myeloid-Derived Suppressor Cells in Amelioration of Experimental Autoimmune Hepatitis Following Activation of TRPV1 Receptors by Cannabidiol (full–2011) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3069975/?tool=pmcentrez
Tak1 Interactions With TRPV1 and CB1 Control IL-6 and IL-8 Release in Human Corneal Epithelial Cells (abst–2011) http://iovs.arvojournals.org/article.aspx? articleid=2349956&resultClick=1
CB1 Activation Reduces TRPV1-induced Responses in Human Corneal Epithelial Cells (abst–2011) http://iovs.arvojournals.org/article.aspx?articleid=2353114&resultClick=1
β−Amyloid exacerbates inflammation in astrocytes lacking fatty acid amide hydrolase through a mechanism involving PPAR-α, PPAR-γ and TRPV1, but not CB1 or CB2 receptors (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3417461/
Opposing Roles for Cannabinoid Receptor Type-1 (CB(1)) and Transient Receptor Potential Vanilloid Type-1 Channel (TRPV1) on the Modulation of Panic-Like Responses in Rats (full–2012) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3242309/
The Contractile Effect of Anandamide in the Guinea-Pig Small Intestine is Mediated by Prostanoids but not TRPV1 Receptors or Capsaicin-Sensitive Nerves (full–2012) http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12041/full
Pharmacological manipulation of cannabinoid neurotransmission reduces neuroinflammation associated with normal aging (full–2012) http://file.scirp.org/Html/1-8201656_23229.htm
Endocannabinoid analogues exacerbate marble-burying behavior in mice via TRPV1 receptor (abst–2012) http://www.sciencedirect.com/science/article/pii/S0028390812000068 TRPV1-mediated calcium signal couples with cannabinoid receptors and sodium-calcium exchangers in rat odontoblasts (abst–2012) http://www.ncbi.nlm.nih.gov/pubmed/22656960?dopt=Abstract CB1 Cannabinoid Receptor Agonist Prevents NGF-Induced Sensitization of TRPV1 in Sensory Neurons (full-2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3752375/
Full Inhibition of Spinal FAAH Leads to TRPV1-Mediated Analgesic Effects in Neuropathic Rats and Possible Lipoxygenase-Mediated Remodeling of Anandamide Metabolism (full–2013) http://www.plosone.org/article/info%3Adoi %2F10.1371%2Fjournal.pone.0060040 Additive antiemetic efficacy of low-doses of the cannabinoid CB1/2 receptor agonist Δ9- THC with ultralow-doses of the vanilloid TRPV1 receptor agonist resiniferatoxin in the least shrew (Cryptotis parva) (abst–2013) http://www.sciencedirect.com/science/article/pii/S001429991300767X
Oleoylethanolamide reduces L-DOPA-induced dyskinesia via TRPV1 receptor in a mouse model of Parkinson´s disease (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/24140894
Modulation by 17β-estradiol of anandamide vasorelaxation in normotensive and hypertensive rats: a role for TRPV1 but not fatty acid amide hydrolase (abst–2013) http://www.ncbi.nlm.nih.gov/pubmed/23340220
Additive antiemetic efficacy of 9-THC with vanilloid TRPV1 receptor agonists in the least shrew (Cryptotis parva) (abst-2013) http://www.sciencedirect.com/science/article/pii/S001429991300767X
Role of TRPV1 receptors on panic-like behaviors mediated by the dorsolateral periaqueductal gray in rats (abst–2013) http://www.sciencedirect.com/science/article/pii/S0091305713000580
Motor effects of the non-psychotropic phytocannabinoid cannabidiol that are mediated by 5-HT1A receptors (abst–2013) http://www.sciencedirect.com/science/article/pii/S0028390813003419
Glucose concentration in culture medium affects mRNA expression of TRPV1 and CB1 receptors and changes capsaicin toxicity in PC12 cells (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4322151/
Iron overload causes osteoporosis in Thalassemia Major patients through interaction with TRPV1 channels (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4258755/
TRPV1 and Endocannabinoids: Emerging Molecular Signals that Modulate Mammalian Vision (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4197638/
TRPV1 mediates cellular uptake of anandamide and thus promotes endothelial cell proliferation and network-formation (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4265754/
Ultramicronized palmitoylethanolamide normalizes intestinal motility in a murine model of post-inflammatory accelerated transit: involvement of CB1 receptors and TRPV1 (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4243976/
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabisderived non-psychotropic cannabinoid (full–2014) http://carcin.oxfordjournals.org/content/35/12/2787.long
Anticonvulsant Effects of N-Arachidonoyl-Serotonin, a Dual FAAH Enzyme and TRPV1 Channel Blocker, on Experimental Seizures: The Roles of Cannabinoid CB1 Receptors and TRPV1 Channels (full–2014) http://onlinelibrary.wiley.com/doi/10.1111/bcpt.12232/full
Activation of CB1 inhibits NGF-induced sensitization of TRPV1 in adult mouse afferent neurons (full–2014) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4626020/
Programming and reprogramming neural cells by (endo-) cannabinoids: from physiological rules to emerging therapies (full–2014) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4765324/
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cn5000524
The dual blocker of FAAH/TRPV1 N-arachidonoylserotonin reverses the behavioral despair induced by stress in rats and modulates the HPA-axis (abst–2014) http://www.sciencedirect.com/science/article/pii/S104366181400067X
NONRETROGRADE ENDOCANNABINOID SIGNALING MODULATES RETINAL GANGLION CELL CALCIUM HOMEOSTASIS THROUGH THE TRPV1 CATION CHANNEL (abst-2014) http://iovs.arvojournals.org/article.aspx? articleid=2268407&resultClick=1
Impairment of Corneal Epithelial Wound Healing in a TRPV1-Deficient Mouse (abst–2014) http://iovs.arvojournals.org/article.aspx?articleid=2128931&resultClick=1
Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://www.arthritis-research.com/content/17/1/226
The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation (full–2015) http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0136546
The skeletal endocannabinoid system: clinical and experimental insights (full–2015) http://www.degruyter.com/view/j/jbcpp.ahead-of-print/jbcpp-2015-0073/jbcpp-2015-0073.xml
TRPV1 Channel: A Potential Drug Target for Treating Epilepsy (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4598436/
Anti-inflammatory effects of N-acylethanolamines in rheumatoid arthritis synovial cells are mediated by TRPV1 and TRPA1 in a COX-2 dependent manner (full–2015) http://www.arthritis-research.com/content/17/1/321
TRPV1 channel inhibition contributes to the antinociceptive effects of Croton macrostachyus extract in mice (full–2015) http://bmccomplementalternmed.biomedcentral.com/articles/10.1186/s12906-015-0816-z Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis (full–2015) http://link.springer.com/article/10.1186/s13075-015-0743-x
Fetal endocannabinoids orchestrate the organization of pancreatic islet microarchitecture (full–2015) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4653226/ The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat (full–2015) http://journals.sagepub.com/doi/full/10.1177/0333102415613766
Sperm Release from the Oviductal Epithelium Depends on Ca2+ Influx Upon Activation of CB1 and TRPV1 by Anandamide (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26129689
CB2 and TRPV1 receptors oppositely modulate in vitro human osteoblast activity (abst–2015) http://www.sciencedirect.com/science/article/pii/S1043661815001243
A multi-target approach for pain treatment – dual inhibition of fatty acid amide hydrolase and TRPV1 in a rat model of osteoarthritis (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/25719612
Chronic stress and peripheral pain: Evidence for distinct, region-specific changes in visceral and somatosensory pain regulatory pathways (abst–2015) http://www.sciencedirect.com/science/article/pii/S0014488615300959
Anandamide-induced endoplasmic reticulum stress and apoptosis are mediated by oxidative stress in non-melanoma skin cancer: Receptor-independent endocannabinoid signaling (abst–2015) http://www.ncbi.nlm.nih.gov/pubmed/26513129
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors (abst  015) http://www.sciencedirect.com/science/article/pii/S1043661815002583
Dorsolateral periaqueductal gray matter CB1 and TRPV1 receptors exert opposite modulation on expression of contextual fear conditioning (abst–2015) http://www.sciencedirect.com/science/article/pii/S0028390815302161
A pathophysiological role of TRPV1 in ischemic injury after transient focal cerebral ischemia in mice (abst–2015) http://www.sciencedirect.com/science/article/pii/S0006291X15307270
Endogenous and Synthetic Cannabinoids as Therapeutics in Retinal Disease (full–2016) http://www.hindawi.com/journals/np/2016/8373020/
Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents (full–2016) http://pubs.rsc.org/en/content/articlehtml/2016/cs/c5cs00916b
Endocannabinoids as Guardians of Metastasis (full–2016) http://www.mdpi.com/1422-0067/17/2/230/htm
Fatty acid amide hydrolase inhibitors confer anti-invasive and antimetastatic effects on lung cancer cells (full–2016) http://www.impactjournals.com/oncotarget/index.php? journal=oncotarget&page=article&op=view&path[]=7592&path[]=21964
New insights into the yin and yang of the endocannabinoid system in health and disease (full–2016) http://onlinelibrary.wiley.com/doi/10.1111/bph.13451/full
A pro-nociceptive phenotype unmasked in mice lacking fatty-acid amide hydrolase (full–2016) http://mpx.sagepub.com/content/12/1744806916649192.long
Modulation of breast cancer cell viability by a cannabinoid receptor 2 agonist, JWH-015, is calcium dependent (full – 2016) https://www.dovepress.com/modulation-of-breast-cancer-cell-viability-by-a-cannabinoid-receptor-2-peerreviewed-fulltext-article-BCTT
Endovanilloids are potential activators of the trigeminovascular nocisensor complex (full–2016) http://thejournalofheadacheandpain.springeropen.com/articles/10.1186/s10194-016-0644-7
Modulation of cellular redox homeostasis by the endocannabinoid system (full–2016) http://rsob.royalsocietypublishing.org/content/6/4/150276
Beyond Cannabis: Plants and the Endocannabinoid System (full–2016) http://ge.tt/3Rgtrsa2
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology (full–2016) https://elifesciences.org/content/5/e14137
The synthetic cannabinoid WIN55,212-2 mesylate decreases the production of inflammatory mediators in rheumatoid arthritis synovial fibroblasts by activating CB2, TRPV1, TRPA1 and yet unidentified receptor targets (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4858820/
The involvement of TRPV1 in emesis and anti-emesis (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4843889/
Lipid mediators involved in the oxidative stress and antioxidant defence of human lung cancer cells (full–2016) http://www.sciencedirect.com/science/article/pii/S2213231716301252
Dual-Acting Compounds Targeting Endocannabinoid and Endovanilloid Systems-A Novel Treatment Option for Chronic Pain Management (full–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00257/full
Targeting Cannabinoid CB2 Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders (full–2016) http://journal.frontiersin.org/article/10.3389/fnins.2016.00406/full
Opposite roles of cannabinoid receptors 1 and 2 in hepatocarcinogenesis (full–2016) http://gut.bmj.com/content/65/10/1721.long
Elevated Systemic Levels of Endocannabinoids and Related Mediators Across the Menstrual Cycle in Women With Endometriosis (full–2016) http://journals.sagepub.com/doi/full/10.1177/1933719116630414
Spatial Distribution of the Cannabinoid Type 1 and Capsaicin Receptors May Contribute to the Complexity of Their Crosstalk (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5032030/
Can cannabinoids be a potential therapeutic tool in amyotrophic lateral sclerosis? (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5270417/
Involvement of TRPV1 in the Olfactory Bulb in Rimonabant-Induced Olfactory Discrimination Deficit (click “Full Text Links” for PDF–2016) http://www.ncbi.nlm.nih.gov/pubmed/26875559 Effect of cannabinoids on CGRP release in the isolated rat lumbar spinal cord (abst–2016) http://www.sciencedirect.com/science/article/pii/S0304394015303517
The endocannabinoid system in the human granulosa cell line KGN (abst-2016) http://www.sciencedirect.com/science/article/pii/S0303720716300065
Endocannabinoids in Cerebrovascular Regulation (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26825517
Protective role of cannabinoid CB1 receptors and vascular effects of chronic administration of FAAH inhibitor URB597 in DOCA-salt hypertensive rats (abst–2016) http://www.sciencedirect.com/science/article/pii/S0024320516301643
Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/26970948
Marine Metabolites Modulating CB Receptors and TRP Channels (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-101352
Endovanilloid control of pain modulation by the rostroventromedial medulla in an animal model of diabetic neuropathy (abst–2016) http://www.sciencedirect.com/science/article/pii/S002839081630079X
Electrophysiological Measurement of Cannabinoid-Mediated Synaptic Modulation in Acute Mouse Brain Slices (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27063786
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Fabp-1 gene ablation impacts brain endocannabinoid system in male mice (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27167970
Anti-inflammatory and antioxidant effects of a combination of cannabidiol and moringin in LPS-stimulated macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S0367326X16301150
TRPV1-FAAH-COX: The Couples Game in Pain Treatment (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27240888
Pharmacological hypothermia: a potential for future stroke therapy? (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27320243
The multiplicity of spinal AA-5-HT anti-nociceptive action in a rat model of neuropathic pain (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816305667
An update on PPAR activation by cannabinoids (abst–2016) http://www.ingentaconnect.com/search/article?option1=tka&value1=cannabinoid&sortDescending=true&sortField=prism_publicationDate&pageSize=10 &index=6
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Female Mice are Resistant to Fabp1 Gene Ablation-Induced Alterations in Brain Endocannabinoid Levels (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27450559
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9- tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303395
Metabolism of endocannabinoids (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27516570
The gastrointestinal tract – a central organ of cannabinoid signaling in health and disease (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27561826
Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPARα (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27623929
N-palmitoylethanolamide in the anterior cingulate cortex attenuates inflammatory pain behaviour indirectly via a CB1 receptor-mediated mechanism (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27649266
CB1 cannabinoid receptor-mediated anandamide signalling reduces the defensive behaviour evoked through GABAA receptor blockade in the dorsomedial division of the ventromedial hypothalamus (abst–2016) http://www.sciencedirect.com/science/article/pii/S0028390816301393
Differential Adulthood Onset mGlu5 Signaling Saves Prefrontal Function in the Fragile X Mouse (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27797833
Potential Future Pharmacological Treatment of Bladder Dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26990140
Cannabidiol as a Potential New Type of an Antipsychotic. A Critical Review of the Evidence (abst–2016) http://journal.frontiersin.org/article/10.3389/fphar.2016.00422/full
PKCβII-mediated cross-talk of TRPV1/CB2 modulates the glucocorticoid-induced osteoclast overactivity (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816310994
A dual inhibitor of FAAH and TRPV1 channels shows dose-dependent effect on depression-like behaviour in rats (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27938441
Expression of Cannabinoid Type 1 Receptors in Human Odontoblast Cells (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27989582
Inflammation of peripheral tissues and injury to peripheral nerves induce diferring effects in the expression of the calcium-sensitive anandamide-synthesising enzyme and related molecules in rat primary sensory neurons (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27997038
Phytocannabinoids: a growing family of plant natural products with increasing pharmacological and clinical importance (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0036-1596088
Somatostatin receptor 5 is a prominent regulator of signaling pathways in cells with coexpression of Cannabinoid receptors 1 (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/27984180
Pharmacology of cannabinoids in the treatment of epilepsy (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28087250
Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats (abst–2017) https://www.ncbi.nlm.nih.gov/pubmed/28112976


CBR-TRPV2 / TRANSIENT RECEPTOR POTENTIAL VANILLOID TYPE 2 CHANNEL
Multiple Changes in Peptide and Lipid Expression Associated with Regeneration in the Nervous System of the Medicinal Leech (link to PDF–2011) http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.713.3790&rank=102
Colon carcinogenesis is inhibited by the TRPM8 antagonist cannabigerol, a Cannabisderived non-psychotropic cannabinoid (full–2014) http://carcin.oxfordjournals.org/content/35/12/2787.long
Advances in Transient Receptor Potential Vanilloid-2 Channel Expression and Function in Tumor Growth and Progression (abst–2014) http://www.ncbi.nlm.nih.gov/pubmed/25001513
Nonpsychotropic Plant Cannabinoids, Cannabidivarin (CBDV) and Cannabidiol (CBD), Activate and Desensitize Transient Receptor Potential Vanilloid 1 (TRPV1) Channels in Vitro: Potential for the Treatment of Neuronal Hyperexcitability (abst–2014) http://pubs.acs.org/doi/abs/10.1021/cn5000524
The involvement of medial septum 5-HT1 and 5-HT2 receptors on ACPA-induced memory consolidation deficit: Possible role of TRPC3, TRPC6 and TRPV2 (full–2015) http://journals.sagepub.com/doi/full/10.1177/0269881115609021
Natural product modulators of transient receptor potential (TRP) channels as potential anti-cancer agents (full–2016) http://pubs.rsc.org/en/content/articlehtml/2016/cs/c5cs00916b
TRPV2 is a novel biomarker and therapeutic target in triple negative breast cancer (full–2016) http://www.impactjournals.com/oncotarget/index.php?journal=oncotarget&page=article&op=view&path%5B%5D=9663&path%5B%5D=30267
The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation (full–2016) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4927043/
Cryo-electron microscopy structure of the TRPV2 ion channel (full–2016) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4876856/
3D Structure of Protein That Guides the Immune System Uncovered (news & abst–2016) http://neurosciencenews.com/trpv2-ion-channel-immune-system-3448/
Marine Metabolites Modulating CB Receptors and TRP Channels (abst–2016) https://www.thieme-connect.com/DOI/DOI?10.1055/s-0042-101352
Cannabinoids for Symptom Management and Cancer Therapy: The Evidence (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27407130
Pure Δ9-tetrahydrocannabivarin and a Cannabis sativa extract with high content in Δ9- tetrahydrocannabivarin inhibit nitrite production in murine peritoneal macrophages (abst–2016) http://www.sciencedirect.com/science/article/pii/S1043661816303395
Potential Future Pharmacological Treatment of Bladder Dysfunction (abst–2016) https://www.ncbi.nlm.nih.gov/pubmed/26990140


CRIP1a / CANNABINOID RECEPTOR INTERACTING PROTEIN 1a
Architecture of cannabinoid signaling in mouse retina (full–2010) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2982216/
Striatal CB1 and D2 receptors regulate expression of each other, crip1a and delta opioid systems (full–2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3697910/
Cannabinoid receptor interacting protein (CRIP1a) attenuates CB1R signaling in neuronal cells (full–2015) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4332989/
Cannabinoid Receptor–Interacting Protein 1a Modulates CB1 Receptor Signaling and Regulation (full–2015) http://molpharm.aspetjournals.org/content/87/4/747.long Cannabinoid Receptor Interacting Protein (CRIP) 1a competition with β-arrestin for CB1 receptor binding sites (link to PDF–2016) http://molpharm.aspetjournals.org/content/early/2016/11/28/mol.116.104638.long Cannabinoid Receptor Interacting Protein (CRIP1a) suppresses agonist-driven CB1 receptor internalization, and regulates receptor replenishment in an agonist-biased manner (abst–2016) http://www.ncbi.nlm.nih.gov/pubmed/27513693
top